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Abstract 
Intestinal inflammation is a major welfare issue for horses causing colic, diarrhoea and 
an inability to thrive. One of the diagnoses with poor prognosis is inflammatory bowel 
disease (eqIBD). Equine IBD comprises different entities of chronic idiopathic 
enteropathies, namely eosinophilic gastroenteritis, granulomatous enteritis and 
lymphoplasmacytic enterocolitis. An exaggerated immune reactivity towards still 
unidentified antigens is suggested in the disease. The aim of this thesis was therefore to 
elaborate methods to characterize cellular infiltrations and to determine cytokine 
profiles associated with various forms of eqIBD. Jejunal tissues were used to describe 
the immune cell populations in situ in healthy horses and in well characterised IBD-
afflicted horses. T cells, regulatory T cells, B cells, IgM- IgG- and IgA-secreting 
plasma cells and MHC II-expressing cells were labelled by immunohistochemistry and 
quantified by image analysis. The inflammation in IBD horses was dominated by T 
cells and MHC II-expressing cells, whereas B cells and plasma cells were decreased 
compared with healthy horses. These features were most prominent in granulomatous 
IBD. The regulatory T cells followed the infiltration pattern of T cells, but were not 
significantly increased in diseased horses. Thus the histopathology in the studied forms 
of eqIBD shows similarities with a delayed hypersensitivity reaction. Seven reference 
genes were evaluated and their optimal combination determined for seven equine 
intestinal segments (the duodenum, mid-jejunum, ileum, caecum, right ventral and 
dorsal colon and rectum). Segments from healthy horses expressed IL-12, IL-17A, IL-
23, TLR4, but not IFN-α. The relative expression of the three interleukins and TLR4 
was analysed using quantitative PCR in rectal biopsies showing chronic or chronic 
active simple proctitis from horses with clinical signs of eqIBD. Horses with chronic 
active proctitis had increased expression of IL-17A and TLR4 compared with healthy 
horses, whereas horses with chronic proctitis had decreased expression of IL-12, 
indicating a TH17 involvement in chronic active disease. Taken together, techniques 
were established to discern patterns of immune reactions and could demonstrate 
differences between entities when applied to eqIBD material. 
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Abbreviations 
β2M β2 microglobulin 
AEC 3-amino-9-ethylcarbazole 
CASP Chronic active simple proctitis 
CD Cluster of differentiation 
cDNA Complementary deoxyribonucleic acid CpG-ODN Deoxycytidylate-phosphate-deoxyguanylate     oligodeoxynucleotide  Cq Quantification cycle 
CSP Chronic simple proctitis 
CXCL-8 Chemokine (C-X-C motif) ligand 8, formerly IL-8 
DAB 3,3’-diaminobenzidine 
EDTA Ethylenediaminetetraacetic acid 
EEG Equine eosinophilic gastroenteritis 
EGE Equine granulomatous enteritis 
FoxP3 Forkhead box P3 
GALT Gut-associated lymphoid tissue 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
H2Atype1 Histone H2A type 1 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPRT Hypoxanthine-guanine phosphoribosyltransferase 
HRP Horseradish peroxidase 
IBD Inflammatory bowel disease 
IFN Interferon Ig Immunoglobulin 
IHC Immunohistochemistry 
IL Interleukin 
LPE Lymphoplasmacytic enterocolitis 
LPS Lipopolysaccharide 
MD-2 Lymphocyte antigen 96 
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MHC Major histocompatibility complex 
mRNA Messenger ribonucleic acid 
NOD Nucleotide-binding oligomerization domain-containing protein 
PBMC Peripheral blood mononuclear cell 
PMA Phorbol myristate acetate 
qRT-PCR Quantitative reverse transcriptase polymerase chain reaction 
RPL32 60S ribosomal protein L32 
RPMI Roswell Park Memorial Institute 
SDHA Succinate dehydrogenase complex subunit A 
TCR T cell receptor 
TFRC Transferrin receptor 1 protein coding 
TH T helper cells 
TLR Toll-like receptor 
TREGS Regulatory T cells 
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1 Background 
Intestinal health is a great concern in horses as gastrointestinal disorders are a 
major reason for medical intervention (Archer & Proudman, 2006). Depending 
on the duration, severity and distribution of lesions, the clinical presentation 
may include different symptoms such as colic, diarrhoea and/or altered 
nutritional status. One of the chronic intestinal inflammations with poor 
prognosis is referred to as equine inflammatory bowel disease (IBD). The term 
IBD includes sporadically occurring chronic idiopathic enteropathies. 
Histologically distinguishable entities of IBD are equine eosinophilic 
gastroenteritis (EEG), equine granulomatous enteritis (EGE) and lympho-
plasmacytic enterocolitis (LPE).  
The disease complex IBD has been recognised in humans since the early 
1900s and in recent decades it has also been diagnosed in cats and dogs 
(Jergens et al., 1992) as well as cattle (Fushimi et al., 2015; Cebra et al., 1998). 
In horses, these enteropathies have been described since the 1970s and the 
clinical aspects, as well as histological features, are well characterized 
(Schumacher et al., 2000). The pathogenesis of IBD is proposed to involve an 
imbalanced immune reaction towards the commensal intestinal flora or other 
antigens in the intestinal lumen. However, little is known about the 
immunological processes in the equine disease development. The present thesis 
sought to develop methods to study equine intestinal immune responses, to 
discern pathological events in the development of equine IBD and to 
distinguish differences between the histological types of the disease. 
1.1 Clinical presentation of equine IBD 
Equine IBD can affect horses of both sexes, including geldings. Documented 
cases of IBD have ranged in age from 7 months to 26 years, although afflicted 
horses are often young adults, mainly 2-12 years. Young horses, aged 0-5 
years, are at higher risk for developing idiopathic focal eosinophilic enteritis 
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(IFEE) compared with other age groups (Archer et al., 2014; Kemper et al., 
2000). Afflicted horses have been reported for various breeds; American Paint 
horse, American Paso Fino (La Perle et al., 1998; Schumacher et al., 1990), 
Arabian, Appaloosa (Scott et al., 1999), crossbreds, Hanoverian (Southwood et 
al., 2000; Clark, 1988), Hunter (Edwards et al., 2000), Icelandic horse (Paper 
IV), Irish draft (Archer et al., 2006), miniature horse (Wong & Crisman, 2004), 
Morgan (Scott et al., 1999), National show horse (Scott et al., 1999), Quarter 
horse, Standardbred, Tennessee walking horse (Schumacher et al., 1990), 
Thoroughbred, Warmblood and ponies. Neither Kemper et al. (2000) nor 
Archer et al. (2006) detected a breed predisposition in their material, but 
Standardbreds have been implicated as overrepresented (Schumacher et al., 
2000).  
Varying clinical manifestations are seen in horses suffering from equine 
IBD. Commonly reported clinical findings are colic, weight loss and/or 
diarrhoea, while anaemia, subcutaneous oedema and dermatitis are less 
frequent. Rare presentations include rectal prolapse (Gibson et al., 2001) and 
high fever (Bosseler et al., 2012). 
Colic is a wide term and includes a vast spectrum of aetiologies. If a horse 
has a colic episode there is a high risk of recurrence, even if the horse is not 
IBD-afflicted (Scantlebury et al., 2011; Cohen & Peloso, 1996). In IBD horses, 
colic is thought to be due to a reduced mobility of the intestine, ileus and 
subsequently intestinal distention (Scott et al., 1999) and can occur without any 
of the other characteristic clinical signs of IBD (Bassage et al., 1997). 
According to Archer (2009), partial obstruction of the intestinal lumen is one 
of the most common causes of recurrent colic and includes strictures as a 
consequence of IBD lesions. Horses with IBD can also present with acute 
endotoxaemia as a consequence of the intestinal inflammation (Grulke et al., 
2008). 
Malabsorption resulting in hypoalbuminaemia, hypoproteinaemia and 
weight loss may be caused by reduced absorption through the intestinal 
mucosa, reduced transportation of nutrients, and/or maldigestion (Mair et al., 
2006; Roberts, 1983). The severity of the albumin and protein losses is 
correlated to poor prognosis (Metcalfe et al., 2013). Infectious diseases are the 
main cause of malabsorption in foals, whereas the most common cause in adult 
horses is infiltrative diseases (Mair et al., 2006). In IBD the intestine is 
inflamed, occasionally flattened with ulcerations and lymphangiectasis. This 
leads to reduction in plasma protein by loss of intestinal fluids into the 
intestinal lumen, as well as reduced absorptive properties of the intestinal 
epithelium (Roberts, 1983; Meuten et al., 1978).  
12 
The symptoms of IBD can appear recurrently, intermittently or even 
seasonally (Archer et al., 2014; Schumacher et al., 2000; Southwood et al., 
2000). The duration of disease varies from an acute onset to a lengthy chronic 
illness. The acute manifestation occurs almost exclusively in cases of 
eosinophilic IBD (Archer et al., 2006; Edwards et al., 2000; Schumacher et al., 
2000), whereas other clinical parameters are mainly non-exclusive for the 
different entities. It is noteworthy that other diseases of the intestinal tract can 
display the same clinical signs as IBD, making diagnosis challenging.  
1.2 Diagnosing equine IBD 
There is no laboratory test that specifically can diagnose IBD. Instead multiple 
tools are used to identify and exclude other diseases. In the clinic, a 
presumptive diagnosis of equine IBD can be made when all other plausible 
diagnoses have been excluded. The relevant differential diagnoses for IBD 
vary depending on the presenting clinical signs (Table 1). Some of the 
differential diagnoses are regarded as highly unlikely based on the prevalence 
in an area and the susceptibility of the horse. Several diagnoses can be 
excluded during clinical examinations, whereas others are excluded in specific 
analysis, such as microbiology testing and radiological examinations.  
1.2.1 Clinical pathology 
The use of oral D-xylose or glucose absorption test for screening of small 
intestinal dysfunction may show normal, reduced or delayed uptake by the 
mucosa for the given sugars (Mair et al., 1991). A disturbed uptake is not 
diagnostic for IBD, but indicative of infiltrative disease (Roberts, 1983). In 
horses with eosinophilic IBD a partial malabsorption or a delayed uptake can 
be seen, whereas horses with granulomatous IBD or lymphoma can display a 
severe malabsorption (Mair et al., 1991; Lindberg et al., 1985). Using 
haematology and biochemistry,  some but not all IBD-afflicted horses display 
deviations from normal. Anaemia, hypoproteinaemia, hypoalbuminaemia and 
elevated liver enzymes have been noted in all the various IBD entities 
(Schumacher et al., 2000). Concerning white blood cell counts, neutrophilia 
can be found in both EGE and EEG, and neutropenia can be present in EGE 
(Schumacher et al., 2000; Gibson & Alders, 1987). The change in neutrophil 
count is presumed to reflect secondary events, such as endotoxaemia. 
However, blood eosinophilia is only described in the eosinophilic form of IBD 
(Gibson & Alders, 1987; Platt, 1986; Lindberg et al., 1985), but has also been 
found in conjunction with intestinal lymphoma (Duckett & Matthews, 1997). 
Furthermore, Lindberg et al. (1985) reported varying immunoglobulin levels in   
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 Table 1. Differential diagnoses for the main clinical symptoms of equine IBD 
Chronic/recurrent colic Hypoproteinaemia/weight loss Chronic diarrhoea 
Alimentary lymphoma Alimentary lymphoma  Alimentary lymphoma 
Crib-biter/windsucker1,2 Amyloidosis Disruption of intestinal flora 
Congestive heart failure* Congestive heart failure Enteric bacterial infection 
Dental abnormalities1 Dental abnormalities    Brachyspira spp.8, 9 
Displacement of the colon Enteric bacterial infection    Salmonellosis 
Enteric bacterial infection    Lawsonia intracellularis Enteric parasitic infection 
   Lawsonia intracellularis    Mycobacterium avium spp.    Cyathostominosis 
Enteric parasitic infection    Rhodococcus equi    Giardia spp.10 
   Cyathostominosis Enteric fungal infection    Strongylus vulgaris 
   Strongylus vulgaris    Aspergillus fumigatus Hyperlipidaemia 
Enterolithiasis    Histoplasma capsulatum Impaction 
Gas colic, intermittent Enteric parasitic infection Intestinal muscular hypertrophy6 
Gastrointestinal ulceration    Cyathostominosis Liver disease 
Impaction    Parascaris equorum NSAID toxicity/right dorsal colitis 
Intestinal adhesions External bleedings or burns Peritonitis 
Intestinal diverticulum Gastrointestinal ulceration Sand ingestion/accumulation 
Intestinal fibrosis3 Grass sickness5  
Intestinal muscular hypertrophy4 Immunodeficiency  
Intussusception Intestinal muscular hypertrophy4, 6  
Liver disease Kidney disease  
Miscellaneous neoplasia Liver disease  
Neural dysfunction/ grass sickness Lymphatic obstruction  
NSAID toxicity/right dorsal colitis Malnutrition  
Obstruction, intra- or extraluminal Miscellaneous neoplasia  
Peritonitis NSAID toxicity/right dorsal colitis  
Sand ingestion/accumulation Pancreatic insufficiency  
Urogenital disease Pleuritis/peritonitis  
 Pulmonary disease7  
   
Modified after: Archer (2009), Kalck (2009), Lecoq & Lavoie (2009), Mair et al. (2006), *Mair & Hillyer (1997), 
Love et al. (1992) and Roberts (1983) 
 
1. Scantlebury et al. (2011) (Scantlebury et al., 2011) 
2. Escalona et al. (2014) (Escalona et al., 2014) 
3. Schultheiss et al. (1995) (Schultheiss et al., 1995) 
4. Chaffin et al. (1992) (Chaffin et al., 1992) 
5. Wylie & Proudman (2009) 
6. Cordes & Dewes (1971) (Cordes & Dewes, 1971) 
7. Dickinson & Lori (2002) ( 
8. Hampson et al. (2006) (Hampson et al., 2006) 
9. Shibahara et al. (2005) (Shibahara et al., 2005) 
10. Kirkpatrick & Skand (1985).  
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blood from IBD horses. Reduced IgG(T) was detected in cases of both EEG 
and EGE horses, whereas IgG was only reduced in EGE cases and IgM only in 
EEG cases. However, the values for IgM did not reach the cut off value for 
IgM deficiency as defined by Perkins et al. (2003).  
The clinical relevance and functionality of immunoglobulin discrepancies in 
the serum of IBD horses compared with healthy horses are not known, 
butcould result from a disturbed humoral immune response as described for 
human IBD patients (Rai et al., 2015) or a loss through the inflamed intestine 
(Lindberg et al., 1985). Taken together, clinical pathology can indicate the 
presence of IBD in horses and be used to establish a plausible diagnosis. The 
diagnosis then needs to be verified and classified by histological evaluation of 
intestinal tissue.  
1.2.2 Intestinal biopsy 
Various approaches to collect equine intestinal biopsy material for 
histopathology examination are possible (Kalck, 2009). Endoscopy can be used 
to both visualize the mucosa and sample it, but collected tissue samples are 
small and several sampling sites are needed. In gastroscopy, the stomach, the 
duodenum and, in miniature breeds, the jejunum can be sampled. Colonoscopy 
can be used to sample the small colon and the rectum. To collect better sized 
rectal sample, rectal biopsy can be applied (Kaikkonen et al., 2014; Lindberg et 
al., 1996). No visualization of mucosa is then possible, but mucosa and 
submucosa are included in the samples, facilitating histopathological diagnosis. 
Evaluation of the significance of rectal biopsies revealed that one third to half 
of them were diagnostic of the specific type of inflammation in the gut, 
revealed at necropsies of diseased horses (Barr, 2006; Lindberg et al., 1996). 
Furthermore, full-thickness intestinal biopsy or material from intestinal 
resections can be made at exploratory surgery. Necropsy is the most exhaustive 
method for diagnosing IBD, as all intestinal segments can be evaluated, grossly 
and histologically, facilitating exclusion of differential diagnoses.  
1.3 Equine eosinophilic gastroenteritis (EEG) 
Idiopathic inflammatory enteropathy in horses, characterised by infiltration of 
eosinophils, was first named as chronic eosinophilic gastroenteritis (Pass & 
Bolton, 1982) and later as eosinophilic granulomatosis (Lindberg et al., 1985). 
Gross lesions can be seen distributed intermittently or segmentally in any part 
of the gastrointestinal tract (Schumacher et al., 2000). The afflicted tissue may 
display macroscopic mucosal ulcerations, serosal plaques and circumferential 
band-formed areas of inflammation. Circumferential mural bands have been 
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suggested to be pathognomonic of EEG (Scott et al., 1999) and are composed 
of inflammatory cells and fibrosis. Depending on the distribution of the gross 
lesions in the intestine, numerous other terms have been used, i.e. eosinophilic 
enterocolitis (Gibson & Alders, 1987), idiopathic focal eosinophilic enteritis 
(IFEE) (Southwood et al., 2000), segmental eosinophilic colitis (Edwards et 
al., 2000) or diffuse eosinophilic enteritis (Mäkinen et al., 2008). In 
accordance with Schumacher et al. (2000), intestinal eosinophilic equine IBD 
will subsequently be referred to as equine eosinophilic gastroenteritis / 
enterocolitis (EEG). IFEE has been suggested to be a sub-entity of EEG 
(Archer et al., 2006; Proudman & Kipar, 2006) as the described horses have 
the characteristic mural bands and a more acute clinical presentation than other 
EEG-afflicted horses. The mural bands may cause constriction of the intestinal 
lumen resulting in luminal obstruction, proximal distention of the intestine and 
acute clinical presentation (Archer et al., 2006; Perez Olmos et al., 2006; Scott 
et al., 1999).  
In EEG, intestinal tissue eosinophilia is histologically accompanied by 
lymphocytes, macrophages, plasma cells and mast cells (Lindberg et al., 1996; 
Pass & Bolton, 1982), which are present in the mucosa, submucosa and may be 
transmural. The lymphocytic infiltrates in EEG lesions have been shown to be 
dominated by T cells (Bosseler et al., 2012; Mäkinen et al., 2008). Other 
features of the entity are microscopic ulcerations of the mucosa, partial 
blunting of villi, fibrosis and occasional goblet cell hyperplasia (Lindberg et 
al., 1996; Lindberg et al., 1985). Eosinophilic granulomas with a central core 
of degenerate eosinophils, surrounded by epithelioid and giant cells often 
occur.  
Tissue eosinophilia and eosinophilic granulomas outside the intestinal tract 
is not uncommon. Eosinophilic infiltrates in the pancreas, liver, mesenteric 
lymph nodes, skin and lung are all described (La Perle et al., 1998; Hillyer & 
Mair, 1992; Sanford, 1989; Lindberg et al., 1985; Nimmo Wilkie et al., 1985; 
Pass & Bolton, 1982). In one described case, severe lung involvement resulted 
in secondary cardiac failure (Pucheu-Haston & Del Piero, 2013). The terms 
hyper-eosinophilic syndrome (Schumacher et al., 1991) and multisystemic 
eosinophilic epitheliotropic disease (MEED) (Nimmo Wilkie et al., 1985) have 
been used to encompass these additional features. MEED is the more accepted 
term. Notably, the term can also include horses that display eosinophilic 
lesions in several organs without lesions in the intestinal tract (Nimmo Wilkie 
et al., 1985). Two horse afflicted by chronic idiopathic enteritis and tissue 
basophilia have been described (Gibson & Alders, 1987; Pass et al., 1984). The 
observed inflammation shared features with EEG including infiltration of 
eosinophils, lymphocytes, plasma cells and macrophages, in addition to the 
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observed basophils. In the review of equine IBD by Schumacher et al. (2000), 
both these horses were included in the MEED classification. 
1.3.1 Eosinophilic gastrointestinal diseases in other species 
In humans, the condition idiopathic eosinophilic gastrointestinal disorder 
(EGID) is characterized by accumulation of eosinophilia in any segment of the 
intestine, associated with abdominal pain and failure to thrive (Rothenberg, 
2004). The disease is suggested to be caused by environmental factors, such as 
food antigens, in genetically susceptible patients (Jawairia et al., 2012; Zuo & 
Rothenberg, 2007). Eotaxin, IL-4, IL-5 and IL-13 are increased in several of 
the disorders included in EGID and delayed TH2-type immune responses are 
considered involved. Even if the disease shares many features, it is not 
considered an entity in the human IBD complex. EGID may precede IBD in 
some patients (Mutalib et al., 2015), suggesting a possible link between the 
pathogenesis of the two diseases.  
Cattle also have been noted to suffer from idiopathic eosinophilic enteritis 
(Fushimi et al., 2015; Cebra et al., 1998). Antibiotic or antihelmintic treatment 
was not effective, whereas glucocorticoid treatment induced remission. Among 
small companion animals, both cats and dogs can be affected by eosinophilic 
enteritis (Sattasathuchana & Steiner, 2014; Jergens et al., 1992). A cat held in a 
closed facility developed eosinophilic IBD, which may suggest a non-
infectious aetiology (Griffin & Meunier, 1990). In dogs, oxidative stress and 
dysbiosis were thought to be the underlying cause for developing disease 
(Minamoto et al., 2015).  
1.4 Equine granulomatous enteritis (EGE) 
Granulomatous diseases can occur in various equine organs, such as the 
alimentary tract, respiratory tract, skin, or spread systemically (Costa, 2016). If 
an antigen is not eliminated and/or a continuous inflammatory stimulus occurs, 
macrophages can cluster together at the site to form granulomas. When 
macrophages cluster, T cells also accumulate at the site and recruit further 
effector cells, such as eosinophils (Co et al., 2004).  
Equine granulomatous enteritis (EGE) was first described in the 1970s 
(Merritt et al., 1976; Cimprich, 1974). The inflammation is characterised by 
infiltration of macrophages, lymphocytes, epithelioid and giant cells that form 
granulomas or diffuse granulomatous infiltrates. The granulomas are non-
necrotizing and are occasionally delineated by fibroblasts. Lesions are found in 
the mucosa, submucosa or as transmural infiltrates (Lindberg, 1984; Cimprich, 
1974). Villous atrophy, crypt hyperplasia, lymphangiectasis, oedema, mucosal 
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erosion and/or ulceration are common features. When the EGE-afflicted 
intestinal mucosa was observed using electron microscopy, shortened and 
widened villi, some fused, occurring as ridges, or a complete lack of villous 
projections was revealed (Lindberg & Karlsson, 1985). Granulomatous lesions 
are, apart from the intestine, common in mesenteric lymph nodes and may also 
be seen in the liver, spleen, pancreas, kidney, endometrium, synovial 
membranes and skin (Lindberg, 1984; Cimprich, 1974).  
Gross lesions are more often diffuse in EGE than the lesions observed in 
EEG (Schumacher et al., 2000). The lesions are mainly present in the small 
intestine, but occasionally also in the large intestine (Lindberg, 1984; 
Cimprich, 1974). The mucosa is often grossly altered, displaying thick 
intestinal folds, sometimes with a corrugated to cobblestone appearance or a 
flattened surface (Lindberg, 1984; Meuten et al., 1978). At necropsy, apparent 
dissemination to regional lymph nodes and a general thickening of the 
intestinal wall are described (Lindberg, 1984; Roberts & Kelly, 1980; Meuten 
et al., 1978).   
1.4.1 Granulomatous gastrointestinal diseases in other species 
In humans, idiopathic granulomatous colitis is referred to as Crohn’s disease 
and is one of the two major entities in human IBD. It shares features with EGE 
and also Johne’s disease in cattle (Greenstein, 2003). Johne’s disease is caused 
by Mycobacterium avium subspecies paratuberculosis, but it is heavily debated 
whether mycobacteria may be a causative agent in Crohn’s disease. Instead, 
Crohn’s disease is thought to be driven by an exaggerated TH1 and TH17 
response, which overwhelms the anti-inflammatory effects of TREGS (Brand, 
2009). 
Young dogs of the Boxer or French bulldog breed may present with 
granulomatous colitis / histiocytic ulcerative colitis (Churcher & Watson, 
1997). Microscopically, periodic acid Schiff (PAS)-positive macrophages are 
characteristic and infiltration of T cells, IgG plasma cells, MHC II-expressing 
cells and granulocytes appear (German et al., 2000). This granulomatous 
disease is thought to be either driven or exaggerated by invasive Escherichia 
coli, and antibiotic treatment can induce remission (Mansfield et al., 2009). In 
cats, a granulomatous form of IBD exists, but is rare (Day & Hall, 2008). 
Mycobacterium paratuberculosis has been detected by PCR in intestinal 
material from both cats and dogs (KuKanich et al., 2013). However, positive 
PCR results did not correlate to alimentary illness and animals diagnosed with 
IBD were negative for the bacterium.  
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1.5 Lymphoplasmacytic enterocolitis (LPE) 
Lymphoplasmacytic enterocolitis (LPE) is rarely documented in horses 
(Schumacher et al., 2000). In LPE, the lamina propria is infiltrated by 
lymphocytes and plasma cells, which occasionally also are noted in the 
submucosa. Thickened villi (MacAllister, 1990) and villous blunting (Kemper 
et al., 2000) or atrophy (Clark, 1988) are reported features. Lesions are in 
general in the small intestine and occasionally also in the large intestine 
(Kemper et al., 2000). Grossly, a thickened intestinal wall can be present, as a 
result of submucosal oedema and sometimes muscle hypertrophy (Kemper et 
al., 2000; MacAllister, 1990). The mucosa may be oedematous, segmentally to 
diffusely congested, and multifocally ulcerated. Mesenteric lymph nodes may 
be oedematous (MacAllister, 1990) or displaying lymphoid hyperplasia (Clark, 
1988).   
1.5.1 Lymphoplasmacytic gastrointestinal diseases in other species 
In humans, no specific lymphoplasmacytic entity is referred to in the IBD 
complex. However in ulcerative colitis, which is part of human IBD, 
lymphocytes and plasma cells increase in the basal lamina propria. The 
characteristic lesions involve architectural alterations of the mucosa and 
infiltration of neutrophils. Previously, the disease was thought to be TH2 
driven, but is now called an atypical TH2 response where TH17 play a role in 
disease development (Roda et al., 2011; Xavier & Podolsky, 2007). In human 
microscopic colitis, primarily lymphocytes infiltrate the lamina propria and 
epithelium for no known reason, causing diarrhoea (Mellander et al., 2016). 
The disorder is generally not considered an entity of human IBD, although 
some investigators have suggested its inclusion (Jegadeesan et al., 2013) and 
some patients show both microscopic colitis and IBD (Mellander et al., 2016).  
For cats and dogs, the lymphoplasmacytic IBD is the dominant entity in the 
disease complex (Jergens et al., 1992). In the lymphocytic infiltration of dogs, 
TH1, but not TH17, are suggested to contribute to the lesions, and TREGS are 
significantly lowered (Maeda et al., 2015; Schmitz et al., 2012; Ridyard et al., 
2002). For cats, the number of T cells was not significantly different in healthy 
cats compared with cats affected by IBD, but lamina propria CD8 positive cells 
decreased in IBD-afflicted cats and MHC II-expressing cells increased (Waly 
et al., 2004). 
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1.6 General aspects of equine mucosal immunology 
For a deeper understanding of the mechanism underlying the various IBD 
lesions, further knowledge of equine intestinal immune system is needed. 
Equine mucosal immunology has mainly been studied in the respiratory tract, 
while less is known of the intestine. The gut-associated lymphoid tissue 
(GALT) is present in both the small and large intestine of the horse as 
lymphoid follicles, Peyer’s patches, diffuse lymphoid infiltrates of the lamina 
propria and mesenteric lymph nodes. Lymphoid and myeloid cells, as well as 
eosinophils, are found throughout the gastrointestinal tract of healthy 
individuals, whereas neutrophils are scarce and basophils are rarely seen. Mast 
cells are present, but not routinely stained or immunolabelled for confirmation. 
A general view of the intestinal immune system with emphasis on the 
parameters considered in the present thesis is summarised in Fig. 1.  
 
 
 
Figure 1.  
A simplified illustration of intestinal immune reactions when encountering an antigen. When an 
antigen breaches the mucosal epithelial barrier resident innate immune cells excrete cytokines and 
chemokines, for further recruitment of innate immune cells. Depending on the type of antigen, 
neutrophils and eosinophils are attracted, ultimately releasing their antimicrobial molecules by 
degranulation. Antigen can be recognised by dendritic cells in the subepithelial dome, being 
delivered to the lamina propria by transcytosis through M-cells or by sampling from the intestinal 
lumen.  Antigens are recognized by innate immune cells through pattern recognition receptors 
that bind conserved ligands expressed by pathogens, such as lipopolysaccharide (LPS) on Gram-
negative bacteria. Binding of LPS to TLR4 and the co-receptors CD14 and MD-2 triggers an 
intracellular signalling cascade resulting in gene activation with cytokine and chemokine 
production.  Dendritic cells present antigen to cells of the Peyer’s patch or migrate to a 
mesenteric lymph node. Lymphatic vessels transport antigen to the mesenteric lymph nodes either 
as free antigen or as material engulfed in dendritic cells.  In the GALT (Peyer’s patch or lymph 
node) antigen fragments are presented to naïve T cells on MHC II by dendritic cells.  
Interaction between MHC II and the T cell receptor stimulates up-regulation of costimulatory 
molecules and activation of T cells under influence of cytokines produced by the antigen 
presenting cell. Activated T cells bind to B cells presenting the same antigen. T cell-produced 
cytokines drive B cell proliferation and immunoglobulin class-switching, and the binding sustains 
the growth of the T cells. Activated T cells and B cells leave the GALT via lymphatic vessels and 
enter the systemic blood circulation.  From the blood circulation, activated lymphocytes home 
to the gut via high endothelial venules with B cells differentiating to plasma cells and T cells 
affecting immune cells in the lamina propria.  The type of T helper cell response is influenced 
by the overall cytokine milieu and promotes an inflammatory reaction or immune tolerance.  At 
inflammation, the T cells exert their effects excreting cytokines and chemokines, accumulating 
innate cells ultimately forming granulomas.  If the antigen encountered is recognised as 
harmless, homeostasis prevails. In homeostasis, induced regulatory T cells produce IL-10 and 
TGF-β favouring IgA production.  
For simplicity, the mucus layers are not illustrated. Abbreviations in the figure: B = B cell; DC = 
dendritic cell; fDC = follicular dendritic cell; IEL = intraepithelial lymphocytes; Ig = 
immunoglobulin; MØ = macrophage; MLN = mesenteric lymph node; T = T cell; TCR = T cell 
receptor; TH = T helper cells; TH0 = naïve T cell 
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1.6.1 Pattern recognition receptors and cytokines 
Pattern recognition receptors (PRRs) are molecules expressed by innate 
immune cell and recognise conserved motifs on antigens (pathogen-associated 
molecular patterns; PAMPs) or structures on dying cells (damage-associated 
molecular patterns; DAMPs). The Toll-like receptor group (TLRs) recognises 
extracellular or endosomal antigens and there are 12 known TLRs in human 
(Akira et al., 2006). The first TLR described in humans is now known as TLR4 
(Medzhitov et al., 1997). TLR4 is expressed on macrophages as well as 
dendritic cells and recognises lipopolysaccharide (LPS) from bacteria, but also 
structures from fungi, parasites and virus (Akira et al., 2006). In the TLR4 
receptor complex, CD14 binds LPS and subsequently associates with the TLR4 
and MD-2 dimer (Guha & Mackman, 2001). In the healthy human intestinal 
epithelium, TLR4 expression is barely detected, but the expression is increased 
in IBD (Cario & Podolsky, 2000).  
In horses, TLR4 is expressed in healthy lung tissue and is increased after 
infusion with LPS (Singh Suri et al., 2006) and in respiratory airway 
obstruction (Berndt et al., 2007). The receptor is expressed in the alveolar 
macrophages, endothelium and bronchial epithelium in lungs and in 
macrophages of lung vessels (Singh Suri et al., 2006). TLR4 can also be 
induced in lamellar tissue of the horse’s hoof after induction of 
hyperinsulinaemia (de Laat et al., 2014). In the endometrium, TLR4 is 
expressed constitutively, and is not affected by insemination (Nash et al., 
2010). Due to its increased expression in human IBD and the known 
expression in horses, TLR4 was included in the gene expression analysis of 
equine IBD horses, in the present thesis. 
Cytoplasmic receptors including the NOD-like receptors (NLRs) 
complement the TLRs to detect intracellular antigen. One NLRs extensively 
studied in human IBD is the NOD2 receptor that recognises muramyl 
dipeptide, a degradation production from most bacteria (Girardin et al., 2003). 
NOD2 is highly conserved between species and in horses the gene is located on 
chromosome 3 (Boyle et al., 2013). All TLRs and NOD2 signal via the 
transcription factor nuclear factor-kappaB (NF-κB) (Hu et al., 2010; Kawai & 
Akira, 2007). The activation of NF-κB leads to its translocation from the 
cytoplasm into the nucleus, where it activates the cell and, amongst other 
effects, increases the transcription of genes encoding pro-inflammatory 
cytokines.  
Cytokines are small proteins that function as signal substances between 
different cells and can be organised into categories; lymphokines, monokines, 
chemokines, interferons and interleukins. Cytokines can be seen as 
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immunomodulating agents that regulate both innate and adaptive immune 
responses and “communicate” with cells of other organ systems. In the only 
previous study of cytokine expression in equine IBD, expression of the pro-
inflammatory cytokine TNFα was increased in IBD-afflicted horses, whereas 
expression of IL-2, IL-4, IL-5, IL-10 and TGF-β was the same as in healthy 
horses. In accordance, TNFα is increased in human IBD and chosen as a target 
for immunotherapy (Ahluwalia, 2012). Other cytokines of interest in human 
IBD are IL-17A and IL-23, possibly important for tissue destruction in the 
disease (Neurath, 2014). These TH17-associated cytokines are also proposed, 
but not proven, to be involved in the development of feline and canine IBD 
(Allenspach, 2011). The present thesis focuses on the expression of the 
cytokines IFN-α, IL-12, IL-17 and IL-23.  
IFN-α and IFN-γ 
Interferons (IFN) are commonly divided into type I IFNs (including IFN-α, -β, 
-ε, -ω, -κ, -v, -δ, -τ and -ζ), type II IFNs (IFN-γ) and type III IFNs (IFN-λ1, - 
λ2, -λ3). In horses, an additional type I IFN has been describe, IFN-μ, which is 
inducible in equine PBMC (Detournay et al., 2013). Type I IFNs are most 
known for their interference with viral infections. IFN-α production increases 
at viral infection, but can also be increased in autoimmune diseases (Ning et 
al., 2011). In horses, IFN-α is e.g. induced in equine tracheal cells after equine 
herpes virus and in blood after equine influenza virus infection (Quinlivan et 
al., 2007).  
Type II IFN, i.e. IFN-γ, is associated with T helper cell (TH) 1 responses. 
Human IBD patients have increased levels of IFN-γ in their blood (Singh et al., 
2016) and IFN-γ positive cells are increased in the lamina propria of one entity 
of human IBD (Crohn’s disease) (Camoglio et al., 1998). In horses, IFN-γ is 
e.g. increased in blood after a Toxoplasma gondii infection and in 
bronchoalveolar lavage fluid in horses with inflammatory airway disease (IAD) 
(Do Carmo et al., 2015; Richard et al., 2014). At a pulmonary Rhodoccoccus 
equi infection in horses IFN-γ is upregulated, and a local TH1 immune response 
in the lungs is suggested to clear the pathogen (Hines et al., 2003).  
IL-12 and IL-23 
IL-12 and IL-23 are heterodimeric cytokines and share one subunit (p40) 
whereas the other subunit is unique (IL-12; p35 and IL-23; p19). Both IL-12 
and IL-23 are regarded as pro-inflammatory cytokines (Vignali & Kuchroo, 
2012) and can be secreted by macrophages and dendritic cells. IL-12 directs 
naïve T cells to a TH1 response, whereas IL-23 stabilizes the TH17 subset (Wu 
et al., 2013). Previously, IL-12 was thought to have a pivotal role in the 
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progression of chronic intestinal inflammations and other immune-mediated 
inflammations as the diseases were ameliorated by antibodies against IL-12p40 
(Neurath et al., 1995). Later, after the discovery of IL-23, some of the effects 
of neutralising the p40 subunit were concluded to be due to regulation of IL-
23. In IBD, it has been suggested that IL-12 regulates the systemic 
inflammation, whilst IL-23 regulates the intestinal inflammation (Uhlig et al., 
2006). In horses, IL-23 has been detected in chronically inflamed eyes using 
immunohistochemistry (Regan et al., 2012). Additionally, IL-23 is expressed 
in IAD (Hughes et al., 2011) and IL-23 rather than IL-12 is expressed in 
response to Rhodococcus equi infection (Nerren et al., 2009).  
IL-17A 
There are six members in the IL-17 family (IL-17A-F) where IL-17A and the 
closely related IL-17F are the most studied. IL-17A is not exclusively 
produced by TH17 cells, but this T cell subset is the high producer (Jin & 
Dong, 2013). Other cells that experimentally or in vivo can secrete IL-17A are 
γδ T cells and invariant natural killer T cells (Cua & Tato, 2010). In a study of 
the kinetics of IL-17A in disease, it was concluded that in an acute disease 
(Candidia albicans infection), as well as in a chronic disease (EAE), IL-17A 
was first produced by γδ T cells and the production was gradually overtaken by 
TH17 cells (Hirota et al., 2011). Interestingly, in the chronic disease, but not 
the acute disease, IL-17A production decreased in favour of a TH1 phenotype 
and these cells were “ex-IL-17A”-producing cells.  
In horses, IL-17A has been sequenced and shows 84% identity with human 
IL-17A (Tompkins et al., 2010). IL-17A is increased in horses suffering from 
chronic respiratory airway obstruction (RAO) when exposed to triggering 
environmental factors (Ainsworth et al., 2007; Debrue et al., 2005), and in 
chronically inflamed eyes (Regan et al., 2012), but not in osteoarthritis (Kamm 
et al., 2010). 
1.6.2 T cell subsets 
Cytokines produced at initiation of an immune response profile the ensuing T 
cell response. Traditionally, αβ T cells are divided into cytotoxic T cells and T 
helper cells and regulatory T cells. The general view is that intracellular 
bacteria trigger IL-12 production in dendritic cells leading to a TH1 response 
with IFN-γ production and enhanced phagocytosis by macrophages. Helminths 
trigger production of IL-4 inducing TH2 responses with IL-4, IL-5 and IL-13 
production, as well as recruitment of eosinophils. TH2 cytokines stimulate 
class-switching and differentiation of B cells to plasma cells in the lamina 
propria. Extracellular bacteria trigger TGF-β and IL-6 production in dendritic 
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cells, thereby inducing a TH17 response with production of IL-17A, IL-17F and 
IL-22. TGF-β can also induce TREGS, for instance when encountering antigen in 
the presence of retinoic acid (Xiao et al., 2008). As previously mentioned, the 
TH17 phenotype is stabilized by IL-23 and the cells can directly and indirectly 
attract neutrophils to the site of inflammation (Pelletier et al., 2010; Fossiez et 
al., 1996). Previously it was thought that once a TH cell had gained a 
phenotype it was set, however more recent studies show that TH cells 
demonstrate plasticity between subtypes (Ueno et al., 2015). IL-12 can drive 
both TH2 and TH17 cells towards a TH1 phenotype, whereas IL-6 can drive 
TREGS to a TH17 phenotype. γδ T cells share features with innate cells, being 
more abundant in tissue than in circulation and being important in the first line 
of defence against infections in the intestine (Ismail et al., 2011). These cells 
recognise other types of antigens than those recognized by αβ T cells and are 
not completely dependent of MHC presentation of the antigens (Chien & 
Konigshofer, 2007). Interestingly, γδ T cells in the intestinal mucosa increase 
in Crohn’s disease, and are suggested to contribute to the pathogenesis 
(Kanazawa et al., 2001) whereas this is not the case in canine IBD (German et 
al., 2001). 
In horses, subpopulations of T cells are detected by aid of monoclonal 
antibodies directed to equine CD2, CD3, CD4, CD5, CD8 using flow-
cytometry or immunolabeling of frozen tissue sections (Platt et al., 2010; 
McClure et al., 2001; Tschetter et al., 1998). Anti-CD3 is routinely used to 
label T cells in formalin-fixed sections and immunohistochemical labelling of 
TREGS has been described (Steinbach et al., 2009). A protocol for 
discrimination of equine TH1, TH2 and TREGS in flow-cytometry by using IL-
10, IL-4 and IFN-γ production has also been elaborated (Wagner et al., 2010). 
Equine TREGS seem to be heterogeneous as they can express either or both the 
cytokines IL-10 and IFN-γ (Robbin et al., 2011). TREGS were detected by an 
anti-FoxP3 antibody, complemented by the labelling of CD4 and CD25 
(Hamza et al., 2011). TH17 cells have been identified by detection of IL-17 and 
IL-23 in formalin-fixed inflamed uvea (Regan et al., 2012). Labelling of CD8 
γδ T cells has been performed on several tissue including intestine and IEL 
(Tschetter et al., 1998). As T cells drive the inflammation in IBD in several 
species and TREGS are supposed to dampen this reaction both these cell types 
were included in the present analysis of equine IBD. Additionally, TH1 and 
TH17 cells are involved in the development of human IBD and therefore the 
expression of IL-12p40, IL-17A and IL-23p19 was studied in the present 
material.  
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1.6.3 B cells and immunoglobulins  
The B cell carries immunoglobulin as their B cell receptor, which can be 
secreted as antibodies by plasma cells. Dependent on the heavy chain, various 
subclasses of immunoglobulins are formed, namely IgA, IgD, IgE, IgG or IgM. 
IgA is the dominant immunoglobulin at mucosal surfaces and plays a key role 
in their immune defence (Lewis et al., 2010). The serum levels of IgA are low, 
and in horses they have been described to decrease during intense training 
(Souza et al., 2010). Even if IgD has been found in horses, its function remains 
unknown. In humans, IgD can be excreted into the respiratory tract lumen, 
binding bacteria or be bound to granulocytes in the blood, probably functioning 
as a pattern recognition receptor (Chen & Cerutti, 2011; Edholm et al., 2011). 
IgE levels are low compared with other Ig subclasses and vary between horses 
(Wagner, 2009). IgE mediates type I hypersensitivity in skin allergy of horses 
(Wagner et al., 2006) and increases in insect bite hypersensitivity and at 
parasite infection (Schaffartzik et al., 2012; Wagner, 2009). Equine IgG can be 
further subdivided into subclasses; IgG1 (formerly IgGa), IgG2 (IgGa) IgG3 
(IgG(T)), IgG4 (IgGb), IgG5 (IgG(T)), IgG6 (IgGc) and IgG7 (IgG(T)) 
(Walther et al., 2015; Wagner et al., 2004). IgG is induced in secondary 
responses, and is important in the response against many pathogens. It is also 
suggested that IgG(T) can bind to mast cells and contribute to skin allergy in 
horses (Wagner et al., 2006). IgM is the first immunoglobulin to appear in 
phylogenetic development. It is produced initially by foetuses and is 
responsible for primary immune responses. IgM deficiency has been 
documented in horses, primarily foals or horses with neoplastic disease 
(Thomas et al., 2005; Perkins et al., 2003). The role of B cells in equine IBD is 
not clear and therefore their distribution in the jejunum was determined by 
immunohistochemistry and morphometric analysis in the present thesis.   
1.7 Suggested aetiologies of IBD 
The aetiology of IBD is unknown. Findings in human patients with IBD 
indicate an immune-mediated disease, which has been evaluated in mouse 
models of IBD and successively also suggested for veterinary species. The 
immune system in the intestine needs to be both reactive towards pathogens 
and tolerant towards the beneficial, commensal flora (Goldszmid & Trinchieri, 
2012). If the balance between responsiveness and non-responsiveness is faulty, 
the intestine is at risk of severe disease from ignoring pathogens or invoking a 
deleterious immune reaction towards harmless antigens. This balance is 
thought to be disrupted in IBD, resulting in an exaggerated, inappropriate 
immune response (Xavier & Podolsky, 2007). Possible causes and contributing 
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factors to the exaggerated immune response have been proposed, but the 
aetiology is still obscure. In humans, a higher risk of developing IBD was seen 
in a population consuming drinking water with high iron content (Aamodt et 
al., 2008). Furthermore, a high prevalence of IBD is found in westernised 
countries, with high living standards (Cosnes et al., 2011). Whether the risk is 
associated with antimicrobial usage, pollution, diet changes or other factors is 
not fully understood. Two of the most compelling pieces of evidence against an 
infectious agent as the sole cause of IBD are the sporadic appearance of the 
disease and the positive treatment outcome achieved with immunosuppressive 
drugs. However, it is still possible that microorganisms in conjunction with 
environmental factors and a genetic predisposition can play major roles in the 
pathogenesis of IBD (Hansen et al., 2010; Podolsky, 2002). 
In the search for an infectious agent in equine IBD, transmission studies 
were performed using equine IBD-affected tissue. However, in inoculated 
animals (rabbits, guinea pigs and one healthy young horse) no lesions could be 
detected (Pass & Bolton, 1982; Merritt et al., 1977). Additionally, no particular 
environmental factor, such as management routine, feeding regimes or 
medication has successfully been linked to the disease (Lindberg et al., 1985). 
However, certain geographical areas have been associated with increased risk 
for eosinophilic equine IBD (Archer et al., 2014). IBD has also been observed 
more frequently in horses during late spring and summer (Southwood et al., 
2000; Nimmo Wilkie et al., 1985) or fall (Archer et al., 2014), suggesting a 
seasonal factor in the pathogenesis. These environmental factors could be 
linked to toxins (Woods et al., 1992), diet, allergic substances or 
microorganisms such as parasites. One case of equine IBD (EGE) has been 
linked to the ingestion of hairy vetch (Anderson & Divers, 1983).   
1.7.1 Hypersensitivity reaction 
Two types of hypersensitivity reactions (type I and type IV) have been 
suggested to be involved in the development of equine IBD. Hypersensitivity is 
an inappropriate, exaggerated immune reactivity and is classified into four 
major categories with additional sub-categories (Uzzaman & Cho, 2012). In an 
immediate (type I) hypersensitivity reaction, mast cells interact with an antigen 
on their Fc-IgE receptor and cross-linking induces release of pre-formed 
mediators, such as histamine and prostaglandin D2. The release of mediators 
causes acute reactions and attracts immune cells to the site and newly 
synthesised cytokines can prolong the inflammatory response. A delayed (type 
IV) hypersensitivity is mediated by persistent activation of T cells. Different 
effector cells are recruited dependent of the TH subset that initiates the reaction, 
i.e. TH1 and macrophages are seen in type IVa hypersensitivity, TH2 and 
27 
eosinophils in type IVb, cytotoxic T cells in type IVc and T cells and 
neutrophils in type IVd (Pichler, 2003). TH17 cells are also thought to 
contribute to delayed hypersensitivity, mainly to the type IVd reaction 
(Iwakura et al., 2008). A link between type I and type IVb is suggested as TH2 
cells induce IgE production (Uzzaman & Cho, 2012).  
Several authors have suggested hypersensitivity reactions as a plausible 
mechanism in the development of equine IBD (Sanford, 1989; Lindberg et al, 
1985; Lindberg, 1984; Roberts, 1983; Pass & Bolton, 1982). Aluminium was 
suggested to have invoked an immediate hypersensitive inflammation in a 
cluster of IBD horses (Fogarty et al., 1998). The mechanism was thought to be 
through alteration of the barrier function, activating dendritic cells and 
macrophages and increasing cytokine expression, including IL-17A and 
CXCL-8 (Pineton de Chambrun et al., 2014; Lerner, 2007). However, this 
report has been disputed as to whether the disease was IBD as lesions were 
non-classical and debris from parasites as well as iron-containing cells could 
have given false positive readings for aluminium (Collery et al., 1999). Mast 
cells are infrequently seen in eosinophilic equine IBD, and therefore a role for 
an immediate hypersensitivity is not agreed upon (Mäkinen et al., 2008; 
Lindberg et al., 1985). However recurrent flares of an immediate reaction in 
combination with delayed responses have been suggested for EEG. In 
eosinophilic equine IBD, vasculitis is a common feature (Schumacher et al., 
2000) and could be driven by immune complex deposition in small vessels in 
the inflamed intestine (Lindberg, 1985), hence possibly a type III 
hypersensitivity.   
The granuloma formation in human IBD is sometimes referred to as a 
delayed hypersensitivity reaction (Co et al., 2004) and both canine and feline 
IBD has been suggested to be mediated by hyper-reactive innate immune cells 
(Allenspach, 2011). IBD can be challenging to distinguish from dietary 
hypersensitivity in both humans and small companion animals (Vojdani & 
Perlmutter, 2013; Mandigers & German, 2010). Little is known of food 
hypersensitivity in horses. Celiac disease is a cell-mediated hypersensitivity 
reaction to gluten (Vojdani et al., 2008) that could possibly affect horses. A 
few cases of equine IBD have had anti-gluten antibodies, although this was 
also recognised in healthy controls fed a high-gluten diet (van der Kolk et al., 
2012). An indirect effect of diet can be a change in the intestinal microbiota, 
which creates a dysbiosis and provokes an inflammation. 
1.7.2 Microbiological agents  
In humans, a dysbiosis of the intestinal microbiota has been suggested to drive 
IBD (Hold et al., 2014). The same theory has been suggested for colitis in 
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horses (Costa et al., 2012) and for IBD in dogs (Allenspach et al., 2010). 
Alternatively, the dysbiosis can be a consequence of intestinal inflammation. 
Therefore an altered microflora as a primary cause of IBD has been debated in 
both humans (Sartor & Mazmanian, 2012) and horses (Lindberg, 1984). Even 
if the dysbiosis is not causative, the microbiota can still serve as a factor in the 
pathogenesis, by containing pathogens or by a defective host immune response 
towards commensal bacteria.  
Mycobacterial infections have been a suggested cause or contributor to the 
development of IBD in horses and humans (Naser et al., 2014; Schumacher et 
al., 2000). Horses are susceptible to Mycobacterium avium subspecies 
paratuberculosis experimentally (Larsen et al., 1972), but the bacterium has 
not been isolated from clinical cases. Infection with Mycobacterium avium 
subspecies avium has been recorded in equine intestines (Cline et al., 1991; 
Buergelt et al., 1988; Platt, 1986; Merritt et al., 1975; Cimprich, 1974) 
resulting in lesion indistinguishable from granulomatous equine IBD. 
However, a true causal relationship has not been confirmed in Swedish EGE 
cases, as no intracellular bacteria was found in Ziehl Neelson nor auramine-
rhodamine or other microbial stains (Lindberg, 1985), concurring with findings 
by Cimprich (1974). Culturing mycobacteria is difficult and time consuming. 
Therefore the exclusion of a mycobacterial infection is difficult. In human, 
some genes are however associated with an increased susceptibility for IBD 
and also an increased susceptibility for mycobacterial infections (Jostins et al., 
2012). Even if it is not a conclusive finding, this dual genetic susceptibility 
could indicate an underlying genetic immune disturbance that increases the risk 
of a mycobacterial infection causing IBD. 
Parasites are not a rare finding in equine intestines, even if continuous 
deworming is commonly performed (Höglund et al., 1997). Cyathostomes are 
regarded to be the most important parasites in equids today (Stratford et al., 
2011; Love et al., 1999). The parasite can be present in dewormed horses and 
give clinical disease when migrating en masse into the lumen of the intestine, 
resulting in protein losses even in adult horses (Love et al., 1999). 
Anoplocephala perfoliata has also been suggested to be important, especially 
in horses presenting with signs of colic, and the infection is possibly 
underdiagnosed (Back et al., 2013). Parasites have been suggested to be part of 
the induction of equine IBD (Cohen et al., 1992; Church et al., 1986; Platt, 
1986; Breider et al., 1985; Jasko & Roth, 1984) and can attract immune cells, 
such as eosinophils as well as other cell types, when invading the tissue 
(Rodríguez-Bertos et al., 1999; Pearson et al., 1993). In both Anoplocephala 
infection (Rodríguez-Bertos et al., 1999) and eosinophilic equine IBD 
(Lindberg, 1985), lesions can be found at the ileocaecal junction. However, in 
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the several reports on eosinophilic equine IBD, parasites or remnants of 
parasites were rare findings (Mäkinen et al., 2008; Archer et al., 2006; 
Southwood et al., 2000; Lindberg, 1985; Pass & Bolton, 1982). The lack of 
intralesional parasites could nevertheless be due to the eradication of the 
initiating parasites. In contrast to parasites as a cause of disease, a protective 
role for helminths has been suggested in experimental IBD (Ruyssers et al., 
2008). The helminths are thought to skew the immune response towards a TH2 
and TREG response rather than a TH1 driven response, which ameliorates the 
severity of disease.  
Less explored microbial agents in the IBD context are fungi and viruses. 
Fungi have been demonstrated in eosinophilic lesion in horses with chronic 
enteritis (Morton et al., 1991), but were absent in other studies of eosinophilic 
intestinal lesions (Mäkinen et al., 2008; Gibson & Alders, 1987). Virus has 
been suggested as a possible aetiology where inflammatory lesions are noted in 
several organs including the intestine, even if virus have not been isolated in 
affected horses (Nimmo Wilkie et al., 1985). In humans, measles virus and 
Epstein-Barr virus have been suggested to induce vascular changes and/or IBD 
lesions (Gehlert et al., 2004; Uhlmann et al., 2002; Wakefield et al., 1993), but 
viruses are also present in healthy individuals and for measles, an aetiological 
role has been strongly challenged (Bustin, 2008; Davis & Bohlke, 2001). 
1.7.3 Genetic associations 
Even if contradictory opinions exist on breed predilection (Archer et al., 2006; 
Kemper et al., 2000; Platt, 1986), related horses have developed IBD (Sweeney 
et al., 1986; Lindberg et al., 1985). This finding suggests that heritability 
contributes to the disease development. For the human IBD entity Crohn’s 
disease, candidate gens associated with intracellular bacterial processing and 
Paneth cells function have been found, whereas the entity ulcerative colitis has 
been linked to barrier dysfunctions (Lees et al., 2011). In addition in both these 
entities, genes associated with the TH17 and TREG pathways, as well as PAMP 
recognition (NOD2) and genes associated with barrier function (MUC19) are 
found to be important (Khor et al., 2011). TLR4 polymorphism is associated 
with human IBD, at least in Caucasians (Cheng et al., 2015), as is the 
polymorphism in MHC II (Goyette et al., 2015). These finding demonstrate the 
importance of both innate and adaptive immune reactivity in the development 
of IBD in genetically susceptible individuals.  
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2 Hypothesis and aims 
Equine IBD is a disorder driven by exaggerated immune reactions induced by 
intestinal lumen antigens and environmental factors. The disorder is manifested 
as an imbalance in the cytokine milieu and the interplay between T cell 
subsets.  
The general aim of the present thesis was to improve the understanding of 
equine mucosal immunology with specific emphasis on the intestine and the 
development of chronic idiopathic enteropathy in the horse.  
 
The specific aims were to:  
 Establish / optimise methods for gene expression analysis and for immune 
cell type identification in multiple intestinal segments.  
 Determine the composition of immune cell populations in chronically 
inflamed intestinal tissue of different histological entities of equine IBD.  
 Explore the usability of rectal biopsies for cytokine profiling. 
 Evaluate cytokine gene expression in healthy and IBD afflicted tissues. 
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3 Comments on material and methods 
This section includes an overview of the material and methods used in the 
present thesis. For further details, please see the individual papers (Paper I-IV).  
3.1 Sampling considerations 
3.1.1 Horses 
Different groups of horses were used for sampling, depending on the material 
required. Healthy Standardbred horses at the Department of Clinical Sciences 
were used for either induction of endotoxaemia or collection of equine PBMC 
for in vitro stimulation (Paper II). Standardbred horses, stabled at a closed 
facility, were biopsied for control rectal biopsy material (Paper IV). All horses 
were considered normal, by daily monitoring and regular clinical evaluation by 
staff. Horses of various breed were sampled at an abattoir for full-thickness 
intestinal control samples (Paper I-III). Horses sampled at the abattoir had little 
known history, apart from the declaration of health given at slaughter. Even if 
episodes of gastrointestinal malaise could possibly have occurred, no signs of 
disease were noted at sampling, as evaluated by gross examination of carcasses 
and histological examination of the intestines. Hence, the material served as a 
good representation of the non-diseased equine population and was a suitable 
control material. 
Equine IBD is a rare condition, thus sampling sufficient and appropriate 
material is challenging. The diseased intestinal material came from clinical 
cases admitted to the University Animal Hospital, Swedish University of 
Agricultural Sciences, Uppsala or the Regional Animal Hospital, Strömsholm, 
Sweden. The material was either rectal biopsies sampled from horses of 
various breed (Paper III, IV) or archived material from Standardbred horses, 
sampled at necropsy (Paper I). For Paper I, the jejunum was chosen for 
analysis as IBD lesions are commonly found in the small intestine 
33 
(Schumacher et al., 2000), and the jejunum was frequently afflicted by lesions 
in the archived material. The clinical cases used in the present thesis had 
clinical signs suggestive of IBD, displayed chronic enteropathy of unknown 
aetiology, and were all sporadic cases.  
The archived material used in Paper I came from thoroughly examined 
clinical cases, with characteristic IBD lesions, sampled in the 1970s to 1980s. 
Horses suffering from severe chronic enteropathy had smaller chance for 
treatment at that time as prognosis was regarded as poor (Lindberg, 1984; 
Roberts & Kelly, 1980). This resulted in more cases for necropsy and 
confirmation of equine IBD. However, archived formalin-fixed material is not 
useable for transcript analysis, as RNA is destroyed and fresh material was 
therefore needed. Material for gene expression analysis was sampled from 
clinical cases in the 2010s. In recent time, horses are more readily treated, 
preferably with antihelmintics and corticosteroids and prognosis is considered 
fair to moderate (Kaikkonen et al., 2014). The diagnosis of the material for 
gene expression was therefore based on the anamnesis, clinical findings and 
rectal biopsy histology, as none of the horses was necropsied. 
Horses used in the present thesis were of all genders. Age has been shown 
to influence mucosal immunity in several species, especially in the young 
animal (Cesta, 2006). In equine neonates and foals, TH1 responses dominate 
over TH2 responses whereas the proportion of TH1 cells and TREGS are the same 
in foals as in adult horses (Wagner et al., 2010). Increased age has been noted 
to decrease the number of TREGS in blood (Robbin et al., 2011). In geriatric 
horses over the age of 20 years, conflicting results have been published for 
immune cell populations, but IFN-γ expression increased with age (Hansen et 
al., 2015). Equine IBD rarely affects animals younger than 1.5 years, and this 
age group was therefore excluded from the studies. The age of the sampled 
horses, for both the healthy and diseased horses, varied between 1.5 –24 years, 
which corresponds to the age span for published cases of equine IBD. The 
oldest horse was however excluded due to deviating reference genes (see 4.2 
Appropriate reference genes), and the upper age range was thereby 20 years.  
3.1.2 Blood sampling 
Collection of PBMC from healthy horses was done through venous puncture 
and sampling blood in heparin tubes (Paper II). Heparin prevent clotting and 
have less effect on cells than EDTA-coated tubes (Brunialti et al., 2002; Son et 
al., 1996).  
Jugular whole blood from horses with induced endotoxaemia was sampled 
through a percutaneous cathether into PAXgene tubes (Paper II). Using 
PAXgene tubes minimizes RNA degradation in blood after collection (Chai et 
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al., 2005). Horses were sampled before infusion of lipopolysaccharide, at the 
end of infusion and up until 48 hours after infusion.  
3.1.3 Tissue sampling 
The material used needed to be as fresh as possible, as intestinal material 
deteriorates quickly post-mortem (Lee et al., 2005; Scheifele et al., 1987) 
whereas GALT is less rapidly affected (Solarino et al., 2009). The drawback in 
using rectal biopsy to diagnose equine IBD is that only approximately 35-50% 
of biopsies show inflammation (Barr, 2006; Lindberg et al., 1996). On the 
other hand, the method is much less invasive than exploratory laparotomy and 
it is possible to perform on more cases and renders more tissue for evaluation 
than endoscopy. Therefore, rectal biopsy of both healthy and diseased horses 
was performed and samples were placed immediately after sampling in 
RNAlater or formalin (Paper III, IV). The intention was to collect full-
thickness samples at necropsy from horses that had received a preliminary 
diagnosis from rectal biopsies. However, clinically suspected cases of IBD 
identified for inclusion in the thesis work did not develop severe disease 
requiring euthanasia, or were unable to be transported to a necropsy facility or 
responded to treatment. Hence, archived diseased material was used for studies 
of full-thickness material (Paper I).  
Full-thickness abattoir control material was collected within 45 minutes of 
killing. All control material was collected in the 2010s and preserved in 
formalin and RNAlater (Paper I-III). The archived necropsy material was 
sampled in the 1970s and 1980s from clinically well-defined horses and 
sampling was done directly following euthanasia (Paper I) (Lindberg, 1985). 
Tissue from several organs and intestinal segments was fixed in formalin and 
archived in paraffin blocks.  
All tissues sampled in RNAlater were intended for transcript analysis 
(Paper II-IV). After collection, samples were kept in the solution for 24h at 
4°C, thereafter at -80°C, to avoid mRNA degradation. Tissues sampled in 
formalin were left in the solution for 24h at room temperature. Thereafter, 
samples were processed routinely by step-wise dehydration in increasing 
alcohol concentration followed by paraffin embedding and sectioning.  
3.2 Immunohistochemistry 
All material used for IHC was formalin-fixed and indirect IHC was applied to 
locate immune cells in situ (Paper I, IV). An unlabelled primary antibody 
followed by a secondary labelled antibody and, when needed, signal 
amplification were used (Table 2). Formalin-fixed material requires heat- 
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treatment to recover the immunoreactivity of the epitope that was lost during 
fixation. This loss of immunoreactivity is suggested to occur due to either 
intermolecular cross-linkage (Metz et al., 2004) or changes to the protein 
structures (Fowler et al., 2011). Sections were placed in Tris-EDTA or citrate 
buffer (Table 2), and either microwaved at 92°C or autoclaved at 121°C for 
heat-induced epitope retrieval, as suggested by the manufacturer of the primary 
antibody or in-house evaluation. Another effect of the antigen-retrieval is a 
reduction in non-specific background staining (Shi et al., 2011). H202 in 
methanol (Streefkerk, 1972) reduced the background as well by eliminating 
endogenous peroxidase. To reduce the risk of background staining further, 
application of appropriate serum (serum from the animal species in which the 
secondary antibody was produced) was applied and in sections labelled for IgG 
an avidin-biotin blocking kit was applied to bind endogenous biotin (Paper I). 
Despite this, sections had background staining with the IgG protocol, in the 
submucosa, crypt abscesses and the necrotic centres of eosinophilic granuloma. 
Specific labelling was noted in areas that were not of interest to quantitate, 
namely IgG (vascular lumen), IgA (intestinal epithelium), IgM (apical portion 
of enterocytes) and MHC II (intestinal epithelium and vascular endothelium). 
None of these additionally labelled cells hindered the analyses in the present 
work as these areas were excluded from the quantitative evaluation in Paper I.  
3.2.1 Primary antibodies 
Labelling of T cells (Paper I, IV), TREGS (Paper I, IV), B cells (Paper I), Ig-
producing cells (Paper I) and antigen-presenting cells (Paper I) was performed 
on rectal and/or jejunal tissue. For detection of all T cells, the CD3 co-receptor 
complex is a useful epitope as it is associated with the TCR on all mature T 
cells (Owen et al., 2012). CD3ε is one of the polypeptides in the co-receptor 
and antisera raised against it in other species cross-react with the equine 
epitope (Collins Kelley et al., 1997). The CD3 antibodies labelled appropriate 
areas of the control material in Paper I and IV (Fig. 2, 3, 6A). To label TREGS, 
an antibody raised against the transcription factor FoxP3 was used (Paper I and 
IV). FoxP3 is present in T cells and promotes a regulatory T cell profile (Hori 
et al., 2003) or makes activated T cells hypo-responsive (Wang et al., 2007). 
The clone FJK-16s, targeted at murine FoxP3, cross-reacts with the equine 
counterpart (Steinbach et al., 2009). In the equine lymph node TREGS were 
noted in the T cell-rich areas, but rarely in the lymphoid nodules (Fig. 2, 3). 
In B cells, the transmembrane heterodimer CD79 is almost exclusively 
expressed by B cells, forming a complex with the B cell receptor. CD79 is 
present in a somewhat wider range of B cells than CD20. CD79-expression is 
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Table 2. Specifications for the immunohistochemical indirect labelling  
 Primary Antibody      Secondary Antibody   
Target Species Type Dilution (buffer) Company Clone  Species Type Dilution Company 
CD3 (Paper I) Rabbit anti-human Polyclonal 1:400 (1% BSA in TBS) Dako -  Goat anti-rabbit EnVision+ - Dako 
CD3ε (Paper IV) Mouse anti-human Monoclonal 1:400 (1% BSA in TBS) Dako F7.2.38  Goat anti-mouse EnVision+ - Dako 
CD20 Rabbit anti-human Polyclonal 1:100 (1% BSA in TBS) Thermo Fisher -  Goat anti-rabbit EnVision+ - Dako 
FoxP3 Rat anti-mouse Monoclonal 1:1 000 (1:6 biotin in TNB) eBioscience FJK-16s  Mouse anti-rat Biotinylated 1:200 Vector 
IgA Goat anti-horse Polyclonal 1:400 (PBS) Bethyl -  Rabbit anti-goat Biotinylated 1:50 Bethyl 
IgG, Fc specific Goat anti-horse Polyclonal 1:1 500 (PBS) Sigma-Aldrich -  Rabbit ant-goat Biotinylated 1:50 Vector 
IgM Goat anti-horse Polyclonal 1: 6 000 (PBS) Bethyl -  Rabbit anti-goat Biotinylated 1:50 Bethyl 
MHC II Mouse anti-human Monoclonal 1:20 (1% BSA in TBS) Dako TAL.1B5  Goat anti-mouse EnVision+ - Dako 
BSA: Bovine serum albumin 
PBS: Phosphate-buffered saline 
TBS: Tris-buffered saline 
TNB: Tris NaCl blocking buffer (PerkinElmer). 
 
Figure 2. Sections labelled with each primary antibody and photographed at x100, in tonsil (all except IgA) or intestinal lamina propria (IgA). 
 
present in pro-B cells (Koyama et al., 1997) and CD20 is present in all B cells 
stages from pre-B cells (Uchida et al., 2004; Tedder & Engel, 1994). Neither 
CD79 nor CD20 is expressed in normal plasma cells, and both antibodies 
labelled the appropriate areas of lymphoid tissue (Fig. 4, 6C). Anti-CD79 is 
commonly used in IHC on equine material, however a major disadvantage is 
the specific labelling of smooth muscle cells (Ramos-Vara, 2014). In a pilot 
study for Paper I, anti-CD79 was used, but muscle cell labelling obscured 
immune cell labelling in intestinal villi, making image analysis unreliable. The 
B-cells markers CD19 and CD21 were not considered as they can also be 
present in plasma cells (Bataille et al., 2006; Huang et al., 1995), which was an 
unwanted feature in the present work as the intention was to discriminate B 
cells from plasma cells. CD20 has previously been used in studies on equine B 
cells (Kalsow et al., 1999). According to the literature, CD20 labels equine B 
cells efficiently (Valli et al., 2016; K alsow et al., 1998). Therefore, CD20 was 
chosen for the following analysis of B cells (Paper I) (Fig. 2, 4, 6C). 
To label plasma cells, anti-horse Ig antibodies were used for the subtypes 
IgA, IgG and IgM (Paper I) (Fig. 2, 5). Labelling of immunoglobulins has been 
long used in formalin-fixed material (Taylor & Burns, 1974), even so several 
equine IgG-specific antibodies needed to be evaluated to find an optimal 
protocol in the present work. Previous publications with the anti-IgA (Taouji et 
al., 2002) and anti-IgM (Pate et al., 2012) antibodies used on formalin-fixed 
equine material found these antibodies to give adequate labelling, as did our in-
house evaluation. In equine lymph node and tonsil, IgA positive cells were 
most prominent in sub-epithelial areas of the tonsil, IgM most prominent in the 
centre of germinal centres and IgG in the cortex (Fig. 5). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Consecutive section of an equine lymph node labelled for T cells (CD3; left) and TREGS 
(FoxP3; right). Magnification x20. 
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Figure 4. Consecutive sections of an equine lymph node labelled for B cells using either anti-
CD20 (left) or anti-CD79 (right). Anti-CD20 labelled cells equally intensely in both the germinal 
centre and the mantle zone, whereas anti-CD79 labelled the germinal centre B cells less intensely 
than the mantle zone subset. This is accordance with the literature for human B cells (Aoun & 
Pirruccello, 2007). Magnification x20. 
 
Figure 5. Lymph node immunolabelled for (A) IgA, (B) IgG and (C) IgM. Some background 
staining is seen in the connective tissue of sections labelled with IgG.  
 
Figure 6. Immunolabelled cells in consecutive slides for (A) CD3, (B) MHC II and (C) CD20 in a 
lymph follicle of a mesenteric lymph node, demonstrating the co-localisation of labelled cells. For 
MHC II and CD20 labelled cells overlap extensively, whereas co-localisation of MHC II and CD3 
is less marked and CD20 and CD3 rarely appear in the same areas of the lymph node. 
Magnification x20. 
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Sections were labelled using an anti-MHC II antibody (Fig. 2, 6B). MHC II is 
mainly expressed by dendritic cells, macrophages and B-cells, but constitutive 
expression has also been described in equine T cells in peripheral blood (Lunn 
et al., 1993; Crepaldi et al., 1986). The antibody clone TAL.1B5 used in the 
present thesis is targeted at the alpha chain of a human MHC II, namely human 
leukocyte antigen (HLA)-DR (Thomas et al., 1988). This particular clone has 
been used in previous publications for detection of equine antigen-presenting 
cells (Bruynsteen et al., 2013; Mäkinen et al., 2008; Kalsow et al., 1999), but 
as activated T cells and B cells could express MHC II the correct terminology 
for labelled cells should be MHC II-expressing cells. Apart from labelling 
macrophage-like cells in the lymph node, tonsil and lamina propria, MHC II-
labelling was noted in endothelium of mostly small capillaries and in 
epithelium. This is in accordance with labelling of the same MHC II-type in 
human tissues (Daar et al., 1984). 
3.2.2 Amplification of labelling 
The use of a secondary antibody amplifies the labelling of the primary 
antibody. Different approaches for detection of the primary antibodies were 
used; labelling by biotin conjugated secondary antibody followed by an avidin-
biotin complex (ABC; Fig. 7A), or a secondary antibody and enzyme-
conjugated dextran polymer (EnVision+; Dako; Fig. 7B). The labelling for 
FoxP3 needed further amplification than the use of a secondary antibody alone. 
Hence, sections were labelled with primary antibody, streptavidin and biotin 
followed by a tyramide signal amplification (LSAB and TSA; Fig. 7C). In the 
FoxP3 protocol, biotinylated tyramide was applied, enabling HRP to oxidise 
the biotinylated tyramine to a free radical. The tyramine could thereby react to 
the primary and secondary antibody complex and deposit multiple biotin sites 
on the complex. A second application of streptavidin and HRP was applied, 
allowing the complex to bind to the many biotin sites. The labelling is in this 
way amplified up to 30-fold compared with non-TSA methods (Kricka, 1993).  
For all the applied protocols, either AEC or DAB was used as chromogen to 
detect the labelling by forming an insoluble precipitate via enzymatic reaction 
with HRP.  
3.2.3 Descriptive analysis and morphometry  
By the use of bright-field microscopy all included intestinal tissue sections 
were described histologically. Where the analysed tissues were preserved in 
RNAlater, corresponding tissue fixed in formalin was evaluated by light 
microscopy. To obtain objective quantitative data on the different cell 
populations, morphometry was applied. For the morphometric analysis, images  
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Figure 7. The schematic outlay of (A) the avidin-biotin complex assay (ABC), (B) the secondary 
antibody and enzyme-conjugated polymer assay (EnVision+) and (C) the labelled streptavidin and 
biotin (LSAB) and tyramide signal amplification assay (TSA). 
of tissue were digitalized at either magnification x20 (Paper I) or x40 (Paper 
IV) in a standardized, randomized order. All sections were blinded to the 
operator to avoid biased selection of investigated areas. Sections pertaining to a 
series were all digitalized in one session to avoid alterations in microscope 
settings resulting in contrived differences between images to be compared. In 
Paper IV, individual cells were counted in an unbiased counting frame 
(Gundersen, 1977) in ten different images, captured in the same level of the 
tissue, from each horse. All cells within the mucosa were accounted for. In 
Paper I, an image analysis approach was used. First, the distributions of 
immunolabelled cells were described in all compartments of the intestinal wall 
of both healthy and diseased horses followed by morphometry. Immune cells 
normally populate the lamina propria and expand during the development of 
equine IBD. Therefore the mucosa was chosen as the tissue compartment for 
morphometric analysis. As lesions occasionally were graded as mild and were 
multifocal in the EEG cases, large areas for analysis were needed. This made 
manual counting of cells infeasible, due to the number of cells included. 
Additionally, difficulties to quantitate MHC II-expressing cells have previously 
been described as well, due to the fact that individual labelled cells are hard to 
discern (Elwood et al., 1997). Therefore the area labelled for each antibody 
was assessed by image analysis in the NIS Elements software (Fig. 8).  
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Figure 8. Schematic view of the image analysis; from immunolabelled image via definition of 
area to analyse (region of interest: ROI), colour deconvolution and applying threshold for 
detection of immunolabelling, to the percentage of immunolabelling within the analysed area.  
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To calculate labelled area, all images were white balanced and uneven 
illumination corrected (Landini, 2014). Thereafter, deconvolution for 
haematoxylin and DAB or AEC was performed, i.e. the image was split into 
sub-images where the resulting images only contained one of the stains. 
Labelling was defined in images only containing the DAB or AEC stain by 
thresholding in the red, green and blue channels. The threshold values were 
established for each antibody and applied to all pertaining sections, with only 
minor adjustments for intensity. Only the IHC labelling in the lamina propria 
was to be measured, therefore a region of interest (ROI) was created 
delineating the lamina propria. Within the ROI, artifacts and non-relevant 
structures were excluded. The area of the IHC labelling was divided by the 
ROI, resulting in a percentage of labelling in the total area. The average 
percentage for each labelling and for each horse was used to compare the cell 
infiltration between groups.  
3.3 Evaluation of gene expression 
3.3.1 Induction of equine PBMC 
To develop appropriate methods for transcript analysis in equine material, in 
vitro activated blood cells expressing the genes of interest were used as 
reference material (Paper II, III). Dependent on the inducer used, blood cells 
increase their expression of certain genes. Ionomycin in combination with 
PMA stimulates production of cytokines by activating a phosphorylating 
cascade and producing a calcium influx (Morgan & Jacob, 1994; Chatila et al., 
1989). Foremost the cytokines IFN-γ, IL-2, TNFα, RANTES and TGFβ are 
induced after ionomycin and PMA stimulation (Ai et al., 2013; Rostaing et al., 
1999). CpG-ODN is present more frequently in bacterial than in vertebrate 
genomes and acts as a PAMP (Krieg et al., 1995). The CpG motif is 
recognized by TLR9 and stimulates cytokine responses (Bauer et al., 2001), 
such as increased IFN-α and IFN-β expression (Wattrang et al., 2005; Krug et 
al., 2001).  
The TLR4-MD-2-CD14-receptor complex recognises LPS and activates 
cytokine production (Guha & Mackman, 2001). In humans, LPS also 
stimulates the up-regulation of TLR4, both after in vivo and in vitro stimulation 
(Wittebole et al., 2005; Muzio et al., 2000). Inducing endotoxaemia in horses 
is known to alter the gene expression in the blood, with up-regulation of pro-
inflammatory cytokines (Nieto et al., 2009). The method in Paper II was used 
to evaluate the expression of the TLR4-complex in in vivo samples. An in vivo 
equine model of endotoxaemia was used to study the expression of TLR4, MD-
2 and CD14 in blood cells at different time points after LPS infusion. 
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Healthy horses were via continuous intravenous infusion given 83.3 ng LPS 
per kg, per hour, for a total of 6 hours to induce endotoxaemia (Paper II). All 
infused horses showed clinical signs of endotoxaemia and blood was sampled 
for subsequent RNA isolation (according to 3.1.2 Blood sampling).  
To obtain equine PBMC for in vitro stimulation, blood from healthy horses 
was pooled and layered onto Ficoll-Paque in a centrifuge tube (Paper II). After 
centrifugation, the band containing the PBMC was collected and washed. The 
cells were re-suspended in cell culture medium (RPMI 1640 medium, HEPES 
buffer, l-glutamine, penicillin, streptomycin, 2-mercaptoenthanol and 5% foetal 
calf serum), adjusted in cell concentration and seeded in 25 cm2 plastic flasks. 
Stimulation using CpG-ODN 2216 (3 µL/mL) or PMA (50 ng/ml) and 
ionomycin (1 µL/ml) was done for 6 or 4 hours, respectively, at 37 °C, 6.5% 
CO2. After stimulation, cells were harvested in TRIzol and stored at -80 °C 
until RNA isolation. 
3.3.2 RNA isolation  
RNA from blood sampled in PAXgene tubes was isolated using the PAXgene 
RNA Kit, i.e. a silica spin column-based nucleic acid purification method. In 
between wash-steps, a DNase solution was applied to the column and 
eliminated remaining contaminating DNA. For RNA extraction from cultured 
PBMC and intestinal tissues, an acid guanidinium thiocyanate-phenol-
chloroform extraction method was used according to Wikström et al. (2011): 
Homogenisation and disruption of samples were performed in TRIzol followed 
by further shearing of DNA using a needle and syringe. After addition of 
chloroform and phase separation by centrifugation, the upper aqueous phase 
containing RNA was collected and purified by a column based method 
(E.Z.N.A. Total RNA Kit).  
For intestinal samples used in Paper II and III, homogenization was 
facilitated using a motorized pestle (Andersson et al., 2011). The pestle left the 
muscle layers intact, thus samples included RNA mainly from the mucosa and 
to a minor extent the submucosa and serosa.  
The amount of total RNA retrieved using the pestle varied and to improve 
the consistency in RNA yield a BulletBlender was used for homogenization in 
Paper IV. The BulletBlender homogenizes the tissue by beads added to the 
sample and application of external motorized force. The entire sample was 
homogenized if sufficient numbers of beads were added and the agitation done 
at high speed (see Paper IV, supplementary table S1). However, if too many 
beads were used the tube was damaged and this led to chemical contamination 
of samples or rupture of the tube. The addition of more beads to the sample-
containing tube rendered higher RNA concentration according to 
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spectrophotometry, but this could in part be a false high value due to the 
damaged tube giving off chemicals that absorb UV light at the same 
wavelength as RNA (Dotti & Bonin, 2011). An optimal number of beads was 
based on the amount of RNA extracted and the purity of samples.  
3.3.3 RNA quality control 
To ensure suitable sampling and extraction methods, the RNA was evaluated 
for the presence of intact 18S and 28S ribosomal RNA, as an indicator of 
minimal RNA degradation. RNA from in vivo induced blood leukocytes was 
optically evaluated after fragment separation by electrophoresis on agarose gel 
stained with ethidium bromide (Paper II). For the tissue and in vitro induced 
samples, two approaches for RNA quality control were used; 
spectrophotometry with absorbance at 230, 260 and 280nm wavelength 
(A260/A230, A260/A280; NanoDrop) and separation of RNA molecules by 
capillary electrophoresis resulting in an electropherogram (Experion) (Paper II-
IV). Spectrophotometry cannot distinguish RNA from contaminating DNA, 
therefore inaccurate values can be generated (Imbeaud et al., 2005). The 
Experion software uses a complex algorithm taking into account both RNA 
integrity and degradation in the electropherogram, and is thereby a more 
suitable method for RNA quality control (Bustin et al., 2009). The outcome of 
the NanoDrop was hence primarily used to confirm purity of sample, excluding 
contamination from the extraction process and residual proteins visible in the 
230nm and 260nm wavelength, and for approximation of RNA quality and 
concentration before the use of Experion.  
3.3.4 DNase treatment and synthesis of cDNA 
RNA of good quality and sufficient concentration was synthesised to cDNA. 
1µg of RNA was always used in the reaction for tissue derived samples and in 
vitro induced PBMC. In the in vivo induced material, the amount of RNA used 
to synthesise cDNA varied between horses. Therefore within each horse, the 
amount of RNA in each cDNA reaction was adjusted to the sample with the 
lowest RNA concentration. Hence, samples from one individual were always 
comparable between time-points and, as reference genes were used for 
normalisation, the fold change in gene expression was comparable between 
horses.   
To reduce the effect of possible contamination of congenital DNA all RNA 
samples were treated with DNase. Thereafter each sample was split into two, 
one part converted to cDNA by reverse transcriptase and one part serving as a 
non-reverse transcribed control sample.  
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3.3.5 Real-time qRT-PCR  
SYBR Green-based assays were used for all real time qRT-PCR reactions. 
Primers were designed or selected from the literature and all assays optimized 
under in-house conditions (Table 3). To get an idea of how well the assay 
might perform, amplicons were analysed for secondary structures using the 
web-based mfold software (Zuker, 2003). When designing the primers, 
sequences spanning an intron were preferred to differentiate between 
amplicons from cDNA and from contaminating genomic DNA. If not spanning 
an intron (as for H2Atype 1, IFN-α, SDHA, TFRC) or if the mRNA sequence 
has pseudogenes in the genome, it is of upmost importance that the level of 
genomic DNA is kept to a minimum. For this reason, non-reversed transcribed 
controls for every sample were always evaluated using either the TFRC or 
GAPDH assay. These control samples always indicated no or neglectable 
levels of contaminating DNA. False positive results due to nonspecific 
fluorescence are an issue in SYBR Green-based assays as the fluorescent dye 
intercalates any double stranded DNA, such as primer dimers and non-specific 
amplicons. To estimate primer dimer formation, the primers were analysed 
using the software Oligo7 (Rychlik, 2007) and all melt curves produced after 
the PCR reaction were checked for one assay specific peak.  
3.3.6 Reference genes and normalisation of gene expression 
Differences in RNA quality, the effectiveness of the cDNA synthesis and the 
amount of cDNA added to the PCR reaction affect the results of all genes 
analysed in a sample. To correct for variations in efficiency of the real-time 
qRT-PCR and quantification between samples, an invariant endogenous 
control is needed. Amplification of reference genes and target genes in the 
same sample provides an internal control if reference genes are selected with 
care (Bustin et al., 2009). A reference gene is only useful if it is stably 
expressed in all included materials, otherwise variation is introduced and 
results in questionable data (Dheda et al., 2005). The selection of reference 
genes is therefore pivotal.  
For the in vitro and tissue samples, the evaluation was achieved using the 
commercial software qBasePLUS (Paper II-IV). The software compares the 
stability of reference genes on the assumption that the expression ratio for two 
reference genes is identical in all samples regardless of the samples analysed. If 
this assumption is not true and the ratio differs between samples, either one or 
both of the reference genes are unsuitable for normalisation due to variation in 
expression. A pair-wise comparison of ratios results in an M-value for each 
analysed reference gene in qBasePLUS (Hellemans et al., 2007; Vandesompele 
et al., 2002). The M-value indicates each reference gene’s stability in the 
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analysed material. Additionally, after normalisation the reference gene should 
be expressed equally in all samples. This equality of expression is calculated as 
coefficients of variation (CV). In consecutive steps, the least suitable gene is 
excluded until a threshold of stability is reached, yielding a set of 
recommended genes for normalisation. The expression of up to seven 
commonly used reference genes (β2M, GAPDH, H2Atype1, HPRT, RPL32, 
SDHA, TFRC) was evaluated in equine PBMC and several intestinal segments 
from both healthy and diseased horses (Paper III, IV). 
In Paper II, the expression of HRPT and SDHA was used for normalisation 
of in vivo stimulated PBMC. The relative change in expression of target genes 
was calculated using the 2-ΔΔCq normalization method (Livak & Schmittgen, 
2001). The returned value is a fold change between a sample and a control, in 
this case the time-point 0. ΔΔCq is calculated according to the following 
equation: 
ΔΔCq  =  (Cqgoi; Sample   – Cqref; Sample ) – (Cqgoi; Control  – Cqref; Control ) 
goi = gene of interest; ref = reference gene 
 
In the in vitro stimulated cells and in all intestinal samples (Paper II-IV), 
expression of the gene of interest was normalised using the qBasePLUS software 
and a suitable set of reference genes. The following equation is used by the 
software: 
NRQ = E𝑔𝑔𝑔𝑔𝑔𝑔ΔCq,   goi
�∏ 𝐸𝐸𝑟𝑟𝑟𝑟𝑟𝑟0  ΔCq,ref0𝑟𝑟0𝑓𝑓  
goi = gene of interest; ref = reference gene 
 
The equation is based on the former described equation, but takes the 
efficiency (E) of the PCR reaction into account. This eliminates the 
assumptions that need to be made using the Livak and Schmittgen-method. 
Additionally, the use of several reference genes is possible in the qBase-
equation compared to the former equation using a single reference gene’s 
expression. The normalised gene expression was presented as a fold change in 
all papers included in this thesis. 
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Table 3. Primer sequences and optimized real time qRT-PCR assay conditions 
Gene Primer sequence Primer 
location 
Target sequence Size (bp) Annealing 
temperature (°C) 
Primer concentration 
(nM) 
E (%) r2 Melting 
point (°C) 
β2M S: CGGGCTACTCTCCCTGACT 
A: GGGTGACGTGAGTAAACCTGAAC 
60-80 
133-109 
NM_001082502.3 72 55 300 95 0.999 82 
CD14 S: GTTGTCAGTCAGTGCAGCTC 
A: GAAGATGCTCCAGGAGAAGA 
68-87 
233-214 
NM_001081927.1 166 60 400 96 0.996 83.5 
GAPDH S: ATCTGACCTGCCGCCTGGAG 
A: CGATGCCTGCTTCACCACCTTC 
779-798 
846-825 
NM_001163856.1 68 64 400 102 0.999 79 
H2A type 1 S: ATATTCAGGCCGTGCTGCT 
A: TTTGGGTTTCAAAGCGTTTC 
380-398 
484-466 
XM_005603621 105 57 400 100 0.994 81 
HPRT S: AATTATGGACAGGACTGAACGG 
A: ATAATCCAGCAGGTCAGCAAAG 
104-125 
224-203 
AY372182.1 121 57 300 95 0.996 80.5 
IFN-α S: CCAGTTCCGGAAGCCTCAAG 
A: GAAGAGGTGGAAGATCTGTTGGAT 
207-226 
273-250 
NM_001099441.1 67 55 300 102 0.996 79 
IL-12p40 S: TGCTGTTCACAAGCTCAAGTATGA 
A: GGGTGGGTCTGGTTTGATGA 
642-665 
717-698 
NM_001082516.1 76 59 300 101 0.998 84 
IL-17A S: CCAGAAGGGCCTCAGATTACCACA 
A: ACCTTCCCTTCGGCATTGACACAG 
173-196 
311-288 
NM_001143792.1 139 56 300 95 0.996 84 
IL-23p19 S: AGTGCGAGGATGGCTGTGAT 
A: GGCTCCCCTGTGAAAATGTCT   
291-310 
414-394 
NM_001082522.2 124 59 400 97 0.992 82 
MD-2 S: TAACATGAAGTCCCCGATTT 
A: TCCCCTGAAGGAGAATGATA  
152-171 
407-388 
NM_001081898.1 256 57 400 105 0.997 81 
RPL32 S: AGCCATCTACTCGGCGTCA 
A: TCCAATGCCTCTGGGTTTC 
81-99 
224-206 
XM_001492042.5 144 59 400 100 0.995 81.5 
SDHA S: GAGGAATGGTCTGGAATACTG 
A: GCCTCTGCTCCATAAATCG 
1478-1498 
1568-1550 
DQ402987.1 91 57 300 98 0.994 80 
TFRC S: TGGCTACTTGGGCTATTGTAAACG 
A: GGTGGTTCTGTTCCCTCTATCTCC  
255-278 
344-321 
NM_001081913.1 90 63 300 97 0.990 78 
TLR4 S: GGAACTGGACCTGAGCTTTA 
A: CAATTTCACACCTGGACAAA 
289-308 
389-370 
NM_001099769.2 101 60 400 95 0.995 80.5 
Present target and primer locations may deviate from those in the published papers, but sizes remain the same.  
E: Efficiency, from serial dilutions of reference cDNA; A: Antisense (3’-5’); S: Sense (5’-3’) 
 
4 Results 
4.1 Cellular contribution to chronic intestinal inflammation 
(Paper I, IV)  
Eosinophils are the characteristic cellular component for EEG, presenting as 
tissue eosinophilia and eosinophilic granulomas. In the jejunal tissue used 
(Paper I), mild infiltrates of eosinophils were noted in healthy horses, and were 
primarily scattered in the submucosa and in the basal areas of lamina propria, 
in accordance with Rötting et al. (2008). In diseased horses, EEG horses 
displayed moderate to marked tissue eosinophilia (Table 2 in Paper I) whereas 
EGE horses showed sparse to no eosinophils. Due to this apparent difference in 
infiltration, eosinophils were not enumerated in more detail, but included in the 
descriptive analysis. In the rectal tissue (Paper IV), all horses regardless of 
disease status displayed normal infiltrates of eosinophils.  
T cells dominated the lymphocyte population in jejunal tissue and were 
numerous in the apical lamina propria of healthy horses (Paper I). Diseased 
horses displayed abundant T cells at the sites of intense cell infiltration, which 
were distributed throughout the tissue. The expansion of T cells was prominent 
and correlated to less B cells in the examined area (Paper I). T cells and TREGS 
also correlated in the jejunum (Paper I) if all horses were included in the 
analysis, but not if only diseased horses were compared (Fig. 9, Paper I). In 
healthy horses, TREGS resided diffusely in the jejunal lamina propria, while in 
the diseased horses this T cell subpopulation accumulated in areas of intense 
cell infiltrates and in streaks outside granulomas. In the rectal tissue obtained 
from healthy horses and horses with simple proctitis (Paper IV), T cells 
constituted a large part of the immune cell population. Clustering of T cells and 
TREGS was noted in the diseased horses and the regulatory cells were somewhat 
more numerous in horses with an active component in their inflammation 
(CASP). No correlation was found between the numbers of T cells and TREGS 
in the rectum (Fig. 9, Paper IV).  
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Figure 9. The correlation in infiltration between T cells and TREGS in (A) the jejunum of both 
healthy and diseased horses, (B) the jejunum of diseased horses, (C) the rectum of both healthy 
and diseased horses and (D) the rectum of diseased horses. (A) and (B) are quantitated by image 
analysis and (C) and (D) by cell counting in an unbiased counting frame.   
In both the jejunal and rectal epithelium, almost all IEL showed labelling for T 
cells (Paper I, IV), only a few were labelled by FoxP3 or by MHC II and none 
displayed B cell characteristic (Paper I). In the healthy equine ileum, 
approximately 50% of the IEL are CD4+ T cells and 50% CD8+ T cells 
(Tschetter et al., 1998). In the present material, the numbers of IEL was not 
significantly different in jejunum obtained from healthy and diseased horses, 
but was markedly increased in a few of the diseased horses (Paper I). 
Additional findings in the jejunal epithelium were reduction in Paneth cells 
seen along with villus atrophy and crypt abscesses in the granulomatous cases. 
Two EEG horses had crypt abscesses, one also displaying goblet cell 
hyperplasia (Paper I) (Fig. 10). In the rectal tissue, one horse diagnosed with 
CASP displayed loss of acid mucin in the goblet cells (see supplementary Fig. 
S2 in Paper IV).  
MHC II-expressing cells were together with T cells the dominant cell type 
in the jejunal lamina propria and submucosa, and the infiltration of the two cell 
types was correlated (Paper I). In healthy horses, most MHC II positive cells 
were situated in the villi lamina propria, just below the epithelium with 
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occasional cells within the epithelium. In horses with granulomatous or 
eosinophilic inflammation, MHC II+ cells accumulated in lymphoid 
aggregates. Most MHC II+ cells were according to their morphology 
macrophages. As several cell types can be induced to express MHC II, some of 
these cells expressing MHC II may not be professional antigen presenting cells 
(Kambayashi & Laufer, 2014; Daar et al., 1984). When comparing the 
infiltrates of B cells and MHC II+ cells, both by light microscopy and by 
morphometry, MHC II-expressing cells far exceeded the B cells. Additionally, 
MHC II-expressing cells were a dominant presence in lymphoid aggregates in 
the diseased horses, whereas B cells were mostly found in the periphery of 
these lesions. In healthy horses, B cells were found in the basal areas of the 
jejunal lamina propria, and only accounted for a smaller fraction of the immune 
cells. For EEG afflicted tissues, B cells were rare in the areas displaying most 
intense immune cell infiltration. Instead B cells were present in areas of more 
normal histology and then in numbers comparable with the healthy horses. For 
EGE-afflicted tissues, B cells were generally fewer compared with healthy 
horses and their distribution was in clusters rather than diffusely spread. Areas 
with nodules of B cells (Fig. 11) could be noted in diseased horses and may 
reflect lymphoid neogenesis (Aloisi & Pujol-Borrell, 2006). 
Plasma cells secreting IgA, IgM and IgG were present, in decreasing order, 
in the healthy jejunal lamina propria (Paper I). IgA and IgM cells were located 
at the junction between villous and mid-area lamina propria, whereas the few 
IgG plasma cells were present in the basal areas of lamina propria. In diseased 
horses, IgA labelled cells were detected in the periphery of intense cell 
infiltrations, and occasionally forming streaks of labelled cells. IgG plasma 
cells were also found in minor streaks in one EEG-afflicted horse, whereas in 
the EGE-afflicted horse these plasma cells were scarce and diffusely spread. 
IgM plasma cells followed the distribution of IgA cells in the EEG group with 
less positive cells than in healthy horses, whereas IgM cells were rare in the 
tissue samples from the EGE group. A strong positive correlation was seen 
between decreased areas of B cells and IgG+ cells (Paper I). IgM+ cells were 
negatively correlated to both T cells and MHC II+ cells. In the epithelium, 
IgA+ enterocytes showed varying intensity of labelling, with the least intense 
staining in the bottom of crypts and in the villi tips. The level of IgA labelling 
in the epithelium was comparable between healthy and EEG horses and both 
these groups showed more labelling than in the EGE horses (Fig. 12). 
As T cells and MHC II-expressing cells dominated the lesions in both EEG 
and EGE, a delayed type hypersensitivity reaction is proposed for both entities. 
The granuloma formation by macrophages in both groups suggests either an   
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Figure 10. The epithelium of (A) a healthy horse, (B) an EEG-afflicted horse with crypt abscess 
and goblet hyperplasia and (C) an EGE-afflicted horse with degranulation or loss of Paneth cells. 
Magnification x40.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Immunohistochemical staining in consecutive sections in eosinophilic gastroenteritis 
Jejunal tissue stained (H&E) and immunolabelled (CD3: T cells, CD20: B cells, FoxP3: TREGS). 
The dotted circle outlines the B cell dense area. Magnification x40. 
 
 
 
 
 
 
 
Figure 12. Immunolabelled IgA-expressing cells in (A) the healthy jejunum, (B) eosinophilic 
enteritis and (C) granulomatous enteritis. Magnification x20.  
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inability of the effector pathways to eradicate the triggering antigen or an 
inability of the regulatory pathways to terminate an immune response when the 
antigen has been eliminated. Whether the quantity and function of TREGS in the 
diseased horses were adequate is not known, but their presence in IBD lesions 
suggests that an attempt to limit the inflammation has occurred, even if not 
successful. The rarity of B cells and plasma cells, especially in EGE horses, 
indicates a lesser role for this lymphocyte lineage in disease development.  
Furthermore, it was possible to demonstrate and quantitate presence of T 
cells as well as TREGS in the rectal biopsies. To quantify the T cell-associated 
gene expression in rectal biopsies, appropriate reference genes were evaluated.  
4.2 Appropriate reference genes (Paper II, III, IV) 
For studies on equine PBMC the genes GAPDH, HPRT and SDHA were 
evaluated as potential reference genes. Independent of sampling methods and 
in vivo or in vitro stimulation, SDHA and HPRT were identified, using the 
qBase software, as the two most optimal reference genes, and hence were used 
for normalisation (Paper II). In contrast, the combination of GAPDH and 
HPRT were more suitable for normalization in healthy equine ileum, right 
dorsal colon and rectum (Paper II).  
To further study gene expression in equine intestinal material, the sampling 
sites were extended to incorporate seven distinct segments (the duodenum, 
mid-jejunum, ileum, caecum, right ventral and dorsal colon and rectum) and 
seven putative reference genes (β2M, GAPDH, H2Atype1, HPRT, RPL32, 
SDHA and TFRC) were evaluated (Paper III). No combination of the evaluated 
reference genes was stable enough for normalization across all analysed 
segments from healthy horses. However, sets of three or four reference genes 
suitable for segment-specific normalization were identified for the duodenum, 
mid-jejunum, right and ventral dorsal colons and rectum. The ileum and 
caecum showed considerably lower reference gene stability. When focusing on 
rectal material from healthy horses and horses with IBD two or three genes 
were identified as useful candidates for normalization of gene expression, 
namely H2Atype1 and TFRC, or SDHA, GAPDH and RPL32, respectively. 
Combined data from both groups identified RPL32, GAPDH, HPRT and 
SDHA for normalisation across the groups. The most stably expressed of these 
genes were GAPDH and RPL32, therefore they were used in Paper IV. qBase 
was again used to control for stability in GAPDH and RPL32 in the rectal 
samples in Paper IV. Both GAPDH and RPL32 were again stably expressed in 
both healthy and diseased material and suitable for normalisation.  
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4.3 Gene expression in equine PBMC (Paper II, III) 
Apart from the reference genes, seven target genes (MD-2, CD14, TLR4, IFN-
α, IL-12p40, IL-23p19 and IL-17A) were evaluated in stimulated and 
unstimulated blood cells (Paper II, III). In LPS in vivo stimulated samples, the 
expression of CD14 was overall unaffected (Paper II). TLR4 expression 
reached its peak in relative expression between 6 to 12 hours after the start of 
infusion, and showed up to a 20-fold increase. The expression levels of TLR4 
remained elevated in all horses except one that was excluded due to severe 
signs of endotoxaemia. For two of the horses, the expression levels of TLR4 
were similar to the levels of MD-2, whereas in one horse, MD-2 levels 
exceeded TLR4 and in the fourth horse MD-2 was expressed at lower levels 
than TLR4.  
Induction of PBMC with CpG-ODN had no effect on the expression of 
CD14, IL-17A or IL-23p19 (Paper II, III). The expression of MD-2 and TLR4 
increased two and half times, IL-12p40 increased over 100 times, and IFN-α 
increased more than 300 times after CpG-ODN stimulation compared with 
unstimulated cells. These findings are in agreement with TLR9 activation by 
CpG-ODN, driving a TH1 cytokine profile. Stimulation of cells with PMA and 
ionomycin had no effect on the expression of CD14 or IL-23p19, but reduced 
the relative expression of IFN-α, IL-12p40, MD-2 and TLR4. In contrast, the 
expression of IL-17A increased 300-fold, thus indicating a TH17 profile. It was 
concluded that CpG-ODN stimulated cells were useful as positive control 
material in the MD-2, IL-12p40, IFN-α and TLR4 assays and PMA and 
ionomycin stimulated cells in the IL-17A assay. Additionally, the assays were 
considered effective in detecting the expression of the targeted genes in 
biological material. The increased TLR4 and MD-2 expression as well as 
clinical signs of endotoxaemia corresponded in time. This validated the 
described method for gene expression analysis also for samples induced in 
vivo.  
4.4 Gene expression in healthy intestine (Paper II, III, IV) 
The seven genes of interest evaluated in PBMC were also evaluated in healthy 
intestinal material. CD14, MD-2 and TLR4 were evaluated in full-thickness 
samples of the ileum, right dorsal colon and rectum and showed no significant 
differences in expression between horses or segments (Paper II). When TLR4 
was evaluated in rectal biopsy material, variations in expression were within a 
2-fold change for all healthy horses but one (Paper IV). IFN-α, IL-12p40, IL-
17A and IL-23p19 were evaluated in seven segments of the equine intestine. 
IFN-α was not detectable in any of the segments. The expression of IL-17A in 
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the ileum and IL-23p19 in the caecum and right dorsal colon varied somewhat, 
whereas the other cytokines and sites showed expression within a 2-fold range 
(Paper III). The expression of IL-23p19 never varied more than twofold in 
healthy rectal biopsies. Likewise, all horses except two in the case of IL-12p40, 
or one in the case of IL-17 were within a 2-fold range. Overall, all cytokines 
but IFN-α were readily detected and segments and individuals in the healthy 
subjects showed little variation in target gene expression. Therefore, IL-12p40, 
IL-17, IL-23p19 and TLR4 were chosen for further analyses.  
4.5 Gene expression in chronically inflamed intestine (Paper IV) 
The gene expression of IL-12p40, IL-17A, IL-23p19 and TLR4 was evaluated 
in rectal tissue displaying lesions consistent with idiopathic chronic 
enteropathy. The expression varied for some of the targeted genes, but was not 
related to either the sex or age of the horse (Fig. 13). The expression of the 
targeted genes in the diseased horses did not differ from the healthy subset 
when compared as one group including both horses with and without an acute 
inflammation. However, when the diseased horses were divided into their 
respective histological diagnosis, differences were noted. Horses with chronic 
simple proctitis (CSP) had a lower expression of IL-12p40 than healthy horses 
and horses with chronic active simple proctitis (CASP). The expression of IL-
17A was significantly higher in the CASP group compared with healthy or 
CSP horses. In all horses, the expression of IL-17A correlated positively with 
the number of TREGS infiltrating the tissue. No significant differences in 
expression of IL23p19 were found. Nevertheless, a correlation between IL-
23p19 expression and the number of TREGS was seen. CSP horses showed no 
difference in expression of TLR4 compared with the other groups, whereas the 
CASP horses had a significantly higher expression of TLR4 than the healthy 
horses. 
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Figure 13. The expression of IL-12p40, IL-17A, IL-23p19 and TLR4 in rectal biopsies from both 
healthy and diseased horses. No correlation for age and gene expression was found for any of the 
tar geted genes.   
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5 Discussion and concluding remarks 
Equine IBD is diagnosed by combining clinical and histological findings. In 
the standing horse, the only easy accessible tissue for histological analysis is 
rectum, from which biopsies can be collected. Using routine staining (H&E, 
Ab-PAS) this tissue is diagnostic in approximately half of the cases. This thesis 
therefore aimed to expand technologies for examination of rectal material and 
to elaborate methods that could be applied in the diagnosis of intestinal 
inflammatory conditions in the horse. For that purpose, rectal biopsies 
displaying simple chronic enteropathy were used for gene expression analysis 
(Paper IV), as specific IBD lesions were found in too few cases to be included. 
However, simple proctitis is not pathognomonic of IBD (Lindberg et al., 
1996). Additionally, not all horses afflicted by IBD have changes in their 
rectum. The use of rectal biopsies from the 2010s reflects the current clinical 
situation, where rectal material is the main tissue available for the diagnosis of 
IBD. Extended histological examinations were therefore carried out on 
archived material (Paper I). This material, albeit limited in its suitability in 
some analyses, was a good source of well-diagnosed cases with characteristic 
lesions and severe disease status. The further analysis of formalin-fixed 
archived material was however limited to immunohistochemistry. The number 
of reagents specific for all equine materials is still limited, and more research is 
needed to create immunological reagents for the detailed investigation of 
disease processes in the horse. The present thesis therefore focused on 
elaboration of methods such as immunohistochemistry and real time qRT-PCR 
to study equine intestinal immune reactions.  
The advantage of using IHC is its ability to label cells in situ. Precautions 
were made to label all sections in a series in the same run and photograph them 
in one session to minimize inter-run differences. Notably, all archived samples 
were re-bedded before sectioning and diseased material displayed labelling of 
each antibody. Therefore, the length of time that the material had been 
archived was considered to have had little impact on the results. For the IHC 
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labelling of FoxP3, the antibody labelled the correct population, but several 
attempts to increase the detection were needed as the chromogen staining was 
faint. The TSA amplification as described by Junginger et al. (2012) for 
detection of FoxP3 cells in canine lamina propria was applied and performed 
well on equine intestinal tissue. For IgG, an antibody from Jackson 
ImmunoResearch (anti-horse IgG, Fc specific; 108-005-008) labelled plasma 
cells, but also gave an intense, obscuring background, whereas an antibody 
from Rockland (anti-horse IgG, Fc specific, 608-1103) labelled non-plasma 
cells in addition to IgG-producing cells. The anti-horse IgG antibody from 
Sigma-Aaldrich (Fc specific, SAB3700143) that was eventually used labelled 
plasma cells and only produced minor background. However, the cells labelled 
in IBD-diseased horses were few. It is therefore possible that the antibody, 
even though it was a polyclonal antibody, might not detect all subclasses of 
equine IgG. To better delineate the understanding of the IgG involvement in 
equine IBD, monoclonal antibodies directed to all subclasses of equine IgG are 
needed to be used on diseased tissues.  
The quantitative analysis of the IHC labelling was restricted to the lamina 
propria as it is thought to be the effector site for immune cells in the 
development of IBD (Xavier & Podolsky, 2007). The lamina propria also 
constituted the main area of rectal biopsies. In Paper IV, labelled cells in the 
rectal mucosa were manually counted in a pre-defined area. To count cells in 
this way gives an estimate of the cell density that is comparable to other 
studies, but requires a randomized selection of areas analysed and is not the 
method of choice in stereology (Gundersen et al., 1988). Instead, when 
applying image analysis (Paper I) the area labelled by an antibody was divided 
by the total area of the analysed lamina propria. The resulting percentage of 
labelling is thus comparable between groups. The image analysis provides an 
estimate of area rather than cell density. Consequently, the results take into 
account the alteration in immune infiltrate, and make group differences more 
reliable. The image analysis method used is applicable to any immunolabelled 
or stained section. Importantly, the image analysis is most valuable when done 
in conjunction with a descriptive analysis and should be seen as a quantitative 
complement to the evaluation by an experienced pathologist (Gurcan et al., 
2009). 
 
For gene expression analysis, a rigorous selection of reference genes is 
necessary for all types of tissue, species and condition. Appropriate reference 
genes ensure a correct normalisation of the data set in both healthy and 
diseased material (Vandesompele et al., 2002). The method used in Paper III 
was time-consuming, but necessary to gain reliable results. The real time qRT-
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PCR protocols for the various cytokine genes were optimised using RNA 
prepared from equine PBMC exposed to PMA/ionomycin or CpG-ODN. 
However, none of these inducers increased the expression of IL-23p19. 
According to Liu et al. (2009), the use of Rhodococcus equi induced IL-23p19, 
but not IL-12p40, in cultures of PBMC obtained from foals. This approach 
could possibly be used to produce improved positive controls for the IL-23p19 
assay. The reference gene expression analysis established in the present thesis 
is the most comprehensive available for equine intestinal segments and will be 
valuable in any future analysis of equine intestinal materials. Likewise, the 
protocols for RNA isolation and purification from the rectal biopsies will aid in 
recovery of high quality RNA from limited amounts of tissues. Furthermore, 
primer design and optimised conditions for real time qRT-PCR analysis of 
equine IL-17A and equine IL-23p19 expands the possibilities to explore 
inflammatory conditions in any equine organ of interest, as long as appropriate 
reference genes for the material are used. 
 
Both descriptive and quantitative analysis of the healthy full-thickness 
material of the jejunum (Paper I) identified a predominance of T cells in the 
lamina propria, which is in agreement with previous publications (Divers et al., 
2006; Packer et al., 2005). The distribution of T cells in the healthy mucosa 
resembled that described for the canine small intestine mucosa (German et al., 
1999). In diseased horses, a T cell dominance of the lymphocytic infiltrate has 
been described for both EEG lesions and LPE in horses (Mäkinen et al., 2008; 
Divers et al., 2006). However, in non-lesion sites of EEG, MHC II-expressing 
cells were the most numerous (Mäkinen et al., 2008). In the present material, 
no differentiation was made between lesion and non-lesion sites in the image 
analysis (Paper I), but MHC II positive cells were markedly increased in all 
diseased horses. This increase was significant in EGE when quantified. Taken 
together, the results strongly indicate a role for MHC II-expressing cells and T 
cells in the development of equine IBD. An important role for these cells has 
also been suggested for equine recurrent uveitis (ERU), which is an idiopathic, 
immune-mediated disease of the eye (Romeike et al., 1998). MHC II-
expressing cells and T cells are increased diffusely in the inflamed uvea, 
suggesting a role for macrophages with aberrant immune responses in the 
disease development (Romeike et al., 1998). T cells and MHC II-expressing 
cells are also central in human IBD (Neurath, 2014; Zenewicz et al., 2009; 
Coombes & Powrie, 2008). In accordance, dendritic cells are suggested to be 
pathogenetic in canine IBD with increased numbers of dendritic cells and 
MHC II-expression in both lymphoplasmacytic and eosinophilic IBD 
(Junginger et al., 2014). It would therefore be of much interest to study further 
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MHC II-expressing cells in equine intestinal disorders, as these cells clearly are 
involved in disease development in several species afflicted with IBD.  
Numerous contributing factors have been described for IBD in several 
species including genetic, microbial and environmental factors. The chronic 
lesions in both EEG and EGE show great similarities to delayed 
hypersensitivity reactions, but in the former entity massive infiltrations of 
eosinophils are noted. A possible difference between EEG and EGE could be 
diverging initiating antigen, driving different types of immune responses. 
Alternatively, it could simply reflect a genetic predisposition for that type of 
immune reaction or reflect environmental influences.  
Chronic eosinophilic inflammation is commonly caused by parasites, 
allergens and viruses attracting eosinophils to sites of inflammation through 
chemokines such as eotaxins and cytokines, including IL-4, IL-5 and IL-13. 
Transient eosinophilia has been diagnosed in the lungs of otherwise healthy 
horses, lacking an increase in IL-4 and IL-5 (Riihimäki et al., 2008). This 
finding demonstrates a partial redundancy of TH2 cytokines in the recruitment 
of eosinophils to equine mucosal surfaces. Eosinophils are also recruited in 
insect bite hypersensitivity of horses (Schaffartzik et al., 2012). The reaction is 
induced by type I hypersensitivity and possibly by type IV reaction (Anderson 
et al., 1991). The insect bite hypersensitivity is a prominent allergic reaction to 
Culicoides antigens and is characteristically diagnosed in Icelandic horses born 
in an environment free of the particular insect, that later move to an area where 
the insect is present. This clinical history supports the theory that an early 
encountering with an antigen is important to induce tolerance rather than 
inflammation. TREGS are suggested to be important in determining whether a 
horse will develop Culicoides hypersensitivity or not. When exposed to the 
insect’s saliva, allergic horses had lower numbers of TREGS and expression of 
regulatory cytokines compared with healthy horses (Hamza et al., 2012; 
Heimann et al., 2011). Additionally, TREGS of the allergic horses in vitro were 
significantly less able to supress the production of pro-inflammatory cytokines 
than TREGS from healthy horses (Hamza et al., 2013). These findings suggest an 
imbalance between the effector T cells and the TREG responses in the diseased 
animals. 
In the present material, no intralesional microorganisms were detected in 
any of the included diseased horses, whereas in some healthy individuals 
intestinal ciliate protozoa were present, which are considered to be normal 
inhabitants of the equine gut (Uzal et al., 2016). However, a microbial 
aetiology to equine IBD is still possible as the initiating insult can have been 
eradicated at the time of sampling or undetected by the methods used (Stratford 
et al., 2011).  
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In a pilot study (Wahlund, 2011), the expression of type I interferons was 
quantitated in equine rectal biopsies from clinically suspected IBD cases. Type 
I interferons were not readily detected in any of the horses, with the exception 
of IFN-κ, which did not differ significantly between healthy and diseased 
horses. To further the understanding of IFNs in IBD, studies on characteristic 
lesions in fresh material would be of interest and could if detected indirect 
indicate a viral infection in the pathogenesis. 
Microbial antigens are sensed by receptors on innate immune cells. 
Dysfunctional TLRs and their contribution to human IBD were reviewed and it 
was concluded that atypical TLR signalling has an important role in disease 
development (Cario, 2010). In both human and canine IBD-afflicted intestinal 
tissues, TLR4 is up-regulated on recruited dendritic cells (Allenspach et al., 
2010; Burgener et al., 2008; Hart et al., 2005) and these cells respond more 
vigorously to LPS with pro-inflammatory cytokine production (Baumgart et 
al., 2009; Hart et al., 2005). A genetic association and increase in susceptibility 
to human and canine IBD have been found for TLR alleles, including 
polymorphism in TLR4 (Cheng et al., 2015; Kathrani et al., 2010; 
Franchimont et al., 2004). The gene polymorphism possibly makes some hosts 
more susceptible to bacterial infections or over-reactive towards non-harmful 
antigens. In the present material, expression of TLR4 could be induced by 
exposure of equine PBMC to CpG-ODN in vitro, and in vivo after endotoxin 
infusion (Paper II). In the intestinal tissue, TLR4 expression varied between 
individuals, but was significantly increased in chronic active proctitis (CASP; 
Paper IV). It is possible that in the chronic active group the lamina propria cells 
were exposed to LPS and therefore increased their TLR4 expression.  
Theoretically, signalling via TLR4 would generate inflammatory mediators 
attracting neutrophils. In horses with chronic recurrent airway obstruction 
(RAO), bronchial epithelial cells have increased expression of TLR4 and 
neutrophils, but not eosinophils, infiltrate the lung. Hence in both IBD and 
RAO, increased TLR4 is seen together with recruitment of neutrophils. These 
disease conditions are thought to be a reaction towards environmental antigens, 
such as dusty, mouldy hay. Even healthy horses respond to provocation with 
this type of hay (Kleiber et al., 2005), but RAO horses are suggested to have an 
exaggerated, sustained immune response. The increased expression of TLR4 
could indicate an enhanced recognition of LPS with recruitment of 
granulocytes for both IBD and RAO.  
RAO has been thought to be a type I hypersensitivity with TH2 cells 
stimulating IgE production (Lavoie et al., 2001). More recent data indicate that 
type IV reactions might be a major contributor to the pathology (Tahon et al., 
2009). Additionally, in RAO horses, increased expression of both TH1 and TH2 
61 
cytokines has been noted. IL-17A is also increased in RAO (Debrue et al., 
2005), which could contribute to the neutrophilia observed. However, one 
study showed that the neutrophilia preceded the increase in IL-17, suggesting 
another role for the cytokine in the disease (Ainsworth et al., 2006). In the 
closely linked disease, inflammatory airway disease (IAD), several types of 
inflammation of the respiratory tract are included; neutrophilic, eosinophilic 
and mastocytic. IAD is either an environmental disease, induced by poor 
housing, or an early onset of RAO (Leclère & Lavoie, 2016). In IAD, cytokine 
levels vary with the type of cell infiltrates. IFN-γ, IL-4 and IL-12 are increased 
in mastocytic inflammation, IL-1β and IL-17 in neutrophilic inflammation 
(Beekman et al., 2012; Lavoie et al., 2011), whereas IL-5 and IL-10 as well as 
CXL-8 are increased in all types (Beekman et al., 2012). Taken together, 
plasticity in the TH subset appears crucial in the development of the 
hypersensitivity reaction in the lung, whereas the role for TREGS in the diseases 
is still unknown.  
A similar question remains for equine IBD, whether the chronic reaction is 
due to a continuous stimulation of an antigen or to a faulty regulation of the 
inflammation. TREGS are suggested to be defective in human IBD (Hardenberg 
et al., 2011). Interestingly, TREGS and IL-10 are reduced in canine IBD 
compared with healthy dogs and dogs with lymphoma (Maeda et al., 2015; 
Junginger et al., 2012). TREGS in the equine intestine have not been evaluated 
previously, but have been suggested to be impaired in horses with insect bite 
hypersensitivity (Hamza et al., 2012). In the present material, TREGS were noted 
in all horses examined (Paper I, IV), but their number did not correlate with the 
infiltrating T cells in diseased horses. This variation in proportion of T cells 
and TREGS might be due to sampling at different time points in the disease 
progression. Further work on TREGS function in equine IBD is needed to see 
whether their cytokine production is altered. Cytokines of special interest are 
IL-10 and TGF-β as these cytokines are suggested to mediate the regulation in 
horses (Hamza et al., 2011). If, as in dogs, a discrepancy between lymphoma 
and IBD can be made by evaluating the infiltrating TREGS this would be helpful 
in distinguishing between equine intestinal lymphoma and LPE, which can be 
difficult for well differentiated lymphoma today.  
 
In the present material, the distribution of B cells and plasma cells in the 
healthy jejunal lamina propria (Paper I) corresponded well with the distribution 
of these cell types described by Packer et al. (2005). For IBD-afflicted horses, 
previous studies have found few B cells as well as less plasma cell than T cells 
(Mäkinen et al., 2008; Divers et al., 2006). It is noteworthy that in one of the 
studies no comparisons with normal tissue were made and in the other study 
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the disease LPE was evaluated. Therefore, the present thesis is the first to 
discriminate between healthy tissue and EEG and EGE lesions. A reduction in 
the B cell linage for diseased horses was shown, which was most significant in 
the EGE group (Paper I). In the diseased horses, B cells were occasionally seen 
in foci in the centre of lymphoid aggregates. The same phenomenon was 
described in equine eyes afflicted by ERU (Regan et al., 2012; Romeike et al., 
1998). In the B cell dense areas of IBD horses, MHC II-expressing cell and T 
cell, including TREGS, were co-localised with the B cells, but few 
immunoglobulin-producing cells were detected. A possible explanation for 
these B cell foci is lymphoid neogenesis, which is found in chronic 
inflammation of human tissues, and represents an attempt to maintain immune 
responses towards a persistent antigen (Aloisi & Pujol-Borrell, 2006).  
In human IBD, immunoglobulins are increased in IBD-afflicted tissues 
(Brandtzaeg et al., 2006). Particularly, the percentage of immunoglobulin 
classes changes from predominantly IgA production in healthy individuals to 
an increase in pro-inflammatory IgG production in IBD patient (Dorn et al., 
2002). A reduction in IgG was noted in dogs afflicted with lymphocytic IBD 
(Jergens et al., 1996), whilst IgG was increased in eosinophilic and unspecified 
IBD (Kleinschmidt et al., 2007; German et al., 2001). In the present material, 
IgA, IgG and IgM positive cells in the jejunal lamina propria were reduced, 
significantly for IgM in the EGE group. In serum, reduced levels of IgG and 
IgM in IBD-afflicted horses were primarily thought to be due to losses through 
the inflamed intestine, and not a true deficiency in production (Lindberg et al., 
1985). The limited involvement of B cells and immunoglobulins in the present 
IBD necropsy material would suggest a down-regulation of TH2 response in the 
IBD lesions. This  may be in favour of a TH1 and/or TH17 cell response. A TH1 
response would correspond well to the granulomatous lesions noted in these 
horses. There was no possibility to evaluate cytokine expression in the severe 
lesions as the material was formalin-fixed. Therefore analysis of inflamed 
rectal biopsies obtained from horses where clinical evaluation was suggestive 
of IBD was undertaken (Paper IV). In diseased rectal tissue, IL-17A was 
increased in chronic active proctitis. Even if IL-17 can be produced by other 
cells, TH17 cells are the main producers. Thus, TH17 are most likely involved 
in the more acute phases of the proctitis. As T cells show plasticity, TH17 cells 
might convert to TH1 in the tissue, stimulating macrophages and granuloma 
formation. However, in chronic proctitis, IL-12 was reduced, which could 
contradict the role of TH1.  
A wide range of possibilities to induce T cell mediated chronic disease in 
the horse has been described. The role of T helper cell subsets in other equine 
chronic diseases are varying; TH2 in insect bite hypersensitivity (Heimann et 
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al., 2011), TH1 and TH17 in ERU (Regan et al., 2012; Zipplies et al., 2012; 
Gilger et al., 1999) and for RAO and IAD the subset varies between TH1, TH2 
and TH17 (Debrue et al., 2005; Cordeau et al., 2004; Ainsworth et al., 2003; 
Beadle et al., 2002). Possibly, the T helper subset varies in equine IBD as well, 
but to clarify such plasticity in T cell subset further studies of these cells in 
known stages of disease are needed. Extended studies of cytokine gene 
expression in the rectal biopsies including those indicative of e.g. TH2 cells are 
warranted. For an evaluation of T cell plasticity in disease development to be 
possible, afflicted horses need to be monitored over time and sampled in 
different stages of disease development. Such an approach is challenging, but 
necessary to understand more fully the immune mechanisms of equine IBD.  
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6 Future perspectives 
Diagnosis of an idiopathic disease is challenging, and in equine IBD the 
diagnosis is complicated by the inaccessibility of the primary lesions. Lesions 
most certainly precede the clinical signs and improved diagnostics are crucial 
as the clinical signs are far from unique. Analysis of accessible tissues, such as 
the rectum, blood and faeces is the method of choice. Here, diagnostic tools for 
human and canine IBD could be applicable, such as visualisation of the mucosa 
by video capsule enteroscopy and measuring faecal markers of inflammation 
(e.g. lactoferrin and calprotectin). Earlier detection of diseased animals may 
increase the chance of finding initiating factors for the disease.  
As environmental factors have been shown to participate in the 
development of IBD in other species, these need to be considered for horses as 
well. Both geographical and seasonal factor have been suggested previously, 
and the possibility that changes in diet might influence IBD progression should 
not be excluded. Today newer tools for microbial identification facilitate the 
detection of non-culturable pathogens and can discern differences in the 
microbiota. It is known that feed alters the composition of microbiota in 
horses. Combining research on seasonal, geographical and feed alterations with 
observations on their effect on the microbiota and immune cells in the host 
could contribute to an understanding of the whole disease process.  
The histopathology of equine IBD indicates a delayed hypersensitivity 
reaction. Several other diseases in the horse share this feature and combining 
the research on several chronic equine diseases would be beneficial for the 
overall understanding of equine immunology. Especially, it would be of great 
interest to study further the contribution of dendritic cells, macrophages and T 
cells, especially TREGS, as these cells seemingly are important in the 
continuation of inflammation in several equine diseases. In the work of the 
present thesis, collected intestinal material was snap-frozen and stored at -
80°C. This stock of frozen material gives the opportunity to study sub-
populations of immune cells, using methods not applicable to formalin-fixed 
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tissue and the investigation of this frozen material would complement the 
present results. Additionally, the bank of frozen samples can be used for future 
research on in vitro cultured cells and cellular responses to microbial antigens. 
Established methods exist regarding the retrieval of frozen cells and the 
methods established in the present thesis can subsequently be used to detect 
altered gene expression in in vitro-stimulated cells.  
The evaluation of genetic alterations that affect intestinal immune cells 
could give insight into the pathogenesis of different chronic inflammations in 
horses. Both TLR4 and MHC II gene alleles are of major interest to study in 
equine IBD, as these genes are associated with other chronic equine diseases or 
IBD in other species. In addition to TLR4 and MHC II, mucus production also 
plays an important role in the intestinal barrier function. Environmental factors 
that disrupt the mucus layer have been found to increase the risk of murine 
intestinal inflammation (Chassaing et al., 2015). Genetic studies of goblet cells 
in horses have been limited to the airways where MUC5AC, but not MUC2 is 
expressed (Gerber et al., 2003). A change in mucins and a break in the barrier 
function could also be an important pathogenetic feature in equine IBD.  
 
In conclusion, equine IBD is a complex disorder and warrants further 
studies to discern its pathogenesis. To increase this understanding, a 
comprehensive approach must be adopted that combines several research areas 
and includes translational as well as comparative studies across species.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. An illustration of the complexity in the suggested development of IBD.  
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7 Populärvetenskaplig sammanfattning 
Kronisk idiopatisk inflammatorisk tarmsjukdom hos häst, även kallat equine 
inflammatory bowel disease (eqIBD), är en ovanlig, men allvarlig sjukdom 
som drabbar vuxna hästar oavsett kön och ras. Symtomen är framförallt 
avmagring, diarré och/ eller kolik. Kliniskt kan proteinförlust (hypoproteinemi 
och/eller hypoalbuminemi), malabsorption (försämrat upptag vid D-xylostest) 
och leverpåverkan ses. Ovanligare symtom är dermatit, anemi och subkutana 
ödem. Ibland kan sjukdomen gå i skov följda av episoder utan klinisk sjukdom. 
IBD är en uteslutningsdiagnos där klinisk utredning och patologanatomisk 
bedömning av affekterad tarm ligger till grunden för diagnos. Tre olika 
histologiska typer av eqIBD finns beskrivna i litteraturen; ekvin eosinofil 
gastroenterit (EEG), ekvin granulomatös enterit (EGE) och lymfoplasmacytär 
enterit (LPE). Prognosen för drabbade hästar bedömdes länge vara dålig, men 
har under senare år förbättrats med hjälp av långtidsbehandlingar med 
glukokortikoider samt kirurgi i utvalda fall. Sjukdomen saknar kända utlösande 
faktorer, men ett överreaktivt immunförsvar misstänks vara grundläggande i 
sjukdomsutvecklingen. Syftet med avhandlingen var att förbättra kunskapen 
om immunologisk reaktivitet i tarmen hos såväl friska hästar som hos hästar 
med kroniska inflammatoriska tarmsjukdomar. Teorin har varit att ett felaktigt 
reglerat immunförsvar ligger till grund för den kroniska tarminflammationen 
som ses vid eqIBD. 
I den friska tarmen återfinns normalt immunceller av varierande typ, så som 
dendritceller, makrofager, lymfocyter och plasmaceller. Immunförsvaret har 
många sätt att känna igen främmande antigen. Ett av dem är receptorn TLR4 
som främst uttrycks av dendritceller och makrofager. För att upprätthålla en 
balans där födoämnen och normalfloran inte initierar ett immunsvar finns 
nedreglerande mekanismer, så kallade regulatoriska celler. En av dessa celler 
är regulatoriska T celler (Tregs) och de hämmar andra T celler från att driva 
inflammatoriska processer. När ett för immunförsvaret okänt agens når tarmen 
startar en inflammation med rekrytering av granulocyter (neutrofiler, 
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eosinofiler), fagocyter (makrofager) och lymfocyter (T celler, B celler). 
Beroende på vilka signalsubstanser (cytokiner) som frisätts attraheras olika 
celltyper, däribland olika typer av T hjälpar (TH) celler. Tidigare har man trott 
att det funnits två typer av TH-celler; TH1 som via IL-12 gett cell-medierade 
immunsvar och TH2 som inducerat ett antikroppssvar (immunoglobuliner). På 
senare år har TH17 upptäckts, en TH-cell som producerar IL-17A och som är 
överuttryck i IBD hos människor. Hos människa har man även sett att IL-23 
stiger i vävnaden hos IBD-patienter, ett cytokin som stabiliserar TH17-celler så 
att de fortsätter driva inflammationen.  
I avhandlingen påvisades i tarmpreparat från både EEG- och EGE-formen 
av eqIBD ett tydligt T-cellsdrivet immunsvar, med involvering av MHC II-
positiva celler (makrofager och dendritceller). De regulatoriska T-cellerna 
följde inget tydligt mönster hos de sjuka hästarna, utan den individuella 
skillnaden var stor. Troligen beror det på att materialet kommer från kliniska 
fall, där hästarna befinner sig i olika stadier av sjukdomen. Få B-celler 
återfanns i det sjuka materialet, något som var mest påtagligt i de 
granulomatösa (EGE) fallen. Mängden immunoglobulinbildande celler skilde 
sig inte åt mellan EEG-drabbade hästar och friska hästar, men för EGE-
hästarna var plasmaceller som bildade IgM mycket få.  
Vid vidare studier av T-celler hos hästar med kronisk tarmsjukdom 
undersöktes rektumbiopsier. Biopsierna från friska hästar samt biopsier som 
uppvisade kronisk inflammation eller kronisk akutiserad inflammation ingick i 
studien. Uttrycket av cytokinerna IL-12, IL-17A och IL-23, samt receptorn 
TLR4 studerades med hjälp av kvantitativ PCR. Hos hästar med kronisk 
inflammation var uttrycket av IL-12 lägre än hos friska hästar och de med 
kronisk akutiserad inflammation. I den senare gruppen av hästar var uttrycker 
av IL-17A ökat. Detta indikerar att Th1-svaret är lågt vid kronisk inflammation 
och TH17-celler bidrar till inflammationen i den akuta, kroniska sjukdomen.   
Sammantaget kan resultaten i avhandlingen påvisa en dominans av T-celler 
i både EEG och EGE. Den samtida infiltrationen av makrofager tyder på att det 
är en fördröjd överkänslighetsreaktion som driver den kroniska inflammation, 
där ett antikroppssvar är av mindre vikt. De regulatoriska cellernas roll är 
fortfarande ej helt klarlagd och kräver vidare studier av cellernas funktion hos 
hästar. Även fortsatta studier för att se hur TH17-celler driver eqIBD är av 
intresse då dessa celler troligen medverkar i de aktiva faserna av sjukdomen.  
 
 
 
 
68 
References 
Aamodt, G., Bukholm, G., Jahnsen, J., Moum, B. & Vatn, M.H. (2008). The association between 
water supply and inflammatory bowel disease based on a 1990-1993 cohort study in 
southeastern Norway. American Journal of Epidemiology, 168(9), pp. 1065-72. 
Ahluwalia, J.P. (2012). Immunotherapy in inflammatory bowel disease. The Medical Clinics of 
North America, 96(3), pp. 525-44. 
Ai, W., Li, H., Song, N., Li, L. & Chen, H. (2013). Optimal method to stimulate cytokine 
production and its use in immunotoxicity assessment. International Journal of Environmental 
Research and Public Health, 10(9), pp. 3834-3842. 
Ainsworth, D.M., Grünig, G., Matychak, M.B., Young, J., Wagner, B., Erb, H.N. & Antczak, 
D.F. (2003). Recurrent airway obstruction (RAO) in horses is characterized by IFN-γ and IL-
8 production in bronchoalveolar lavage cells. Veterinary Immunology and Immunopathology, 
96(1-2), pp. 83-91. 
Ainsworth, D.M., Wagner, B., Franchini, M., Grunig, G., Erb, H.N. & Tan, J.Y. (2006). Time-
dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses 
with recurrent airway obstruction. American Journal of Veterinary Research, 67(4), pp. 669-
77. 
Ainsworth, D.M., Wagner, B., Erb, H.N., Young, J.C. & Retallick, D.E. (2007). Effects of in vitro 
exposure to hay dust on expression of interleukin-17, -23, -8, and -1β and chemokine (C-X-C 
motif) ligand 2 by pulmonary mononuclear cells isolated from horses chronically affected 
with recurrent airway disease. American Journal of Veterinary Research, 68(12), pp. 1361-
1369. 
Akira, S., Uematsu, S. & Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell, 
124(4), pp. 783-801. 
Allenspach, K., House, A., Smith, K., McNeill, F.M., Hendricks, A., Elson-Riggins, J., Riddle, 
A., Steiner, J.M., Werling, D., Garden, O.A., Catchpole, B. & Suchodolski, J.S. (2010). 
Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of 
Toll-like receptors in German shepherd dogs with chronic enteropathies. Veterinary 
Microbiology, 146(3–4), pp. 326-335. 
69 
Allenspach, K. (2011). Clinical immunology and immunopathology of the canine and feline 
intestine. Veterinary Clinics of North America: Small Animal Practice, 41(2), pp. 345-360. 
Aloisi, F. & Pujol-Borrell, R. (2006). Lymphoid neogenesis in chronic inflammatory diseases. 
Nature Reviews Immunology, 6(3), pp. 205-217. 
Anderson, C.A. & Divers, T.J. (1983). Systemic granulomatous inflammation in a horse grazing 
hairy vetch. Journal of the American Veterinary Medical Association, 183(5), pp. 569-70. 
Anderson, G.S., Belton, P. & Kleider, N. (1991). Culicoides obsoletus (Diptera: 
Ceratopogonidae) as a causal agent of Culicoides hypersensitivity (sweet itch) in British 
Columbia. Journal of Medical Entomology, 28(5), pp. 685-93. 
Andersson, M., Ahlberg, V., Jensen-Waern, M. & Fossum, C. (2011). Intestinal gene expression 
in pigs experimentally co-infected with PCV2 and PPV. Veterinary Immunology and 
Immunopathology, 142(1–2), pp. 72-80. 
Aoun, P. & Pirruccello, S.J. (2007). Hematopoetic cell differentiation: Monoclonal antibodies and 
cluster designation defined hematopoetic cell antigens. In: Carey, J.L., McCoy, J.P. & Keren, 
D.F. (Eds.) Flow cytometry in clinical diagnosis. 4th ed. Chicago: The American Society for 
Clinical Pathology, p. 48.  
Archer, D.C., Barrie Edwards, G., Kelly, D.F., French, N.P. & Proudman, C.J. (2006). 
Obstruction of equine small intestine associated with focal idiopathic eosinophilic enteritis: 
An emerging disease? The Veterinary Journal, 171(3), pp. 504-512. 
Archer, D.C. & Proudman, C.J. (2006). Epidemiological clues to preventing colic. The Veterinary 
Journal, 172(1), pp. 29-39. 
Archer, D.C. (2009). Chronic colic: Diagnosis and treatment. In: Robinson, N.E. & Sprayberry, 
K.A. (Eds.) Current Therapy in Equine Medicine. 6th ed. Philadelphia: Saunders, pp 424-429.  
Archer, D.C., Costain, D.A. & Sherlock, C. (2014). Idiopathic focal eosinophilic enteritis (IFEE), 
an emerging cause of abdominal pain in horses: The effect of age, time and geographical 
location on risk. PLoS ONE, 9(12), e112072. 
Back, H., Nyman, A. & Osterman Lind, E. (2013). The association between Anoplocephala 
perfoliata and colic in Swedish horses - A case control study. Veterinary Parasitology, 197(3–
4), pp. 580-585. 
Barr, B.S. (2006). Infiltrative intestinal disease. Veterinary Clinics of North America: Equine 
Practice, 22(1), pp. e1-7. 
Bassage, L.H., Johnston, J.K., Krotec, K.L. & Meyer, B.S. (1997). Eosinophilic enterocolitis 
associated with recurrent colonic impactions in a mare. Equine Veterinary Journal, 29(4), pp. 
322-325. 
Bataille, R., Jégo, G., Robillard, N., Barillé-Nion, S., Harousseau, J.-L., Moreau, P., Amiot, M. & 
Pellat-Deceunynck, C. (2006). The phenotype of normal, reactive and malignant plasma cells. 
Identification of "many and multiple myelomas" and of new targets for myeloma therapy. 
Haematologica, 91(9), pp. 1234-1240. 
Bauer, S., Kirschning, C.J., Hacker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H. & 
Lipford, G.B. (2001). Human TLR9 confers responsiveness to bacterial DNA via species-
70 
specific CpG motif recognition. Proceedings of the National Academy of Sciences, 98(16), 
pp. 9237-42. 
Baumgart, D.C., Thomas, S., Przesdzing, I., Metzke, D., Bielecki, C., Lehmann, S.M., Lehnardt, 
S., Dorffel, Y., Sturm, A., Scheffold, A., Schmitz, J. & Radbruch, A. (2009). Exaggerated 
inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in 
patients with inflammatory bowel disease. Clinical & Experimental Immunology, 157(3), pp. 
423-36. 
Beadle, R.E., Horohov, D.W. & Gaunt, S.D. (2002). Interleukin-4 and interferon-gamma gene 
expression in summer pasture-associated obstructive pulmonary disease affected horses. 
Equine Veterinary Journal, 34(4), pp. 389-94. 
Beekman, L., Tohver, T. & Léguillette, R. (2012). Comparison of cytokine mRNA expression in 
the bronchoalveolar lavage fluid of horses with Inflammatory Airway Disease and 
bronchoalveolar lavage mastocytosis or neutrophilia using REST software analysis. Journal 
of Veterinary Internal Medicine, 26(1), pp. 153-161. 
Berndt, A., Derksen, F.J., Venta, P.J., Ewart, S., Yuzbasiyan-Gurkan, V. & Robinson, N.E. 
(2007). Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is 
associated with airway inflammation in horses with recurrent airway obstruction. American 
Journal of Physiology - Lung Cellular and Molecular Physiology, 292(4), pp. L936-L943. 
Bosseler, L., Verryken, K., Bauwens, C., de Vries, C., Deprez, P., Ducatelle, R. & Vandenabeele, 
S. (2012). Equine multisystemic eosinophilic epitheliotropic disease: A case report and 
review of literature. New Zealand Veterinary Journal, 61(3), pp. 177-182. 
Boyle, J.P., Mayle, S., Parkhouse, R. & Monie, T.P. (2013). Comparative genomic and sequence 
analysis provides insight into the molecular functionality of NOD1 and NOD2. Frontiers in 
Immunology, 4(Article ID: 317), pp. 1-12. 
Brand, S. (2009). Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new 
immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s 
disease. Gut, 58(8), pp. 1152-1167. 
Brandtzaeg, P., Carlsen, H.S. & Halstensen, T.S. (2006). The B-cell system in inflammatory 
bowel disease. In: Blumberg, R.S. & Neurath, M.F. (Eds.) Immune Mechanisms in 
Inflammatory Bowel Disease. New York: Springer Science, pp 149-167.  
Breider, M.A., Kiely, R.G. & Edwards, J.F. (1985). Chronic eosinophilic pancreatitis and 
ulcerative colitis in a horse. Journal of the American Veterinary Medical Association, 186(8), 
pp. 809-11. 
Brunialti, M.K., Kallas, E.G., Freudenberg, M., Galanos, C. & Salomao, R. (2002). Influence of 
EDTA and heparin on lipopolysaccharide binding and cell activation, evaluated at single-cell 
level in whole blood. Cytometry, 50(1), pp. 14-8. 
Bruynsteen, L., Erkens, T., Peelman, L.J., Ducatelle, R., Janssens, G.P., Harris, P.A. & Hesta, M. 
(2013). Expression of inflammation-related genes is associated with adipose tissue location in 
horses. BMC Veterinary Research, 9(1), pp. 1-9. 
71 
Buergelt, C.D., Green, S.L., Mayhew, I.G., Wilson, J.H. & Merritt, A.M. (1988). Avian 
mycobacteriosis in three horses. The Cornell Veterinarian, 78(4), pp. 365-80. 
Burgener, I., König, A., Allenspach, K., Sauter, S., Boisclair, J., Doherr, M. & Jungi, T. (2008). 
Upregulation of Toll-like receptors in chronic enteropathies in dogs. Journal of Veterinary 
Internal Medicine, 22(3), pp. 553-560. 
Bustin, S.A. (2008). RT-qPCR and molecular diagnostics: No evidence for measles virus in the 
GI tract of autistic children. European Pharmaceutical Review, 4(1), pp. 11-16. 
Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, 
T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J. & Wittwer, C.T. (2009). The MIQE 
guidelines: Minimum information for publication of quantitative real-time PCR experiments. 
Clinical Chemistry, 55(4), pp. 611-622. 
Camoglio, L., Te Velde, A.A., Tigges, A.J., Das, P.K. & Van Deventer, S.J. (1998). Altered 
expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. 
Inflammatory Bowel Diseases, 4(4), pp. 285-90. 
Cario, E. & Podolsky, D.K. (2000). Differential alteration in intestinal epithelial cell expression of 
Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infection and 
Immunity, 68(12), pp. 7010-7017. 
Cario, E. (2010). Toll-like receptors in inflammatory bowel diseases: A decade later. 
Inflammatory Bowel Diseases, 16(9), pp. 1583-1597. 
Cebra, M.L., Cebra, C.K., Garry, F.B. & Gould, D.H. (1998). Idiopathic eosinophilic enteritis in 
four cattle. Journal of the American Veterinary Medical Association, 212(2), pp. 258-61. 
Cesta, M.F. (2006). Normal structure, function, and histology of mucosa-associated lymphoid 
tissue. Toxicologic Pathology, 34(5), pp. 559-608. 
Chaffin, M.K., Fuenteabla, I.C., Schumacher, J., Welch, R.D. & Edwards, J.F. (1992). Idiopathic 
muscular hypertrophy of the equine small intestine: 11 cases (1980-1991). Equine Veterinary 
Journal, 24(5), pp. 372-8. 
Chai, V., Vassilakos, A., Lee, Y., Wright, J.A. & Young, A.H. (2005). Optimization of the 
PAXgene blood RNA extraction system for gene expression analysis of clinical samples. 
Journal of Clinical Laboratory Analysis, 19(5), pp. 182-8. 
Chassaing, B., Koren, O., Goodrich, J.K., Poole, A.C., Srinivasan, S., Ley, R.E. & Gewirtz, A.T. 
(2015). Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic 
syndrome. Nature, 519(7541), pp. 92-6. 
Chatila, T., Silverman, L., Miller, R. & Geha, R. (1989). Mechanisms of T cell activation by the 
calcium ionophore ionomycin. The Journal of Immunology, 143(4), pp. 1283-9. 
Chen, K. & Cerutti, A. (2011). The function and regulation of immunoglobulin D. Current 
Opinion in Immunology, 23(3), pp. 345-352. 
Cheng, Y., Zhu, Y., Huang, X., Zhang, W., Han, Z. & Liu, S. (2015). Association between TLR2 
and TLR4 gene polymorphisms and the susceptibility to inflammatory bowel disease: A 
meta-analysis. PLoS ONE, 10(5), e0126803. 
72 
Chien, Y.-h. & Konigshofer, Y. (2007). Antigen recognition by γδ T cells. Immunological 
Reviews, 215(1), pp. 46-58. 
Church, S., Kelly, D.F. & Obwolo, M.J. (1986). Diagnosis and successful treatment of diarrhoea 
in horses caused by immature small strongyles apparently insusceptible to anthelmintics. 
Equine Veterinary Journal, 18(5), pp. 401-3. 
Churcher, R.K. & Watson, A.D.J. (1997). Canine histiocytic ulcerative colitis. Australian 
Veterinary Journal, 75(10), pp. 710-713. 
Cimprich, R.E. (1974). Equine granulomatous enteritis. Veterinary Pathology, 11(6), pp. 535-
547. 
Clark, E.S. (1988). Lymphocytic enteritis in a filly. Journal of the American Veterinary Medical 
Association, 193(10), pp. 1281-3. 
Cline, J.M., Schlafer, D.W., Callihan, D.R., Vanderwall, D. & Drazek, F.J. (1991). Abortion and 
granulomatous colitis due to Mycobacterium avium complex infection in a horse. Veterinary 
Pathology, 28(1), pp. 89-91. 
Co, D.O., Hogan, L.H., Il-Kim, S. & Sandor, M. (2004). T cell contributions to the different 
phases of granuloma formation. Immunology Letters, 92(1–2), pp. 135-142. 
Cohen, N.D., Loy, J.K., Lay, J.C., Craig, T.M. & McMullan, W.C. (1992). Eosinophilic 
gastroenteritis with encapsulated nematodes in a horse. Journal of the American Veterinary 
Medical Association, 200(10), pp. 1518-20. 
Cohen, N.D. & Peloso, J.G. (1996). Risk factors for history of previous colic and for chronic, 
intermittent colic in a population of horses. Journal of the American Veterinary Medical 
Association, 208(5), pp. 697-703. 
Collery, P., McElroy, M., Sammin, D. & White, P. (1999). Equine granulomatous enteritis linked 
with aluminum? Veterinary and Human Toxicology, 41(1), pp. 49-50. 
Collins Kelley, L., Mahaffey, E.A., Bounous, D.I., Antczak, D.F. & Brooks, R.L. (1997). 
Detection of equine and bovine T- and B-lymphocytes in formalin-fixed paraffin-embedded 
tissues. Veterinary Immunology and Immunopathology, 57(3-4), pp. 187-200. 
Coombes, J.L. & Powrie, F. (2008). Dendritic cells in intestinal immune regulation. Nature 
Reviews Immunology, 8(6), pp. 435-446. 
Cordeau, M.E., Joubert, P., Dewachi, O., Hamid, Q. & Lavoie, J.P. (2004). IL-4, IL-5 and IFN-
gamma mRNA expression in pulmonary lymphocytes in equine heaves. Veterinary 
Immunology and Immunopathology, 97(1-2), pp. 87-96. 
Cordes, D.O. & Dewes, H.F. (1971). Diverticulosis and muscular hypertrophy of the small 
intestine of horses, pigs and sheep. New Zealand Veterinary Journal, 19(5), pp. 108-11. 
Cosnes, J., Gower-Rousseau, C., Seksik, P. & Cortot, A. (2011). Epidemiology and natural 
history of inflammatory bowel diseases. Gastroenterology, 140(6), pp. 1785-94. 
Costa, L.R.R. (2016). Granulomatous diseases. In: Felippe, M.J.B. (Ed.) Equine Clinical 
Immunology. Oxford: Wiley, pp 101-112.  
Costa, M.C., Arroyo, L.G., Allen-Vercoe, E., Stämpfli, H.R., Kim, P.T., Sturgeon, A. & Weese, 
J.S. (2012). Comparison of the fecal microbiota of healthy horses and horses with colitis by 
73 
high throughput sequencing of the V3-V5 region of the 16S rRNA gene. PLoS ONE, 7(7), 
e41484. 
Crepaldi, T., Crump, A., Newman, M., Ferrone, S. & Antczak, D. (1986). Equine T lymphocytes 
express MHC class II antigens. International Journal of Immunogenetics, 13(4), pp. 349-360. 
Cua, D.J. & Tato, C.M. (2010). Innate IL-17-producing cells: The sentinels of the immune 
system. Nature Review Immunology, 10(7), pp. 479-489. 
Daar, A.S., Fuggle, S.V., Fabre, J.W., Ting, A. & Morris, P.J. (1984). The detailed distribution of 
MHC Class II antigens in normal human organs. Transplantation, 38(3), pp. 293-8. 
Davis, R.L. & Bohlke, K. (2001). Measles vaccination and inflammatory bowel disease: 
Controversy laid to rest? Drug Safety, 24(13), pp. 939-46. 
Day, M.J. & Hall, E.J. (2008). Immune-mediated alimentary disease. In: Day, M.J. (Ed.) Clinical 
Immunology of the Dog and Cat. 2nd ed. London: Manson, pp. 201-227.  
de Laat, M.A., Clement, C.K., McGowan, C.M., Sillence, M.N., Pollitt, C.C. & Lacombe, V.A. 
(2014). Toll-like receptor and pro-inflammatory cytokine expression during prolonged 
hyperinsulinaemia in horses: Implications for laminitis. Veterinary Immunology and 
Immunopathology, 157(1–2), pp. 78-86. 
Debrue, M., Hamilton, E., Joubert, P., Lajoie-Kadoch, S. & Lavoie, J.-P. (2005). Chronic 
exacerbation of equine heaves is associated with an increased expression of interleukin-17 
mRNA in bronchoalveolar lavage cells. Veterinary Immunology and Immunopathology, 
105(1-2), pp. 25-31. 
Detournay, O., Morrison, D.A., Wagner, B., Zarnegar, B. & Wattrang, E. (2013). Genomic 
analysis and mRNA expression of equine type I interferon genes. Journal of Interferon & 
Cytokine Research, 33(12), pp. 746-59. 
Dheda, K., Huggett, J.F., Chang, J.S., Kim, L.U., Bustin, S.A., Johnson, M.A., Rook, G.A.W. & 
Zumla, A. (2005). The implications of using an inappropriate reference gene for real-time 
reverse transcription PCR data normalization. Analytical Biochemistry, 344(1), pp. 141-143. 
Dickinson, C.E. & Lori, D.N. (2002). Diagnostic workup for weight loss in the geriatric horse. 
Veterinary Clinics of North America: Equine Practice, 18(3), pp. 523-31. 
Divers, T.J., Pelligrini-Masini, A. & McDonough, S. (2006). Diagnosis of inflammatory bowel 
disease in a Hackney pony by gastroduodenal endoscopy and biopsy and successful treatment 
with corticosteroids. Equine Veterinary Education, 18(6), pp. 284-287. 
Do Carmo, G.M., Da Silva, A.S., Klauck, V., Pazinato, R., Moura, A.B., Duarte, T., Duarte, 
M.M.M.F., Bochi, G.V., Moresco, R.N. & Stefani, L.M. (2015). Immunological response and 
markers of cell damage in seropositive horses for Toxoplasma gondii. Comparative 
Immunology, Microbiology and Infectious Diseases, 38, pp. 9-13. 
Dorn, I., Schlenke, P., Mascher, B., Stange, E.F. & Seyfarth, M. (2002). Lamina propria plasma 
cells in inflammatory bowel disease: intracellular detection of immunoglobulins using flow 
cytometry. Immunobiology, 206(5), pp. 546-57. 
Dotti, I. & Bonin, S. (2011). Quantification of Nucleic Acids. In: Stanta, G. (Ed.) Guidelines for 
Molecular Analysis in Archive Tissues. Berlin: Springer, pp 75-79.  
74 
Duckett, W.M. & Matthews, H.K. (1997). Hypereosinophilia in a horse with intestinal 
lymphosarcoma. The Canadian Veterinary Journal, 38(11), pp. 719-720. 
Edholm, E.-S., Bengten, E. & Wilson, M. (2011). Insights into the function of IgD. 
Developmental & Comparative Immunology, 35(12), pp. 1309-1316. 
Edwards, G.B., Kelly, D.F. & Proudman, C.J. (2000). Segmental eosinophilic colitis: A review of 
22 cases. Equine Veterinary Journal, 32(S32), pp. 86-93. 
Elwood, C.M., Hamblin, A.S. & Batt, R.M. (1997). Quantitative and qualitative 
immunohistochemistry of T cell subsets and MHC class II expression in the canine small 
intestine. Veterinary Immunology and Immunopathology, 58(3-4), pp. 195-207. 
Escalona, E., Okell, C. & Archer, D. (2014). Prevalence of and risk factors for colic in horses that 
display crib-biting behaviour. BMC Veterinary Research, 10(Suppl 1:S3), pp. 1-8. 
Fogarty, U., Perl, D., Good, P., Ensley, S., Seawright, A. & Noonan, J. (1998). A cluster of 
equine granulomatous enteritis cases: The link with aluminium. Veterinary and Human 
Toxicology, 40(5), pp. 297-305. 
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J.J., 
Garrone, P., Garcia, E., Saeland, S., Blanchard, D., Gaillard, C., Das Mahapatra, B., Rouvier, 
E., Golstein, P., et al. (1996). T cell interleukin-17 induces stromal cells to produce 
proinflammatory and hematopoietic cytokines. Journal of Experimental Medicine, 183(6), pp. 
2593-2603. 
Fowler, C.B., Evers, D.L., O’Leary, T.J. & Mason, J.T. (2011). Antigen retrieval causes protein 
unfolding: Evidence for a linear epitope model of recovered immunoreactivity. Journal of 
Histochemistry and Cytochemistry, 59(4), pp. 366-381. 
Franchimont, D., Vermeire, S., El Housni, H., Pierik, M., Van Steen, K., Gustot, T., Quertinmont, 
E., Abramowicz, M., Van Gossum, A., Devière, J. & Rutgeerts, P. (2004). Deficient host-
bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 
Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut, 53(7), 
pp. 987-992. 
Fushimi, Y., Takagi, M., Kawaguchi, H., Miyoshi, N., Tsuka, T. & Deguchi, E. (2015). Three 
cases of idiopathic eosinophilic enteritis with chronic obstinate diarrhea in Japanese Black 
fattening cattle. The Journal of Veterinary Medical Science, 77(3), pp. 337-340. 
Gehlert, T., Devergne, O. & Niedobitek, G. (2004). Epstein-Barr virus (EBV) infection and 
expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic 
inflammatory bowel disease. Journal of Medical Virology, 73(3), pp. 432-8. 
Gerber, V., Robinson, N.E., Venta, P.J., Rawson, J., Jefcoat, A.M. & Hotchkiss, J.A. (2003). 
Mucin genes in horse airways: MUC5AC, but not MUC2, may play a role in recurrent airway 
obstruction. Equine Veterinary Journal, 35(3), pp. 252-257. 
German, A.J., Hall, E.J. & Day, M.J. (1999). Analysis of leucocyte subsets in the canine intestine. 
Journal of Comparative Pathology, 120(2), pp. 129-145. 
75 
German, A.J., Hall, E.J., Kelly, D.F., Watson, A.D. & Day, M.J. (2000). An 
immunohistochemical study of histiocytic ulcerative colitis in boxer dogs. Journal of 
Comparative Pathology, 122(2-3), pp. 163-75. 
German, A.J., Hall, E.J. & Day, M.J. (2001). Immune cell populations within the duodenal 
mucosa of dogs with enteropathies. Journal of Veterinary Internal Medicine, 15(1), pp. 14-25. 
Gibson, K.T. & Alders, R.G. (1987). Eosinophilic enterocolitis and dermatitis in two horses. 
Equine Veterinary Journal, 19(3), pp. 247-252. 
Gibson, K.T., O'Hara, A.J. & Huxtable, C.R. (2001). Focal eosinophilic proctitis with associated 
rectal prolapse in a pony. Australian Veterinary Journal, 79(10), pp. 679-681. 
Gilger, B.C., Malok, E., Cutter, K.V., Stewart, T., Horohov, D.W. & Allen, J.B. (1999). 
Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent 
uveitis. Veterinary Immunology and Immunopathology, 71(1), pp. 17-28. 
Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D.J. & 
Sansonetti, P.J. (2003). Nod2 is a general sensor of peptidoglycan through muramyl dipeptide 
(MDP) detection. Journal of Biological Chemistry, 278(11), pp. 8869-8872. 
Goldszmid, R.S. & Trinchieri, G. (2012). The price of immunity. Nature Immunology, 13(10), pp. 
932-938. 
Goyette, P., Boucher, G., Mallon, D., Ellinghaus, E., Jostins, L., Huang, H., Ripke, S., Gusareva, 
E.S., Annese, V., Hauser, S.L., Oksenberg, J.R., Thomsen, I., Leslie, S., Daly, M.J., Van 
Steen, K., et al. (2015). High-density mapping of the MHC identifies a shared role for HLA-
DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative 
colitis. Nature Genetics, 47(2), pp. 172-179. 
Greenstein, R.J. (2003). Is Crohn's disease caused by a mycobacterium? Comparisons with 
leprosy, tuberculosis, and Johne's disease. The Lancet Infectious Diseases, 3(8), pp. 507-514. 
Griffin, H.E. & Meunier, L.D. (1990). Eosinophilic enteritis in a specific-pathogen-free cat. 
Journal of the American Veterinary Medical Association, 197(5), pp. 619-20. 
Grulke, S., Franck, T., Gangl, M., Péters, F., Salciccia, A., Deby-Dupont, G. & Serteyn, D. 
(2008). Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastrointestinal 
disease. Canadian Journal of Veterinary Research, 72(1), pp. 37-42. 
Guha, M. & Mackman, N. (2001). LPS induction of gene expression in human monocytes. 
Cellular Signalling, 13(2), pp. 85-94. 
Gundersen, H.J.G. (1977). Notes on the estimation of the numerical density of arbitrary profiles: 
The edge effect. Journal of Microscopy, 111(2), pp. 219-223. 
Gundersen, H.J.G., Bendtsen, T.F., Korbo, L., Marcussen, N., Møller, A., Nielsen, K., 
Nyengaard, J.R., Pakkenberg, B., Sørensen, F.B., Vesterby, A. & West, M.J. (1988). Some 
new, simple and efficient stereological methods and their use in pathological research and 
diagnosis. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 96(1-6), pp. 
379-394. 
76 
Gurcan, M.N., Boucheron, L.E., Can, A., Madabhushi, A., Rajpoot, N.M. & Yener, B. (2009). 
Histopathological image analysis: A review. IEEE Reviews in Biomedical Engineering, 2, pp. 
147-171. 
Hampson, D.J., Lester, G.D., Phillips, N.D. & La, T. (2006). Isolation of Brachyspira pilosicoli 
from weanling horses with chronic diarrhoea. Veterinary Record, 158(19), pp. 661-2. 
Hamza, E., Gerber, V., Steinbach, F. & Marti, E. (2011). Equine CD4+ CD25high T cells exhibit 
regulatory activity by close contact and cytokine-dependent mechanisms in vitro. 
Immunology, 134(3), pp. 292-304. 
Hamza, E., Steinbach, F. & Marti, E. (2012). CD4+CD25+ T cells expressing FoxP3 in Icelandic 
horses affected with insect bite hypersensitivity. Veterinary Immunology and 
Immunopathology, 148(1-2), pp. 139-44. 
Hamza, E., Akdis, C.A., Wagner, B., Steinbach, F. & Marti, E. (2013). In vitro induction of 
functional allergen-specific CD4+ CD25high Treg cells in horses affected with insect bite 
hypersensitivity. Clinical & Experimental Allergy, 43(8), pp. 889-901. 
Hansen, R., Thomson, J.M., El-Omar, E.M. & Hold, G.L. (2010). The role of infection in the 
aetiology of inflammatory bowel disease. Journal of Gastroenterology, 45(3), pp. 266-76. 
Hansen, S., Baptiste, K.E., Fjeldborg, J. & Horohov, D.W. (2015). A review of the equine age-
related changes in the immune system: Comparisons between human and equine aging, with 
focus on lung-specific immune-aging. Ageing Research Reviews, 20, pp. 11-23. 
Hardenberg, G., Steiner, T.S. & Levings, M.K. (2011). Environmental influences on T regulatory 
cells in inflammatory bowel disease. Seminars in Immunology, 23(2), pp. 130-138. 
Hart, A.L., Al-Hassi, H.O., Rigby, R.J., Bell, S.J., Emmanuel, A.V., Knight, S.C., Kamm, M.A. 
& Stagg, A.J. (2005). Characteristics of intestinal dendritic cells in inflammatory bowel 
diseases. Gastroenterology, 129(1), pp. 50-65. 
Heimann, M., Janda, J., Sigurdardottir, O.G., Svansson, V., Klukowska, J., von Tscharner, C., 
Doherr, M., Brostrom, H., Andersson, L.S., Einarsson, S., Marti, E. & Torsteinsdottir, S. 
(2011). Skin-infiltrating T cells and cytokine expression in Icelandic horses affected with 
insect bite hypersensitivity: A possible role for regulatory T cells. Veterinary Immunology 
and Immunopathology, 140(1-2), pp. 63-74. 
Hellemans, J., Mortier, G., De Paepe, A., Speleman, F. & Vandesompele, J. (2007). qBase 
relative quantification framework and software for management and automated analysis of 
real-time quantitative PCR data. Genome Biology, 8(2), p. R19. 
Hillyer, M. & Mair, T. (1992). Multisystemic eosinophilic epitheliotropic disease in a horse: 
Attempted treatment with hydroxyurea and dexamethasone. Veterinary Record, 130(18), pp. 
392-395. 
Hines, S.A., Stone, D.M., Hines, M.T., Alperin, D.C., Knowles, D.P., Norton, L.K., Hamilton, 
M.J., Davis, W.C. & McGuire, T.C. (2003). Clearance of virulent but not avirulent 
Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma 
interferon production by CD4+ and CD8+ T lymphocytes. Clinical and Diagnostic 
Laboratory Immunology, 10(2), pp. 208-15. 
77 
Hirota, K., Duarte, J.H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D.J., Ahlfors, H., Wilhelm, C., 
Tolaini, M., Menzel, U., Garefalaki, A., Potocnik, A.J. & Stockinger, B. (2011). Fate 
mapping of IL-17-producing T cells in inflammatory responses. Nature Immunology, 12(3), 
pp. 255-63. 
Hold, G.L., Smith, M., Grange, C., Watt, E.R., El-Omar, E.M. & Mukhopadhya, I. (2014). Role 
of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the 
past 10 years? World Journal of Gastroenterology : WJG, 20(5), pp. 1192-1210. 
Hori, S., Nomura, T. & Sakaguchi, S. (2003). Control of regulatory T cell development by the 
transcription factor Foxp3. Science, 299(5609), pp. 1057-61. 
Hu, C., Sun, L., Hu, Y., Lu, D., Wang, H. & Tang, S. (2010). Functional characterization of the 
NF-κB binding site in the human NOD2 promoter. Cellular and Molecular Immunology, 7(4), 
pp. 288-295. 
Huang, N., Kawano, M.M., Mahmoud, M.S., Mihara, K., Tsujimoto, T., Niwa, O. & Kuramoto, 
A. (1995). Expression of CD21 antigen on myeloma cells and its involvement in their 
adhesion to bone marrow stromal cells. Blood, 85(12), pp. 3704-12. 
Hughes, K.J., Nicolson, L., Da Costa, N., Franklin, S.H., Allen, K.J. & Dunham, S.P. (2011). 
Evaluation of cytokine mRNA expression in bronchoalveolar lavage cells from horses with 
inflammatory airway disease. Veterinary Immunology and Immunopathology, 140(1–2), pp. 
82-89. 
Höglund, J., Ljungstrom, B.L., Nilsson, O., Lundquist, H., Osterman, E. & Uggla, A. (1997). 
Occurrence of Gasterophilus intestinalis and some parasitic nematodes of horses in Sweden. 
Acta Veterinaria Scandinavica, 38(2), pp. 157-65. 
Imbeaud, S., Graudens, E., Boulanger, V., Barlet, X., Zaborski, P., Eveno, E., Mueller, O., 
Schroeder, A. & Auffray, C. (2005). Towards standardization of RNA quality assessment 
using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids 
Research, 33(6), p. e56. 
Ismail, A.S., Severson, K.M., Vaishnava, S., Behrendt, C.L., Yu, X., Benjamin, J.L., Ruhn, K.A., 
Hou, B., DeFranco, A.L., Yarovinsky, F. & Hooper, L.V. (2011). Gammadelta intraepithelial 
lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal 
surface. Proceedings of the National Academy of Sciences, 108(21), pp. 8743-8. 
Iwakura, Y., Nakae, S., Saijo, S. & Ishigame, H. (2008). The roles of IL-17A in inflammatory 
immune responses and host defense against pathogens. Immunological Reviews, 226, pp. 57-
79. 
Jasko, D.J. & Roth, L. (1984). Granulomatous colitis associated with small strongyle larvae in a 
horse. Journal of the American Veterinary Medical Association, 185(5), pp. 553-4. 
Jawairia, M., Shahzad, G. & Mustacchia, P. (2012). Eosinophilic gastrointestinal diseases: 
Review and update. International Scholarly Research Notices: Gastroenterology, 
2012(Article ID: 463689), pp. 1-8. 
78 
Jegadeesan, R., Liu, X., Pagadala, M.R., Gutierrez, N., Butt, M. & Navaneethan, U. (2013). 
Microscopic colitis: Is it a spectrum of inflammatory bowel disease? World Journal of 
Gastroenterology 19(26), pp. 4252-4256. 
Jergens, A.E., Moore, F.M., Haynes, J.S. & Miles, K.G. (1992). Idiopathic inflammatory bowel 
disease in dogs and cats: 84 cases (1987-1990). Journal of the American Veterinary Medical 
Association, 201(10), pp. 1603-8. 
Jergens, A.E., Moore, F.M., Kaiser, M.S., Haynes, J.S. & Kinyon, J.M. (1996). Morphometric 
evaluation of immunoglobulin A-containing and immunoglobulin G-containing cells and T 
cells in duodenal mucosa from healthy dogs and from dogs with inflammatory bowel disease 
or nonspecific gastroenteritis. American Journal of Veterinary Research, 57(5), pp. 697-704. 
Jin, W. & Dong, C. (2013). IL-17 cytokines in immunity and inflammation. Emerging Microbes 
& Infections, 2(Article ID: e60), pp. 1-5. 
Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Philip 
Schumm, L., Sharma, Y., Anderson, C.A., Essers, J., Mitrovic, M., Ning, K., Cleynen, I., 
Theatre, E., et al. (2012). Host-microbe interactions have shaped the genetic architecture of 
inflammatory bowel disease. Nature, 491(7422), pp. 119-124. 
Junginger, J., Schwittlick, U., Lemensieck, F., Nolte, I. & Hewicker-Trautwein, M. (2012). 
Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and 
diseased dogs. Veterinary Research, 43(1), p. 23. 
Junginger, J., Lemensieck, F., Moore, P.F., Schwittlick, U., Nolte, I. & Hewicker-Trautwein, M. 
(2014). Canine gut dendritic cells in the steady state and in inflammatory bowel disease. 
Innate Immunity, 20(2), pp. 145-160. 
Kaikkonen, R., Niinistö, K., Sykes, B., Anttila, M., Sankari, S. & Raekallio, M. (2014). 
Diagnostic evaluation and short-term outcome as indicators of long-term prognosis in horses 
with findings suggestive of inflammatory bowel disease treated with corticosteroids and 
anthelmintics. Acta Veterinaria Scandinavica, 56(1), pp. 35-35. 
Kalck, K.A. (2009). Inflammatory bowel disease in horses. Veterinary Clinics of North America: 
Equine Practice, 25(2), pp. 303-315. 
Kalsow, C.M., Albrecht, T.R., Steinberg, N.P. & Lunn, D.P. (1998). Antibody selection for 
immunohistochemical survey of equine tissue. Journal of Comparative Pathology, 119(4), pp. 
467-472. 
Kalsow, C.M., Dubielzig, R.R. & Dwyer, A.E. (1999). Immunopathology of pineal glands from 
horses with uveitis. Investigative Ophthalmology & Visual Science, 40(7), pp. 1611-5. 
Kambayashi, T. & Laufer, T.M. (2014). Atypical MHC class II-expressing antigen-presenting 
cells: Can anything replace a dendritic cell? Nature Reviews Immunology, 14(11), pp. 719-30. 
Kamm, J.L., Nixon, A.J. & Witte, T.H. (2010). Cytokine and catabolic enzyme expression in 
synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi. 
Equine Veterinary Journal, 42(8), pp. 693-699. 
79 
Kanazawa, H., Ishiguro, Y., Munakata, A. & Morita, T. (2001). Multiple accumulation of 
Vdelta2+ gammadelta T-cell clonotypes in intestinal mucosa from patients with Crohn's 
disease. Digestive Diseases and Sciences, 46(2), pp. 410-6. 
Kathrani, A., House, A., Catchpole, B., Murphy, A., German, A., Werling, D. & Allenspach, K. 
(2010). Polymorphisms in the tlr4 and tlr5 gene are significantly associated with 
inflammatory bowel disease in German Shepherd dogs. PLoS ONE, 5(12), e15740. 
Kawai, T. & Akira, S. (2007). Signaling to NF-κB by Toll-like receptors. Trends in Molecular 
Medicine, 13(11), pp. 460-469. 
Kemper, D.L., Perkins, G.A., Schumacher, J., Edwards, J.F., Valentinen, B.A., Divers, T.J. & 
Cohen, N.D. (2000). Equine lymphocytic-plasmacytic enterocolitis: A retrospective study of 
14 cases. Equine veterinary journal. Supplement, 32(S32), pp. 108-112. 
Khor, B., Gardet, A. & Xavier, R.J. (2011). Genetics and pathogenesis of inflammatory bowel 
disease. Nature, 474(7351), pp. 307-17. 
Kirkpatrick, C.E. & Skand, D.L. (1985). Giardiasis in a horse. Journal of the American 
Veterinary Medical Association, 187(2), pp. 163-4. 
Kleiber, C., McGorum, B.C., Horohov, D.W., Pirie, R.S., Zurbriggen, A. & Straub, R. (2005). 
Cytokine profiles of peripheral blood and airway CD4 and CD8 T lymphocytes in horses with 
recurrent airway obstruction. Veterinary Immunology and Immunopathology, 104(1-2), pp. 
91-7. 
Kleinschmidt, S., Meneses, F., Nolte, I. & Hewicker-Trautwein, M. (2007). Characterization of 
mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with 
lymphocytic-plasmacytic or eosinophilic gastroenterocolitis. Veterinary Immunology and 
Immunopathology, 120(3-4), pp. 80-92. 
Koyama, M., Ishihara, K., Karasuyama, H., Cordell, J.L., Iwamoto, A. & Nakamura, T. (1997). 
CD79 alpha/CD79 beta heterodimers are expressed on pro-B cell surfaces without associated 
mu heavy chain. Int Immunol, 9(11), pp. 1767-72. 
Kricka, L.J. (1993). Ultrasensitive immunoassay techniques. Clinical Biochemistry, 26(5), pp. 
325-331. 
Krieg, A.M., Yi, A.-K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., Koretzky, 
G.A. & Klinman, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. 
Nature, 374(6522), pp. 546-549. 
Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Blackwell, S., Ballas, Z., Endres, S., 
Krieg, A. & Hartmann, G. (2001). Identification of CpG oligonucleotide sequences with high 
induction of IFN alpha/beta in plasmacytoid dendritic cells. European Journal of 
Immunology, 31, pp. 2154 - 63. 
KuKanich, K.S., Vinasco, J. & Scott, H.M. (2013). Detection of Mycobacterium avium 
subspecies paratuberculosis from intestinal and nodal tissue of dogs and cats. ISRN Veterinary 
Science, 2013, p. 323671. 
80 
La Perle, K.M.D., Piercy, R.J., Long, J.F. & Blomme, E.A.G. (1998). Multisystemic, 
eosinophilic, epitheliotropic disease with intestinal lymphosarcoma in a horse. Veterinary 
Pathology, 35(2), pp. 144-146. 
Landini, G. (2014-03-14). How to correct background illumination in brightfield microscopy. 
Available at: http://imagejdocu.tudor.lu/doku.php?id=howto:working:how_to_correct_ 
background_illumination_in_brightfield_microscopy [2016-02-17]. 
Larsen, A.B., Moon, H.W. & Merkal, R.S. (1972). Susceptibility of horses to Mycobacterium 
paratuberculosis. American Journal of Veterinary Research, 33(11), pp. 2185-9. 
Lavoie, J.P., Maghni, K., Dednoyers, M., Taha, R., Martin, J.G. & Hamid, Q.A. (2001). 
Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type 
cytokine profile. American Journal of Respiratory and Critical Care Medicine, 164(8), pp. 
1410-1413. 
Lavoie, J.P., Cesarini, C., Lavoie-Lamoureux, A., Moran, K., Lutz, S., Picandet, V., Jean, D. & 
Marcoux, M. (2011). Bronchoalveolar lavage fluid cytology and cytokine messenger 
ribonucleic acid expression of racehorses with exercise intolerance and lower airway 
inflammation. Journal of Veterinary Internal Medicine, 25(2), pp. 322-9. 
Leclère, M. & Lavoie, J.P. (2016). Inflammatory airway disease. In: Felippe, M.J.B. (Ed.) Equine 
Clinical Immunology. Oxford: Wiley, pp 145-152.  
Lecoq, L. & Lavoie, J.-P. (2009). Diagnostic approach to chronic weight loss. In: Robinson, N.E. 
& Sprayberry, K.A. (Eds.) Current Therapy in Equine Medicine. 6th ed. Philadelphia: 
Saunders, pp 898-901.  
Lee, J., Hever, A., Willhite, D., Zlotnik, A. & Hevezi, P. (2005). Effects of RNA degradation on 
gene expression analysis of human postmortem tissues. The FASEB Journal, 19(10), pp. 
1356-8. 
Lees, C.W., Barrett, J.C., Parkes, M. & Satsangi, J. (2011). New IBD genetics: Common 
pathways with other diseases. Gut, 60(12), pp. 1739-53. 
Lerner, A. (2007). Aluminum is a potential environmental factor for Crohn's disease induction. 
Annals of the New York Academy of Sciences, 1107(1), pp. 329-345. 
Lewis, M.J., Wagner, B., Irvine, R.M. & Woof, J.M. (2010). IgA in the horse: Cloning of equine 
polymeric Ig receptor and J chain and characterization of recombinant forms of equine IgA. 
Mucosal Immunology, 3(6), pp. 610-621. 
Lindberg, R. (1984). Pathology of equine granulomatous enteritis. Journal of Comparative 
Pathology, 94(2), pp. 233-247. 
Lindberg, R. (1985). On granulomatous enteritis and eosinophilic granulomatosis in the horse. 
PhD Thesis. Uppsala: Swedish University of Agricultural Sciences. 
Lindberg, R. & Karlsson, L. (1985). Topography and enterocyte morphology of the small bowel 
mucosal surface in equine granulomatous enteritis. Journal of Comparative Pathology, 95(1), 
pp. 65-78. 
81 
Lindberg, R., Persson, S., Jones, B., Thoren-Tolling, K. & Ederoth, M. (1985). Clinical and 
pathophysiological features of granulomatous enteritis and eosinophilic granulomatosis in the 
horse. Zentralblatt für Veterinärmedizin Reihe A, 32(1-10), pp. 526-539. 
Lindberg, R., Nygren, A. & Persson, S.G.B. (1996). Rectal biopsy diagnosis in horses with 
clinical signs of intestinal disorders: A retrospective study of 116 cases. Equine Veterinary 
Journal, 28(4), pp. 275-284. 
Liu, T., Nerren, J., Liu, M., Martens, R. & Cohen, N. (2009). Basal and stimulus-induced 
cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn 
foals. Vaccine, 27(5), pp. 674-683. 
Livak, K.J. & Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time 
quantitative PCR and the 2−ΔΔCT method. Methods, 25(4), pp. 402-408. 
Love, S., Mair, T.S. & Hillyer, M.H. (1992). Chronic diarrhoea in adult horses: A review of 51 
referred cases. Veterinary Record, 130(11), pp. 217-9. 
Love, S., Murphy, D. & Mellor, D. (1999). Pathogenicity of cyathostome infection. Veterinary 
Parasitology, 85(2–3), pp. 113-122. 
Lunn, D.P., Holmes, M.A. & Duffus, W.P.H. (1993). Equine T-lymphocyte MHC II expression: 
Variation with age and subset. Veterinary immunology and immunopathology, 35(3), pp. 225-
238. 
MacAllister, C.G. (1990). Lymphocytic-plasmacytic enteritis in two horses. Journal of the 
American Veterinary Medical Association, 196(12), pp. 1995-8. 
Maeda, S., Ohno, K., Fujiwara-Igarashi, A., Uchida, K. & Tsujimoto, H. (2015). Changes in 
Foxp3-positive regulatory T cell number in the intestine of dogs with idiopathic inflammatory 
bowel disease and intestinal lymphoma. Veterinary Pathology, 53(1), pp. 102-112. 
Mair, T.S., Hillyer, M.H., Taylor, F.G. & Pearson, G.R. (1991). Small intestinal malabsorption in 
the horse: An assessment of the specificity of the oral glucose tolerance test. Equine 
Veterinary Journal, 23(5), pp. 344-6. 
Mair, T.S. & Hillyer, M.H. (1997). Chronic colic in the mature horse: A retrospective review of 
106 cases. Equine Veterinary Journal, 29(6), pp. 415-420. 
Mair, T.S., Pearson, G.R. & Divers, T.J. (2006). Malabsorption syndromes in the horse. Equine 
Veterinary Education, 18(6), pp. 299-308. 
Mandigers, P. & German, A.J. (2010). Dietary hypersensitivity in cats and dogs. Tijdschrift voor 
Diergeneeskunde, 135(19), pp. 706-10. 
Mansfield, C.S., James, F.E., Craven, M., Davies, D.R., O'Hara, A.J., Nicholls, P.K., Dogan, B., 
MacDonough, S.P. & Simpson, K.W. (2009). Remission of histiocytic ulcerative colitis in 
Boxer dogs correlates with eradication of invasive intramucosal Escherichia coli. Journal of 
Veterinary Internal Medicine, 23(5), pp. 964-9. 
McClure, J.T., Young, K.M., Fiste, M., Sharkey, L.C. & Lunn, D.P. (2001). Immunophenotypic 
classification of leukemia in 3 horses. Journal of Veterinary Internal Medicine, 15(2), pp. 
144-152. 
82 
Medzhitov, R., Preston-Hurlburt, P. & Janeway, C.A., Jr. (1997). A human homologue of the 
Drosophila Toll protein signals activation of adaptive immunity. Nature, 388(6640), pp. 394-
7. 
Mellander, M.R., Ekbom, A., Hultcrantz, R., Löfberg, R., Öst, A. & Björk, J. (2016). Microscopic 
colitis: A descriptive clinical cohort study of 795 patients with collagenous and lymphocytic 
colitis. Scandinavian Journal of Gastroenterology, 51(5), pp. 556-62. 
Merritt, A.M., Merkal, R.S., Skye, D. & Selway, S. (1975). A case of avian tuberculosis of the 
intestinal tract of a horse. The American Journal of Digestive Diseases, 20(6), p. 598. 
Merritt, A.M., Cimprich, R.E. & Beech, J. (1976). Granulomatous enteritis in nine horses. 
Journal of the American Veterinary Medical Association, 169(6), pp. 603-9. 
Merritt, A.M., Cimprich, R.E. & Beech, J. (1977). Granulomatous enteritis in horses - Clinical 
and transmission studies. The American Journal of Digestive Diseases, 22(6), p. 570. 
Metcalfe, L.V., More, S.J., Duggan, V. & Katz, L.M. (2013). A retrospective study of horses 
investigated for weight loss despite a good appetite (2002-2011). Equine Veterinary Journal, 
45(3), pp. 340-5. 
Metz, B., Kersten, G.F., Hoogerhout, P., Brugghe, H.F., Timmermans, H.A., de Jong, A., 
Meiring, H., ten Hove, J., Hennink, W.E., Crommelin, D.J. & Jiskoot, W. (2004). 
Identification of formaldehyde-induced modifications in proteins: Reactions with model 
peptides. Journal of Biological Chemistry, 279(8), pp. 6235-43. 
Meuten, D.J., Butler, D.G., Thomson, G.W. & Lumsden, J.H. (1978). Chronic enteritis associated 
with the malabsorption and protein-losing enteropathy in the horse. Journal of the American 
Veterinary Medical Association, 172(3), pp. 326-33. 
Minamoto, Y., Otoni, C.C., Steelman, S.M., Buyukleblebici, O., Steiner, J.M., Jergens, A.E. & 
Suchodolski, J.S. (2015). Alteration of the fecal microbiota and serum metabolite profiles in 
dogs with idiopathic inflammatory bowel disease. Gut Microbes, 6(1), pp. 33-47. 
Morgan, A.J. & Jacob, R. (1994). Ionomycin enhances Ca2+ influx by stimulating store-regulated 
cation entry and not by a direct action at the plasma membrane. Biochemical Journal, 300(Pt 
3), pp. 665-672. 
Morton, L.D., Morton, D.G., Baker, G.J. & Gelberg, H.B. (1991). Chronic eosinophilic enteritis 
attributed to pythium sp. in a horse. Veterinary Pathology, 28(6), pp. 542-544. 
Mutalib, M., Blackstock, S., Evans, V., Huggett, B., Chadokufa, S., Kiparissi, F. & Elawad, M. 
(2015). Eosinophilic gastrointestinal disease and inflammatory bowel disease in children: Is it 
a disease continuum? European Journal of Gastroenterology & Hepatology, 27(1), pp. 20-3. 
Muzio, M., Bosisio, D., Polentarutti, N., D'Amico, G., Stoppacciaro, A., Mancinelli, R., van't 
Veer, C., Penton-Rol, G., Ruco, L.P., Allavena, P. & Mantovani, A. (2000). Differential 
expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective 
expression of TLR3 in dendritic cells. Journal of Immunology, 164(11), pp. 5998-6004. 
Mäkinen, P.E., Archer, D.C., Baptiste, K.E., Malbon, A., Proudman, C.J. & Kipar, A. (2008). 
Characterisation of the inflammatory reaction in equine idiopathic focal eosinophilic enteritis 
and diffuse eosinophilic enteritis. Equine Veterinary Journal, 40(4), pp. 386-392. 
83 
Naser, S.A., Sagramsingh, S.R., Naser, A.S. & Thanigachalam, S. (2014). Mycobacterium avium 
subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease 
patients. World Journal of Gastroenterology, 20(23), pp. 7403-7415. 
Nash, D.M., Sheldon, I.M., Herath, S. & Lane, E.A. (2010). Markers of the uterine innate immune 
response of the mare. Animal Reproduction Science, 119(1–2), pp. 31-39. 
Nerren, J.R., Payne, S., Halbert, N.D., Martens, R.J. & Cohen, N.D. (2009). Cytokine expression 
by neutrophils of adult horses stimulated with virulent and avirulent Rhodococcus equi in 
vitro. Veterinary Immunology and Immunopathology, 127(1-2), pp. 135-143. 
Neurath, M.F., Fuss, I., Kelsall, B.L., Stüber, E. & Strober, W. (1995). Antibodies to interleukin 
12 abrogate established experimental colitis in mice. The Journal of Experimental Medicine, 
182(5), pp. 1281-1290. 
Neurath, M.F. (2014). Cytokines in inflammatory bowel disease. Nature Reviews Immunology, 
14(5), pp. 329-342. 
Nieto, J.E., Macdonald, M.H., Braim, A.E.P. & Aleman, M. (2009). Effect of lipopolysaccharide 
infusion on gene expression of inflammatory cytokines in normal horses in vivo. Equine 
Veterinary Journal, 41(7), pp. 717-719. 
Nimmo Wilkie, J.S., Yager, J.A., Nation, P.N., Clark, E.G., Townsend, H.G.G. & Baird, J.D. 
(1985). Chronic eosinophilic dermatitis: A manifestation of a multisystemic, eosinophilic, 
epitheliotropic disease in five horses. Veterinary Pathology, 22(4), pp. 297-305. 
Ning, S., Pagano, J.S. & Barber, G.N. (2011). IRF7: activation, regulation, modification and 
function. Genes and Immunity, 12(6), pp. 399-414. 
Owen, J., Punt, J. & Stranford, S. (2012). Kuby Immunology. 7th ed. New York: W.H. Freeman, p. 
98. 
Packer, M., Patterson-Kane, J.C., Smith, K.C. & Durham, A.E. (2005). Quantification of immune 
cell populations in the lamina propria of equine jejunal biopsy specimens. Journal of 
Comparative Pathology, 132(1), pp. 90-95. 
Pass, D.A. & Bolton, J.R. (1982). Chronic eosinophilic gastroenteritis in the horse. Veterinary 
Pathology, 19(5), pp. 486-496. 
Pass, D.A., Bolton, J.R. & Mills, J.N. (1984). Basophilic enterocolitis in a horse. Veterinary 
Pathology, 21(3), pp. 362-364. 
Pate, D.O., Clode, A.B., Olivry, T., Cullen, J.M., Salmon, J.H. & Gilger, B.C. (2012). 
Immunohistochemical and immunopathologic characterization of superficial stromal immune-
mediated keratitis in horses. American Journal of Veterinary Research, 73(7), pp. 1067-1073. 
Pearson, G., Davies, L., White, A. & O'Brien, J. (1993). Pathological lesions associated with 
Anoplocephala perfoliata at the ileo-caecal junction of horses. Veterinary Record, 132(8), pp. 
179-182. 
Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., Cosmi, L., 
Lunardi, C., Annunziato, F., Romagnani, S. & Cassatella, M.A. (2010). Evidence for a cross-
talk between human neutrophils and Th17 cells. Blood, 115(2), pp. 335-343. 
84 
Perez Olmos, J.F., Schofield, W.L., Dillon, H., Sadlier, M. & Fogarty, U. (2006). Circumferential 
mural bands in the small intestine causing simple obstructive colic: A case series. Equine 
Veterinary Journal, 38(4), pp. 354-9. 
Perkins, G.A., Nydam, D.V., Flaminio, M.J. & Ainsworth, D.M. (2003). Serum IgM 
concentrations in normal, fit horses and horses with lymphoma or other medical conditions. 
Journal of Veterinary Internal Medicine, 17(3), pp. 337-42. 
Pichler, W.J. (2003). Delayed drug hypersensitivity reactions. Annals of Internal Medicine, 
139(8), pp. 683-693. 
Pineton de Chambrun, G., Body-Malapel, M., Frey-Wagner, I., Djouina, M., Deknuydt, F., Atrott, 
K., Esquerre, N., Altare, F., Neut, C., Arrieta, M.C., Kanneganti, T.D., Rogler, G., Colombel, 
J.F., Cortot, A., Desreumaux, P., et al. (2014). Aluminum enhances inflammation and 
decreases mucosal healing in experimental colitis in mice. Mucosal Immunology, 7(3), pp. 
589-601. 
Platt, H. (1986). Chronic inflammatory and lymphoproliferative lesions of the equine small 
intestine. Journal of Comparative Pathology, 96(6), pp. 671-684. 
Platt, R., Sponseller, B.A., Chiang, Y.-W. & Roth, J.A. (2010). Cell-mediated immunity 
evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow 
cytometry. Veterinary Immunology and Immunopathology, 135(3–4), pp. 275-281. 
Podolsky, D.K. (2002). Inflammatory bowel disease. New England Journal of Medicine, 347(6), 
pp. 417-429. 
Proudman, C.J. & Kipar, A. (2006). IFEE: new acronym, new challenge. Equine Veterinary 
Journal, 38(4), pp. 290-291. 
Pucheu-Haston, C.M. & Del Piero, F. (2013). Equine multi-systemic eosinophilic epitheliotropic 
disease. Equine Veterinary Education, 25(12), pp. 614-617. 
Quinlivan, M., Nelly, M., Prendergast, M., Breathnach, C., Horohov, D., Arkins, S., Chiang, Y.-
W., Chu, H.-J., Ng, T. & Cullinane, A. (2007). Pro-inflammatory and antiviral cytokine 
expression in vaccinated and unvaccinated horses exposed to equine influenza virus. Vaccine, 
25(41), pp. 7056-7064. 
Rai, T., Wu, X. & Shen, B. (2015). Frequency and risk factors of low immunoglobulin levels in 
patients with inflammatory bowel disease. Gastroenterology Report, 3(2), pp. 115-121. 
Ramos-Vara, J.A. (2014). Immunohistochemical methods. In: Howard, G.C. & Kaser, M.R. 
(Eds.) Making and Using Antibodies: A Practical Handbook Boca Raton: CRC Press, p. 313.  
Regan, D.P., Aarnio, M.C., Davis, W.S., Carmichael, K.P., Vandenplas, M.L., Lauderdale, J.D. & 
Moore, P.A. (2012). Characterization of cytokines associated with Th17 cells in the eyes of 
horses with recurrent uveitis. Veterinary Ophthalmology, 15(3), pp. 145-152. 
Richard, E.A., Depecker, M., Defontis, M., Leleu, C., Fortier, G., Pitel, P.H. & Courouce-
Malblanc, A. (2014). Cytokine concentrations in bronchoalveolar lavage fluid from horses 
with neutrophilic inflammatory airway disease. Journal of Veterinary Internal Medicine, 
28(6), pp. 1838-44. 
85 
Ridyard, A.E., Nuttall, T.J., Else, R.W., Simpson, J.W. & Miller, H.R.P. (2002). Evaluation of 
Th1, Th2 and immunosuppressive cytokine mRNA expression within the colonic mucosa of 
dogs with idiopathic lymphocytic-plasmacytic colitis. Veterinary Immunology and 
Immunopathology, 86(3–4), pp. 205-214. 
Riihimäki, M., Lilliehöök, I., Raine, A., Berg, M. & Pringle, J. (2008). Clinical alterations and 
mRNA levels of IL-4 and IL-5 in bronchoalveolar cells of horses with transient pulmonary 
eosinophilia. Research in Veterinary Science, 85(1), pp. 52-5. 
Robbin, M.G., Wagner, B., Noronha, L.E., Antczak, D.F. & de Mestre, A.M. (2011). 
Subpopulations of equine blood lymphocytes expressing regulatory T cell markers. 
Veterinary Immunology and Immunopathology, 140(1–2), pp. 90-101. 
Roberts, M.C. & Kelly, W.R. (1980). Granulomatous enteritis in a young standardbred mare. 
Australian Veterinary Jounal, 56(5), pp. 230-3. 
Roberts, M.C. (1983). Protein-losing enteropathy in the horse. Compendium on Continuing 
Education for the Practising Veterinarian 5(10), pp. S550-556. 
Roda, G., Marocchi, M., Sartini, A. & Roda, E. (2011). Cytokine networks in ulcerative colitis. 
Ulcers, 2011(Article ID: 391787), pp. 1-5. 
Rodríguez-Bertos, A., Corchero, J., Castan o, M., Pen a, L., Luzón, M., G, M., ómez, B. & 
Meana, A. (1999). Pathological alterations caused by Anoplocephala perfoliata infection in 
the ileocaecal junction of equids. Journal of Veterinary Medicine Series A, 46(5), pp. 261-
269. 
Romeike, A., Brugmann, M. & Drommer, W. (1998). Immunohistochemical studies in equine 
recurrent uveitis (ERU). Veterinary Pathology, 35(6), pp. 515-26. 
Rostaing, L., Tkaczuk, J., Durand, M., Peres, C., Durand, D., de Préval, C., Ohayon, E. & Abbal, 
M. (1999). Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow 
cytometry following in vitro activation of peripheral blood mononuclear cells. Cytometry, 
35(4), pp. 318-328. 
Rothenberg, M.E. (2004). Eosinophilic gastrointestinal disorders (EGID). Journal of Allergy and 
Clinical Immunology, 113(1), pp. 11-28. 
Rumbley, C.A., Sugaya, H., Zekavat, S.A., El Refaei, M., Perrin, P.J. & Phillips, S.M. (1999). 
Activated eosinophils are the major source of Th2-associated cytokines in the schistosome 
granuloma. The Journal of Immunology, 162(2), pp. 1003-1009. 
Ruyssers, N.E., De Winter, B.Y., De Man, J.G., Loukas, A., Herman, A.G., Pelckmans, P.A. & 
Moreels, T.G. (2008). Worms and the treatment of inflammatory bowel disease: Are 
molecules the answer? Clinical and Developmental Immunology, 2008, p. 567314. 
Rychlik, W. (2007). OLIGO 7 primer analysis software. Methods in Molecular Biology 402, pp. 
35-60. 
Rötting, A.K., Freeman, D.E., Constable, P.D., Eurell, J.A.C. & Wallig, M.A. (2008). Mucosal 
distribution of eosinophilic granulocytes within the gastrointestinal tract of horses. American 
Journal of Veterinary Research, 69(7), pp. 874-879. 
86 
Sanford, S.E. (1989). Multisystemic eosinophilic epitheliotropic disease in a horse. The Canadian 
Veterinary Journal, 30(3), pp. 253-4. 
Sartor, R.B. & Mazmanian, S.K. (2012). Intestinal microbes in inflammatory bowel diseases. 
American Journal of Gastroenterology Supplements, 1(1), pp. 15-21. 
Sattasathuchana, P. & Steiner, J.M. (2014) Canine eosinophilic gastrointestinal disorders. Animal 
Health Research Reviews, 15(1), pp. 76-86. 
Scantlebury, C.E., Archer, D.C., Proudman, C.J. & Pinchbeck, G.L. (2011). Recurrent colic in the 
horse: Incidence and risk factors for recurrence in the general practice population. Equine 
Veterinary Journal. Supplement, (39), pp. 81-8. 
Schaffartzik, A., Hamza, E., Janda, J., Crameri, R., Marti, E. & Rhyner, C. (2012). Equine insect 
bite hypersensitivity: What do we know? Veterinary Immunology and Immunopathology, 
147(3–4), pp. 113-126. 
Scheifele, D., Bjornson, G. & Dimmick, J. (1987). Rapid postmortem gut autolysis in infant rats: 
A potential problem for investigators. Canadian Journal of Veterinary Research, 51(3), pp. 
404-406. 
Schmitz, S., Garden, O.A., Werling, D. & Allenspach, K. (2012). Gene expression of selected 
signature cytokines of T cell subsets in duodenal tissues of dogs with and without 
inflammatory bowel disease. Veterinary Immunology and Immunopathology, 146(1), pp. 87-
91. 
Schultheiss, P.C., Traub-Dargatz, J.L., Knight, A.P., Applehans, F.M. & Christopher, O.E. 
(1995). Intestinal fibrosis and vascular remodeling in ten horses and two ponies. Journal of 
Veterinary Diagnostic Investigation, 7(4), pp. 575-578. 
Schumacher, J., Moll, H.D., Spano, J.S., Barone, L.M. & Powers, R.D. (1990). Effect of intestinal 
resection on two juvenile horses with granulomatous enteritis. Journal of Veterinary Internal 
Medicine, 4(3), pp. 153-156. 
Schumacher, J., Spano, J.S., Oliver, J.L. & Smith, R.A. (1991). Hypereosinophilic syndrome in 
an american paint horse. Journal of Equine Veterinary Science, 11(6), pp. 346-348. 
Schumacher, J., Edwards, J.F. & Cohen, N.D. (2000). Chronic idiopathic inflammatory bowel 
diseases of the horse. Journal of Veterinary Internal Medicine, 14(3), pp. 258-265. 
Scott, E.A., Heidel, J.R., Snyder, S.P., Ramirez, S. & Whitler, W.A. (1999). Inflammatory bowel 
disease in horses: 11 cases (1988-1998). Journal of the American Veterinary Medical 
Association, 214(10), pp. 1527-1530. 
Shi, S.-R., Shi, Y. & Taylor, C.R. (2011). Antigen retrieval immunohistochemistry: Review and 
future prospects in research and diagnosis over two decades. Journal of Histochemistry and 
Cytochemistry, 59(1), pp. 13-32. 
Shibahara, T., Kuwano, A., Ueno, T., Katayama, Y., Ohya, T., Taharaguchi, S., Yamamoto, S., 
Umemura, T., Ishikawa, Y. & Kadota, K. (2005). Immunohistochemical and ultrastructural 
detection of intestinal spirochetes in Thoroughbred horses. Journal of Veterinary Diagnostic 
Investigation, 17(2), pp. 145-50. 
87 
Singh Suri, S., Janardhan, K.S., Parbhakar, O., Caldwell, S., Appleyard, G. & Singh, B. (2006). 
Expression of Toll-like receptor 4 and 2 in horse lungs. Veterinary Research, 37(4), pp. 541-
551. 
Singh, U.P., Singh, N.P., Murphy, E.A., Price, R.L., Fayad, R., Nagarkatti, M. & Nagarkatti, P.S. 
(2016). Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine, 77, 
pp. 44-49. 
Solarino, B., Vella, G.D., Magrone, T., Jirillo, F., Tafaro, A., Piscitelli, D., Casiello, M., Amati, 
L., Jirillo, E. & Tattoli, L. (2009). Postmortem morphology and viability of human Peyer’s 
Patches in distal ileum: A technical note. Immunopharmacology and Immunotoxicology, 
31(4), pp. 563-569. 
Son, B.K., Roberts, R.L., Ank, B.J. & Stiehm, E.R. (1996). Effects of anticoagulant, serum, and 
temperature on the natural killer activity of human peripheral blood mononuclear cells stored 
overnight. Clinical and Diagnostic Laboratory Immunology, 3(3), pp. 260-4. 
Southwood, L.L., Kawcak, C.E., Trotter, G.W., Stashak, T.S. & Frisbie, D.D. (2000). Idiopathic 
focal eosinophilic enteritis associated with small intestinal obstruction in 6 horses. Veterinary 
Surgery, 29(5), pp. 415-419. 
Souza, C.M., Miotto, B.A., Bonin, C.P. & Camargo, M.M. (2010). Lower serum IgA levels in 
horses kept under intensive sanitary management and physical training. Animal, 4(12), pp. 
2080-3. 
Steinbach, F., Bischoff, S., Freund, H., Metzner-Flemisch, S., Ibrahim, S., Walter, J., Wilke, I. & 
Mauel, S. (2009). Clinical application of dendritic cells and interleukin-2 and tools to study 
activated T cells in horses - First results and implications for quality control. Veterinary 
Immunology and Immunopathology, 128(1–3), pp. 16-23. 
Stratford, C.H., McGorum, B.C., Pickles, K.J. & Matthews, J.B. (2011). An update on 
cyathostomins: Anthelmintic resistance and diagnostic tools. Equine veterinary journal. 
Supplement, (39), pp. 133-9. 
Streefkerk, J.G. (1972). Inhibition of erythrocyte pseudoperoxidase activity by treatment with 
hydrogen peroxide following methanol. Journal of Histochemistry & Cytochemistry, 20(10), 
pp. 829-831. 
Sweeney, R.W., Sweeney, C.R., Saik, J. & Lichtensteiger, C.A. (1986). Chronic granulomatous 
bowel disease in three sibling horses. Journal of the American Veterinary Medical 
Association, 188(10), pp. 1192-4. 
Tahon, L., Baselgia, S., Gerber, V., Doherr, M.G., Straub, R., Robinson, N.E. & Marti, E. (2009). 
In vitro allergy tests compared to intradermal testing in horses with recurrent airway 
obstruction. Veterinary Immunology and Immunopathology, 127(1-2), pp. 85-93. 
Taouji, S., Breard, E., Peyret-Lacombe, A., Pronost, S., Fortier, G. & Collobert-Laugier, C. 
(2002). Serum and mucosal antibodies of infected foals recognized two distinct epitopes of 
VapA of Rhodococcus equi. FEMS Immunology and Medical Microbiology, 34(4), pp. 299-
306. 
88 
Taylor, C.R. & Burns, J. (1974). The demonstration of plasma cells and other immunoglobulin-
containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labelled 
antibody. Journal of Clinical Pathology, 27(1), pp. 14-20. 
Tedder, T.F. & Engel, P. (1994). CD20: A regulator of cell-cycle progression of B lymphocytes. 
Immunology Today, 15(9), pp. 450-4. 
Thomas, A., Lindsay, J., Wilkinson, M. & Bodmer, J. (1988). HLA-D region alpha-chain 
monoclonal antibodies: Cross-reaction between an anti-DP alpha-chain antibody and smooth 
muscle. The Journal of Pathology, 154(4), pp. 353-63. 
Thomas, G.W., Bell, S.C. & Carter, S.D. (2005). Immunoglobulin and peripheral B-lymphocyte 
concentrations in Fell pony foal syndrome. Equine Veterinary Journal, 37(1), pp. 48-52. 
Tompkins, D., Hudgens, E., Horohov, D. & Baldwin, C.L. (2010). Expressed gene sequences of 
the equine cytokines interleukin-17 and interleukin-23. Veterinary Immunology and 
Immunopathology, 133(2-4), pp. 309-313. 
Tschetter, J.R., Davis, W.C., Perryman, L.E. & McGuire, T.C. (1998). CD8 dimer usage on alpha 
beta and gama delta T lymphocytes from equine lymphoid tissues. Immunobiology, 198(4), 
pp. 424-38. 
Uchida, J., Lee, Y., Hasegawa, M., Liang, Y., Bradney, A., Oliver, J.A., Bowen, K., Steeber, 
D.A., Haas, K.M., Poe, J.C. & Tedder, T.F. (2004). Mouse CD20 expression and function. 
International Immunology, 16(1), pp. 119-129. 
Ueno, A., Ghosh, A., Hung, D., Li, J. & Jijon, H. (2015). Th17 plasticity and its changes 
associated with inflammatory bowel disease. World Journal of Gastroenterology, 21(43), pp. 
12283-95. 
Uhlig, H.H., McKenzie, B.S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., 
Robinson, N., Buonocore, S., Tlaskalova-Hogenova, H., Cua, D.J. & Powrie, F. (2006). 
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. 
Immunity, 25(2), pp. 309-318. 
Uhlmann, V., Martin, C.M., Sheils, O., Pilkington, L., Silva, I., Killalea, A., Murch, S.B., 
Walker-Smith, J., Thomson, M., Wakefield, A.J. & O'Leary, J.J. (2002). Potential viral 
pathogenic mechanism for new variant inflammatory bowel disease. Molecular Pathology, 
55(2), pp. 84-90. 
Uzal, A.A., Plattner, B.L. & Hostetter, J.M. (2016). Alimentary system. In: Maxie, M.G. (Ed.) 
Jubb, Kennedy, Palmer's pathology of domestic animals. 6th ed. St. Loius: Elsevier, pp 69-
128.  
Uzzaman, A. & Cho, S.H. (2012). Chapter 28: Classification of hypersensitivity reactions. 
Allergy and Asthma Proceedings, 33(3), pp. S96-S99. 
Wagner, B., Miller, D.C., Lear, T.L. & Antczak, D.F. (2004). The complete map of the Ig heavy 
chain constant gene region reveals evidence for seven IgG isotypes and for IgD in the horse. 
Journal of Immunology, 173(5), pp. 3230-42. 
89 
Wagner, B., Miller, W.H., Morgan, E.E., Hillegas, J.M., Erb, H.N., Leibold, W. & Antczak, D.F. 
(2006). IgE and IgG antibodies in skin allergy of the horse. Veterinary Research, 37(6), pp. 
813-25. 
Wagner, B. (2009). IgE in horses: Occurrence in health and disease. Veterinary Immunology and 
Immunopathology, 132(1), pp. 21-30. 
Wagner, B., Burton, A. & Ainsworth, D. (2010). Interferon-gamma, interleukin-4 and interleukin-
10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a 
delay of the Th2 cell response in equine neonates and foals. Veterinary Research, 41(4), p. 
47. 
Wahlund, C. (2011). Detection and quantification of equine type I interferons. Bachelor Thesis. 
Uppsala: Uppsala University. 
Wakefield, A.J., Pittilo, R.M., Sim, R., Cosby, S.L., Stephenson, J.R., Dhillon, A.P. & Pounder, 
R.E. (1993). Evidence of persistent measles virus infection in Crohn's disease. Journal of 
Medical Virology, 39(4), pp. 345-53. 
Valli, V.E.O., Kiupel, M. & Bienzle, D. (2016). Hematopoetic system. In: Maxie, M.G. (Ed.) 
Jubb, Kennedy, Palmer's Pathology of domestic animals. 6th ed. St. Lois: Elsevier, pp 215-
242.  
Walther, S., Rusitzka, T.V., Diesterbeck, U.S. & Czerny, C.P. (2015). Equine immunoglobulins 
and organization of immunoglobulin genes. Developmental and Comparative Immunology, 
53(2), pp. 303-19. 
Waly, N.E., Stokes, C.R., Gruffydd-Jones, T.J. & Day, M.J. (2004). Immune cell populations in 
the duodenal mucosa of cats with inflammatory bowel disease. Journal of Veterinary Internal 
Medicine, 18(6), pp. 816-825. 
van der Kolk, J.H., van Putten, L.A., Mulder, C.J., Grinwis, G.C.M., Reijm, M., Butler, C.M. & 
von Blomberg, B.M.E. (2012). Gluten-dependent antibodies in horses with inflammatory 
small bowel disease (ISBD). Veterinary Quarterly, 32(1), pp. 3-11. 
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. & Speleman, 
F. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric 
averaging of multiple internal control genes. Genome Biology, 3(7), pp. research0034.1 - 
research0034.11. 
Wang, J., Ioan-Facsinay, A., van der Voort, E.I.H., Huizinga, T.W.J. & Toes, R.E.M. (2007). 
Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. European 
Journal of Immunology, 37(1), pp. 129-138. 
Wattrang, E., Berg, M. & Magnusson, M. (2005). Immunostimulatory DNA activates production 
of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro. 
Veterinary Immunology and Immunopathology, 107(3–4), pp. 265-279. 
Vignali, D.A.A. & Kuchroo, V.K. (2012). IL-12 family cytokines: Immunological playmakers. 
Nature Immunology, 13(8), pp. 722-728. 
Wikström, F.H., Fossum, C., Fuxler, L., Kruse, R. & Lövgren, T. (2011). Cytokine induction by 
immunostimulatory DNA in porcine PBMC is impaired by a hairpin forming sequence motif 
90 
from the genome of Porcine Circovirus type 2 (PCV2). Veterinary Immunology and 
Immunopathology, 139(2–4), pp. 156-166. 
Wittebole, X., Coyle, S.M., Kumar, A., Goshima, M., Lowry, S.F. & Calvano, S.E. (2005). 
Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral 
blood leucocytes of human volunteers after endotoxin challenge: A comparison of flow 
cytometric light scatter and immunofluorescence gating. Clinical and Experimental 
Immunology, 141(1), pp. 99-106. 
Vojdani, A., O'Bryan, T. & Kellermann, G.H. (2008). The immunology of immediate and delayed 
hypersensitivity reaction to gluten. European Journal of Inflammation, 6(1), pp. 1-10. 
Vojdani, A. & Perlmutter, D. (2013). Differentiation between celiac disease, nonceliac gluten 
sensitivity, and their overlapping with Crohn's disease: A case series. Case Reports in 
Immunology, 2013(Article ID: 248482), pp. 1-9. 
Wong, D.M. & Crisman, M.V. (2004). Eosinophilic enterocolitis in a 4-year old miniature horse 
stallion. The Canadian Veterinary Journal, 45(1), pp. 73-75. 
Woods, L.W., Johnson, B., Hietala, S.K., Galey, F.D. & Gillen, D. (1992). Systemic 
granulomatous disease in a horse grazing pasture containing vetch (Vicia sp.). Journal of 
Veterinary Diagnostic Investigation, 4(3), pp. 356-60. 
Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., Regev, A. & Kuchroo, V.K. 
(2013). Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature, 
496(7446), pp. 513-7. 
Wylie, C.E. & Proudman, C.J. (2009). Equine grass sickness: Epidemiology, diagnosis, and 
global distribution. Veterinary Clinics of North America: Equine Practice, 25(2), pp. 381-
399. 
Xavier, R.J. & Podolsky, D.K. (2007). Unravelling the pathogenesis of inflammatory bowel 
disease. Nature, 448(7152), pp. 427-434. 
Xiao, S., Jin, H., Korn, T., Liu, S.M., Oukka, M., Lim, B. & Kuchroo, V.K. (2008). Retinoic acid 
increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing 
TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. Journal 
of Immunology, 181(4), pp. 2277-84. 
Zenewicz, L.A., Antov, A. & Flavell, R.A. (2009). CD4 T-cell differentiation and inflammatory 
bowel disease. Trends in Molecular Medicine, 15(5), pp. 199-207. 
Zipplies, J.K., Hauck, S.M., Eberhardt, C., Hirmer, S., Amann, B., Stangassinger, M., Ueffing, M. 
& Deeg, C.A. (2012). Miscellaneous vitreous-derived IgM antibodies target numerous retinal 
proteins in equine recurrent uveitis. Veterinary Ophthalmology, 15, pp. 57-64. 
Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic 
Acids Research, 31(13), pp. 3406-3415. 
Zuo, L. & Rothenberg, M.E. (2007). Gastrointestinal eosinophilia. Immunology and allergy 
clinics of North America, 27(3), pp. 443-455. 
 
 
91 
  
92 
Acknowledgements 
The studies in this thesis were supported by a grant from the Swedish-
Norwegian Foundation for Equine Research (Stiftelsen Hästforskning). The 
work was performed at the Section of Pathology and the Section of 
Immunology, Department of Biomedical Sciences and Veterinary Public 
Health (BVF), Swedish University of Agricultural Sciences (SLU), Uppsala 
and at the Section of Anatomy and Pathology, Department of Basic Sciences 
and Aquatic Medicine, Norwegian University of Life Sciences (NMBU). 
 
I am most thankful for the support, contribution and guidance from my 
supervisors:  
Ronny, you have opened my eyes to the wonderful world of gastrointestinal 
pathology. For that I am forever grateful. Our conversations have covered 
everything from pathology to arts, in locations as contrasting as the dungeon-
like abattoir to the city hall of Léon. These are fond memories that I treasure!  
Caroline, you taught me everything about veterinary immunology, literally. 
Your thoroughness in research and the writing process, as well as your keen 
interest in all aspects of immunology have motivated me. Your personal 
interest in us PhDs and honest concern for me is heart-warming. Keep on 
investigating! 
Charles, first and foremost; thanks for your hard work included in this 
thesis. All those IHCs and the manuscript corrections for “compared to” and 
“IHC staining” must have been agony! You have been an excellent host for our 
visits in Oslo and your kindness was a blessing for an alien at NVH (NMBU).  
 
I have had the most wonderful colleagues. Some people have been crucial 
for the completion of this thesis:  
93 
Bernt, you have looked over my shoulder when pipetting so often I almost 
can’t pipette without having you beside me saying ‘Oups’. You are humble, 
wise and (too) kind, which I’ve appreciated enormously.  
Lisbeth, you made me feel at home at BMC from day 1 (back in 2006). 
I’ve missed you, more than you can imagine.  
Elisabet, you’re the boss, figuratively and literally. The best one an 
employee can ever wish for. 
Agneta: the patient and warm-hearted guardian of the histology lab. You 
have always been there when we needed you – you’re golden.  
Laila and Inger, you never hesitated when I needed your guidance, 
regarding everything from IHC to finding my way in Oslo. Now I miss NVH. 
Past and present clinicians at Strömsholm and UDS equine hospitals. 
Without your great efforts this thesis would lack a huge part. You have taken 
time to discuss the project with owners, waited for me to get to location for 
sampling etc. etc. You are my heroes.  
Kia for the work involved in this thesis I’m forever grateful. You came 
through when everything looked dark – I hope I can return that favour.  
 
Vanik and Krister.  
 
Past and present staff at SLU. You’re simply the best; sorry I can’t 
mention you all by name! Coming to work has been a delight, thanks to your 
support and encouragement Thank you also for moving all my stuff during the 
big move, when I was on maternity leave – I think I timed that kid perfectly! 
Some of you need a special mention: 
Camilla, without you I’m not whole. I wish I could write in words what 
you mean to me. 
Johanna N, to share Sjöhästen with you was bliss. When you went to 
Göteborg, a peace of me went with you.   
Maria, all the laughter, highs and lows we’ve had together at Ponnyklubben 
have been life changing for me. Ett helvete i taget! 
Viktor, you’ve ruined gin for me. And I thank you for it – it was epic. 
Having you around has not only been useful but also a lot of fun.  
Sweet Emilia, you light up Ponnyklubben with your presence.   
Calle, your confidence is refreshing. I wish we could gossip more. 
Doktandrådsgänget, you taught me to never give up. The years in the 
council made me admire (and envy) you all. 
Jenny, your ambition baffles me. You’ll go far, but please never quit 
pathology. Your support, especially in the writing process, was astonishing. 
94 
Tuff och Tålmodig, det är tack vare er jag kom in på den här banan. Ni är 
roliga, empatisk och enormt duktiga. Jag önskar jag kunde bli precis som er, 
med all er värme.  
Dear Sanna, let’s save all horses from chronic diseases – yes we can!  
Oskar K, your care for people is amazing. I just wish you’d care for 
yourself. You’re worth it! 
Frida K det är du som är beundransvärd.  
Anna-Karin, you’re not only a friend, but a true inspiration. Please come 
back from Chicago! 
Present and former immunologist at UU, it was inspiring to share 
corridor with you. I miss the busy lab and all you fun and kind people. You 
taught me a lot of advanced immunology and I taught you that a farmer don’t 
wear Wellingtons all the time! 
 
Axel, my faults are your virtues, and vice versa. They say true love is 
knowing a person’s faults and loving them even more for them. I concur. 
You’re courageous and far too kind to me and Pelle. I know that you’d catch 
the moon for me. DO NOT catch the moon for me! Let go of the space suit, 
step away from the shuttle! 
Familjen Olofsson, you are my everything. All the love and support have 
given me the most solid foundation anyone can stand on! Tack för att ni lät mig 
släpa hem alla dessa djur genom åren! Jag vet att ni inte var enorma 
entusiaster, men tack vare era stora hjärtan visste ni att det var viktigt för mig. 
Utan er hade väldigt lite i mitt liv varit möjligt. 
Nougat hoppas hundhimlen innehåller många julkorvar.  
Ellinor, Jonas and Markus, if I had all the money in the world (and the 
skills) I’d build a teleporter so I could be with you every day. I miss you so 
much it hurts.  
Familjen Sannö, I honestly feel like a part of the family and that your 
homes are my homes. Having you in my life rewards me with so much joy 
(and properties ☺)! I wish we would see each other more often. 
Pelle, I’m still your mother, even if you haven’t seen me lately. The day 
you get kids you’ll understand how much I love you: I love you to the moon 
and back. Axel, let go of the moon! 
 
Family and friends, it was obvious to dedicate this thesis to you all! It 
takes one person to defend a thesis, and an army of friends and family to 
survive a PhD!   
 
To all those I’ve forgotten; my sincere apologies.  
95 
